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INTRODUCTION 
 
Siddha Medicine is the oldest and the foremost all other medical systems of the 
world. The word  Siddha  comes  from  the word  “Siddhi”.  Which  means  on object  to 
attain  perfection or heavenly bliss. There were 18 important  siddhars  in olden  days  and 
they  developed  this  system  of medicine. Hence it is called Siddha medicine.   
 
 The Siddha system of medicine is well founded on the basic principles like “96 
thatvas”,   “Pancha  bootha  theory” and   “Three  humors”  after  a  careful  and 
thorough  study of  the system  and  mother  nature. 
 
According to siddha medical  science  the  universe consists of 5 elements, Earth, 
Water, Fire, Air and Ether which corresponds to the five sense of the human body.  Man 
consumes water and food, breathes the air and thus maintain the heat in the body.  He is alive 
because of the life force given by ether.   
 
A suitable proportion of these five elements in combination with each other produce a 
healthy person. 
 
In siddha system of medicine the three humors namely, Vatha, Pitha and Kapha are 
essential constituents of the living body which are responsible for regulating all the body 
functions the normal order of Vatha, Pitha, Kapha is in the proportion of 1: ½ : ¼ 
respectively. 
 
In healthy persons, the three humours maintain proper functioning of all organs and 
tissues depending upon individual needs.  Siddha system of medicine lays great emphasis on  
early changes caused by disturbances of doshas in the whole body, as a result of excessive 
turn over of these substances and it is at these stages that one can prevent the development of 
disease in a full fledged manner. 
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One of these diseases, which is caused due to the derangement of these humors is 
Vellai noi.  Vellai noi is a common disease for female among all social status which is a 
headache to them.  All females of reproductive age groups are prone to Leucorrhoea, some 
time or the other. 
 
“NtH ghU> jio ghU> kpQ;rpdf;fhy; 
nky;y> nky;y gw;g nre;J}uk; ghNu" 
   
As per above words, in siddha system administration of herbs & herbal  formulations 
may be the preferative  choice for any disease. Depending upon the virulence of the disease 
only, potent minerals and metals should be tried. 
 
Because of the ready availability of the medicinal herbs, their low cost of production 
and less toxic action compared to those of the synthetic compound, the World health 
organisation has been advocating the use of traditional remedies.  So the world has now 
turned to herbal therapies. 
 
According to Siddha literature Vellai noi is a condition due to the vitiated azhal 
humour. The pathology of Vellai noi was described in Siddha literature as follows, the 
derangement of  azhal humor results in diminished urine output, accumulation of waste 
products in blood and debilitation of the patient. 
 
As per mentioned in the mooligai text that ‘Vila’  neutralises the three doshas. Also it 
is mentioned as follows, 
 
‘ey;y tpshk;gprpid ew;ghfQ; nra;jUe;jj; 
njhy;iyajp rhue; njhiytnjhd;Nwh - nky;ypauhy; 
te;j nts;is jd;DlNd khjH ngUk;ghLk; 
ce;JePH Nghf;Fkhk; cd;’ 
 
 Thus “Vilampisin” neutralises the vitiated azhal humor which is the main cause for 
the “Vellai noi”.  Hence the author has selected Vilampisin for the management of Vellainoi 
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AIM AND OBJECTIVES 
 
Aim 
 
 To evaluate the efficacy of Vilampisin chooranam (Powder of Limonia acidissma 
gum) in the management of Vellai noi (Leucorrhoea) 
 
Objective: 
 
 The clinical efficacy of Vilampisin chooranam has been evaluated in the following 
aspects. 
 
 Collection of evidences in Siddha aspects. 
 Collection of evidences in Botanical aspects 
 Bio Chemical analysis. 
 Physical properties 
 Preliminary phytochemical  screening of plant constituents. 
 Pharmacological study. 
 Open clinical trial on Vellai noi given orally. 
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REVIEW OF LITERATURE 
GUNAPADAM ASPECT  
(tpshk;gprpd;) 
Gum of Limonia acidissima.Linn 
NtWngaHfs; 
 fbg;gif> fgpj;jk;> tpsT> nts;spy;. 
Vernacular names: 
           Tam : Vilankay maram (tpshq;fha; kuk;) 
 Eng  : Wood apple (tree), Elephant apple , curd  fruit, monkey fruit 
 Tel : Velaga 
 Mal : Vilav 
 Kan : Baelada 
 Hindi : Kavitha, Dharkanth, Kaveet  
 Sans : Kapitha 
 Beng : Kath. bel 
  
,k;kuk; ,e;jpah Kw;wpYk; gapuhFk;.  ,jd; goj;jpw;fhfNt ,J tPLfis 
mLj;j Njhl;lq;fspYk; itj;J tsHf;fg;gLfpwJ.  ,J tdNjtijapd; ngauhd 
‘Feronia” itNa tpQ;Qhd ngauhff; nfhz;Ls;sJ. 
 
   gad;gLk; cWg;G: 
 ,iy, fha;> gok;> goj;jpd; XL , gl;il> gprpd; 
      ,iy 
Rit  : JtHg;G> tpWtpWg;G 
 jd;ik : ntg;gk; 
 gphpT  : fhHg;G 
 nra;if :  kz%l;b> mfl;Ltha;mfw;wp, JtHg;gp 
 
   fha; 
 Rit  : JtHg;G 
 jd;ik : jl;gk; 
 gphpT  : ,dpg;G 
 nra;if : JtHg;gp 
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gok; 
 
 Rit  : ,dpg;G 
 jd;ik : jl;gk; 
 gphpT  : ,dpg;G 
 nra;if : kz%l;b 
    FspHr;rpAz;lhf;fp 
   gprpd;: 
 nra;if : cs;soyhw;wp 
  
  
   Fzk; : 
,iy:   grp cz;lhFk;> mfl;L thA ePq;Fk; 
kug;gl;il: 
 ,jdhy; ,Uky;> ,iug;G> Ritapd;ik, ePHNtl;if> fz;lthW gpjw;Wfpd;w 
ntwpNeha; ,itfs; NghFk;. 
tpsh: 
 kd;dd; Kjy;%tH khWgh by;yhk 
 Yd;d epidj;j JjTjyhw; - gd;dpr; 
 nrgpj;j Tlyhz;ik NrHtpj; jplyhw; 
 fgpj;jktpo; jf;fw;g fk; 
     (Njud; ntz;gh) 
 tpsh> tsp Kjypa %d;iwAk; jd;dpiyg;gLj;jp clyhz;ikiaj; 
jUkhjyhy; ,/J xU fw;gtifahk;. 
tpsh: 
 fgpj;jkh fpatpshf; fdpKjw; fhAz 
 tgj;jkhk; gapj;jpa tue;ijnag; gbANk 
                         (Njud; fhg;gpak;) 
nghUs;                         
tpshq;fha;> tpshk;gok; ,tw;iwg; Grpj;Jthpd; moy; Neha;fs; ahTk; ngha;aha; 
xope;JNghk;. 
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tpsh: 
 nts;spapiy ahf;f Kjy; Ntz;bdtHf;nfg;NghJk; 
 nts;spapiy ahf;ftU Nky; 
 nghUs;: 
 tpsh kuj;jpd; NtH> ,iy> fha;> fdp Kjypatw;iw KiwNa fw;g 
Kiwahff; nfhz;L te;jhy;> Neha; mZfhJ.  ePz;l fhyk; thoyhk;. 
fha; - fopr;ry;NghFk; 
gok;: 
 ,/J <is> ,Uky;> Nfhio> ntg;gj;jhYz;lhd ePHNtl;if ,itfisg; 
Nghf;Fk;. md;wpAk; grpia cz;lhf;Fk;.  clw;F ed;ik nra;Ak;. 
gprpd;: 
 J}a;ikg;gLj;jpa tpshk;gprpidg; nghbj;J> khj;jpiu Kjypa kUe;Jfs; nra;J 
cz;lhy;> ePbj;j fopr;ry; nts;is ngUk;ghL> ePhpopT Mfpa ,it ePq;Fk;. 
 
 ey;y tpshk;gprpid ew;ghfQ; nra;jUe;jj; 
 njhy;iyajp rhue; njhiytnjhd;Nwh – nky;ypauhy; 
 te;j nts;is jd;DlNd khjH ngUk;ghLk; 
 ce;JePHg; Nghf;Fkhk; cd;. 
tof;F: 
 nfhOe;jpiy urj;ijg; ghYldhtJ> japUldhtJ NrHj;J> 
fw;fz;Lg;nghb fye;J cl;nfhs;s> moy; Neha;fs; jPUk;. 
 nfhOe;ijf; FbePhpl;Lf; nfhLf;f> tapw;wpy; thA jq;fp cz;lhFk; 
NfhshWfs; ePq;fpg; grp cz;lhFk;. 
 nfhOe;jpd; urj;ij NkYf;Fj; jlt> nfhg;Gsq;fs;> Nfhilf; 
fhyj;jpYz;lhFk; tpaHitf;FU ePq;Fk;. 
 fhia XL ePf;fpj; jdpj;NjDk;> tpy;tg;goj;NjhL NrHj;NjDk; fopr;ry; 
cs;stHfSf;Ff; nfhLf;f> ed;ik cz;lhFk;. 
 fhiag; gr;rb nra;J rhg;gpLtJ ,e;jpaHfspd; tof;fk;.  ,jdhy; 
tha;g;Gz;> cs;soiy khWk;. 
 goj;jpd; Xl;il ePf;fpg; goj;ij khj;jpuk; rhg;gpl tha;ePH Cwj; 
njhz;ilg;Gz;> gy;yPw;Wg;Gz;fs Nghk;.  grpj;jP cz;lhFk;. 
 gorr;ijAld; jpg;gpypr; R+uzq; $l;b> Nky;%r;R> tpf;fy; ,itfSf;Ff; 
nfhLf;fyhk;. 
 ,ijg; ghz;L> fhkhiy> Nrhig Mfpa Neha;fSf;Fr; nra;Ak; 
,Nyfpaq;fspw; NrHf;fyhk;. (Nghfu; 7000) 
 ,g;goj;jpd; kzg;ghF> jP (gpj;j) Neha;fis Nghf;Fk;. 
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tpshNtHf; FbePH 
 tpshNtH> MthiuNtH> g+yhNtH> ,ytq;fk;> fhl;L ky;ypNtH ,tw;iw xNu 
mstpy; vLj;J vUik Nkhhpy; Ntfitj;;J japhpy; fye;J mUe;j kpFe;j 
ePhpopT jPUk;. 
 Xl;Lld; goj;ij miuj;J mjpy; rpwpJk; Nrjg;glhky; nfhLj;J tu ,LkUe;J 
KwpAk;. 
 xU Jz;L gprpid thapypl;L mlf;fp mjdpd;W cz;lhFk; ,urj;ij 
tpOq;fpf; nfhz;bUe;jhy;> twl;bUky;> neQ;nrhpT ePq;Fk;. (my;yJ) gprpd; 
gq;F 4 vLj;J 60 gq;F ePhpy; NrHj;J mbf;fb fyf;fpf; nfhz;L te;J gprpd; 
ed;wha; fiue;J ePhpw; NrHe;j gpwF rPiyapy; tbfl;b 17-60 fpuhk; tPjk; jpdk; 
2> 3 Kiw nfhLf;f Nkw;fz;l Neha;fs; jPUk;. 
 gprpid nghb nra;J Njd; (m) vUikj; japhpy; fye;J nfhLf;f rPjf;fopr;ry;> 
nrhpahf; fopr;ry; ePq;Fk;. 
 tpshk; gprpd; xl;L vUitf;F Gz;fs; MWk;. 
 tpshk;gprpd; khj;jpiuf;F ePHNtl;if> nts;is> cl;fha;r;ry; ePq;Fk;. 
 Njw;whd; tpij> fLf;fha;> rptg;G Mthiu tpij> tpshk;gprpd; Mfpa 
,e;ehd;ifAk; gq;Ff;F fhy; gykha; vLj;J> gRtpd; Nkhhpy; nfhs;s nghq;fp 
tUk; ePhpopT NghFk;.  
 
tpshk;gprpd; NrUk; kUe;Jfs;:2 
1.  kfh Mthuk; gl;il ,Nyfpak;: 
 Mthuk; NtHg;gl;il gyk; 40 (1400fpuhk;)> mj;jpg;gl;il> ehty;;gl;il tiff;F 
gyk; 20 (700fpuhk;)> ,bj;J 60(120yp;) gb [yj;jpypl;L vl;by; xd;whf fha;r;rpd 
frhaj;Jld; njd;dq;FWk;ig gyk; 40 (1400fpuhk;)> ePHg;g+yhNtH gyk; gyk; 20 
(700fpuhk;)> mbj;J 40 (800yp;) gb [yj;jpypl;L fha;r;rp vl;by; xd;whf tw;witj;J 
NrHj;J mj;Jld; ,Q;rpr;rhW gb ½  (1yp), KRKRf;ifr;rhW gb 1 (2yp), rPdp gyk; 10 
(350fpuhk;)> NrHj;J ghF nra;J mjpy; rPufk;> kpsF. mjpkJuk;> Jj;jpNtH> tiff;F 
gyk; 2 (70fpuhk;)> nrq;fOePHf;fpoq;F> jhkiuf;fpoq;F fpuhk;G> rhjpf;fha;> rhjpg;gj;jphp> 
rpWfPiu NtH> gryp NtH> Vyk;, ney;ypg; gUg;G tiff;F gyk; 1 (35fpuhk;)> Mthiu 
mhprp gyk; 4 (140fpuhk;)> nts;Ntyk;gprpd;> tpshk;gprpd;> Ntg;gk;gprpd;> nts;Ntyk;NtH> 
tpyhkpr;RNtH> mWfq;fpoq;F> tiff;F gyk; ½ (17.5fpuhk;)> jpg;gpyp gyk; 5 (175fpuhk;)> 
cyHj;jp R+uzpj;Jg; Nghl;L md;wpAk;> Mthiuf; nfhOe;J gyk; 2 (70fpuhk;)>  
Mthiug;g+ gyk; 4 (140fpuhk;)> miuj;J NrHj;J gpwF nea; gb 4 (8yp)> Njd; gb ½ 
(1yp) > tpl;L fpz;b Nyfpakhf;fp nfhs;sTk;. 
 msT: fhiy> khiy ney;ypf;fha; msT  
 ehssT : 48ehs; 
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jPUk; Neha;fs; : rfy ePhpopT> ePH vhpT> ngUk;ghL> fphpr;ruk;> Nkffhq;if> 
ntl;il> nts;is tpOjy; FzkhFk;. 
  
2.  Mthiu nea; :³ 
 MthiuNtHg;gl;il> njd;dq; FUk;ig tiff;F 20 gyk; (700fpuhk;)>  
ehtw;gl;il mj;jpg;gl;il> ePHg;g+yhNtH tiff;F 10 gyk; (350fpuhk;)> ,tw;iw ,bj;J 
20 gb (40yp), jz;zPhpy; Nghl;L vl;by; xd;wha; tw;witj;J tbj;j FbePhpy; gRtpd; 
nea; 2 gb (4yp), ,Q;rpr;rhW fhy; gb (1/2yp), KRKRf;ifr;rhW miug;gb (1yp) tpl;L 
mjpkJuk;> ew;rPufk;> kpsF, Jj;jpNtH> gok;ghrpNtH> ehfty;ypNtH tiff;F 1 gyk;: 
(35fpuhk;) nrq;fOePHf;fpoq;F> jhkiuf;fpoq;F> fpuhk;G> rhjpf;fha;> rhjpg;gj;jphp> 
rpWfPiuNtH> grypNtH> ney;yptw;wy;> Vyk; tiff;F miug; gyk; (17.5fpuhk;), 
Htqbr<ogim<jm! Okiz<?! Nuijv! niqsq?! uvh<H,zig<ogiPf<K! ujgg<G! 3! hzl<! )81!
gqvil<*?! fUNtyk;gprpd;> tpshk;gprpd;> khk;gprpd;> ntl;bNtH> tpyhkpr;rk;NtH> 
mWfd;fpoq;F tiff;F fhy; gyk; (8.75fpuhk;;) ,tw;iw miuj;Jg; Nghl;Lf; fha;r;rp 
nea;ia tbj;J Mw;wp fhw;gyk; (8.75fpuhk;;), jpg;gpypg; nghbAk; ,uz;L gyk; (70 
fpuhk;) rHf;fiuAk; fhy;gb(1/2yp),  Njd; NrHj;J Ntis xd;Wf;F xU fuz;b tPjk; 
rhg;gpl;LtuTk;  
jPUk; Neha;fs; : rfyNkfk;> ePhpopT> vhpT> milg;G> tplha;> ePHr;RUf;F 
(%j;jpuf;fphpr;ruk;)> vYk;GUf;fp> ngUk;ghL> njhlHfopr;ry; Mfpa Neha;fs; jPUk;. 
 
3.  [k;GfpUjk;:¹º 
 ruf;F - ,Ugj;ije;J gyk; ehtw;gl;iliar; rpW Jz;Lfshf eWf;fpg; 
gQ;RNghypbj;J> 4 gb (8yp) [yk; tpl;L> miug;gbahfr; Rz;lf;fha;r;rp tbj;j 
frhak;> Vyk;> ,ytq;fg;gl;il> fw;flfrpq;fp> fhl;lhj;jpg;;g+> fha;r;Rf;fl;b> kukQ;rs;> 
rPufk;> rpWehfg;g+> mjpkJuk;> Nfh]<lk;> tpshk;gprpd; ,itfspd; R+uzk; tiff;F 
gyk; ½ (17.5fpuhk;)> mgpdp gyk; ¼ (8.75fpuhk;) 
   nra;Kiw: 
 ,q;F $wg;gl;l fw;fq;fisf; frhaj;jhy; nefpo miuj;J> kpFjpAs;s 
f]haj;jhy; fiuj;J mjDld; gRtpd; nea; ½ gb (1yp) NrHj;Jg; gjKwf; fha;r;rpf; 
nfhs;f. 
 msT : Ntisf;F ½ my;yJ 1 fuz;b (2- 4 kp.yp)  fhiy> khiy 
fw;fj;Jld; cl;nfhz;LtuTk;. 
 jPUk; Neha;fs;: ngUk;ghL> vYk;GUf;fp> kJNkfk;> ePhpopT Kjypad Fzg;gLk;. 
gj;jpak; : ,r;rhgj;jpak;. 
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5. <isfhrj;jpw;F R+uzk;:9 
 
  ruf;F: 
gwq;fpr;rf;if   gyk;    3 (105fpuhk;) Fg;igNkdp 
,iyr; R+uzk;  
gyk; 2 (70fpuhk;) 
rpWehfg;g+ gyk;    6 (210fpuhk;) Nfhl;lk; gyk; 1 (35fpuhk;) 
fpuhk;G  gyk;    1 (35fpuhk;) [hjpgj;jphp  gyk; 1 (35fpuhk;) 
[hjpf;fha; gyk;    1 (35fpuhk;) fpuhk;G gyk; 1 (35fpuhk;) 
jhd;wpf;fha;j;Njhy; gyk;    1 (35fpuhk;) tpshk;gprpd; gyk; 1 (35fpuhk;) 
gw;glhfk; gyk;    1 (35fpuhk;) G+z;L gyk; 1 (35fpuhk;) 
trk;G gyk;    1 (35fpuhk;) Xkk; gyk; 1 (35fpuhk;) 
NfhNuhrid gyk;         ½  (17.5fpuhk;) 
 
   
nra;ghfk; : 
 ,itfis nay;yhk; ,bj;Jg; gPq;fhd; jl;Lfspy; Nghl;Lg; gug;gp utpapy; 
itj;J ed;wha; cyHj;jTk;.  kPz;Lk; fha;e;j gjj;jpy; ,bj;Jr; R+uzk; nra;J 
itj;Jf; nfhs;f. 
 
gpuNahfk;: 
 Ntisf;F jphpfbg; gpukhzk;. fhiy> khiy  
 
ehssT : 48ehs; 
 
jPUk; tpahjp: 
 <is> fhrk;> ,Uky;> Kjypait jPUk;. 
 
gj;jpak;: 
 gpzpf;Nfw;wthW Gspiaj; js;spAk; NrHj;Jk; ,r;rhgj;jpak; Nfhly; eyk;. 
 
tpshk;gprpd; NrUk; gpwkUe;Jfs;: 
5. CHf;FUtp ,sfk; 7 
6. nfsrp ,Nyfpak; 11 
7. kjd fhNkRu Fspif 3 
8. gpj;jj;jhYz;lhd Njf vhpr;rYf;F fpahok; 9 
9. je;jNuhf ehrpdp2 
10. Ngjpkhj;jpiu2 
11. Jw;ghjp tlfk;12 
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12. [k;g+fhjp fpUjk;12 
13. kjd fhNkRu Fspif13 
14. mjptplaf; FbePH14 
15. rfLf;F nea; 14 
16. rhjp ,ypq;f khj;jpiu15 
17. Ezhf;fha; fLF15 
18. rhjpg;gj;jphp cUz;il15 
19. NghPr;rk; ,Nyfpak; 16 
20. rhykphprp ,Nyfpak; 16 
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BOTANICAL  ASPECTS 
 
SCIENTIFIC CLASSIFICATION OF LIMONIA ACIDISSIMA ,  LINN 
 
Kingdom - Plantae 
  Division - Mangnoliophyta 
  Class  - Magnoliopsida 
  Order  - Sapindales 
  Family  - Rutaceae 
  Genus  - Limonia 
  Species - L.acidissima 
  Binomial Name - Limonia acidissima 
 
LIMONIA ACIDISSIMA, LINN 
Synonyms: 
F . elephantum 
 F . limonia 
Vernacular Names 
 Eng  - Elephant apple 
 Tam  - Vilanga 
 Malayalam - Vila 
 Hind  - Kavitha 
 Sans  - Kapitha 
 Tel  - Velaga 
 Kan  - Bela 
 Guj  - Kavit 
 Beng  - Kait 
 Mar  - Kavatha 
 Fren  - Citron des mois 
 Arab  - Kabit 
. 
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Habit: 17 
 A small deciduous tree with short, erect, cylindrical stem, 30 – 40 feet high and 2 – 4 
feet in girth bearing throny branches, Leaves pinnate, 3- 4 inches  long with small ovate or 
obovate leaflets; flowers polygamous in lax panicles; fruit large, globose or oblate 1.0 – 2.5 
inches in diameter  with hard, rough woody pericarp; seeds numerous, small compressed, 
embedded in a sweetish aromatic edible pulp. 
 
Feronia gum:17 
 From the trunk and branches of the tree exceeds a gum resembling gum Arabic in 
properties.  The exudation is profuse after the rainy season.  It is considered to be a good  
substitute for gum Arabic and commercial  samples of the latter often contain feronia gum in 
admixture. 
 
Habitat:17 
 The plant is a native of India and Cylon and is found throughout the plains of India, 
particularly in dry situations. It occurs, wild or cultivated, up to an elevation of 1,500 ft in 
western Himalayas. It is more common in the Deccan, Thana district of Bombay and  
S.chanda district of Madhya Pradesh.  It is also reported to occur in parts of Hazaribagh and  
palamau in Chota Nagpur.  It is often cultivated on borders of fields and as a roadside tree 
near villages and is sometimes planted in orchards. 
 
Parts Used:20 
 Bark, Leaves, fruits, gum. 
 
Chemical Constituents:19,22,17 
 Fruits and seeds contains oil, protein, Vitamin, C, Fruit shell contains 2, 6 – 
dimethoxybenzoquinone and osthenol. 
 Analysis  of the edible part of the fruit (55 – 58%) gave the following values moisture 
– 1.9; Protein – 7.3:  ether extract – 0.6: mineral matter – 1.9%, fibre – 5.2: Carbohydrate – 
15.5: calcium – 0.13: Phosphorus – 0.11%;  Iron – 0.6 mg / 100 mg; riboflavin – 170 ug / 
100g; Vitamin  C –2.0 mg/ 100gm.Wood apple is rich in mineral constituents especially 
Calcium and Phosphorus. 
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 The acid content of the pulp various from 7.6% in unripe fruits to 2-3% in fully ripe 
ones.  It contains 3 – 5% pectin and forms an excellent material for making jelly. 
 The seed oil contains linoleic, linolenic, oleic, palmitic, lupeol, B- sitosterol, 
sigmasterol. 
 The leaves contains psoralen, saponarin, vitexin ,tannin and Xanthotoxin.  On steam 
distillation they yield  0.73% of an essential oil.  The Chief constitutent is estragol methyl 
chavicol, thymol and p-cymen – 7-01 . 
 The bark contains feronolide, feronone, limonoids,  alkaloids, quinolones, N(b) – 
methyltry.  ptamine and amides. 
 The Heart wood contains 7-0 methylporiol – 4-β-D- Xylo – pyronosyl – D – 
glucopyranoside and ursolic acid. 
 The gum contains 12-17% water and 4-5% ash.  On hydrolysis it yields 35.5% 
pentoses (arabinose and xylose), 42.7% d- galactose traces of rhamnose and glucuronic acid.  
By the graded hydrolysis of the gum an aldobiouronic acid (3-(glucuronopyranosyl) – d- 
galactopyranose) has been separated.17. 
 
Physical Properties:17 
 Limonia gum occurs in irregular, semi-transparent tears varying in colour from 
reddish brown to pale yellow or colourless. The gum dissolves in water forming a tasteless 
mucilage, more viscous than that of gum Arabic made in the same proportion and not in 
ferior to it in adhesive properties. 
 
Biological activities:19 
 Feronolide – potent depressor of blood pressure and stimulant of gut.  It had potent 
parasympathonimetic properties.  Ferononoe showed depressant action of frog heart. 
 
Antimicrobial activities:  19,23 
 The essential oil from the leaves of Feronia limonia (L), rich in methyl chavicol, has 
been studied for its antibacterial and antifungal activity against ten bacteria and ten 
fungi using filter paper disc agar diffusion technique.  The oil exhibited strong to 
moderate activitiy against most of the test  organisms.  Bacillus subtilis, E-scherchia 
coli, Proteus vulgaris, Pseudomonas aeruginosa, shigella sp, Aspergillus niger, 
Rhizopus nodosus, Trichophyton rubrum 5S  and Trichoderma viride had remarkable 
susceptibility to the oil. 
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 The stem bark of Feronia Limonia yielded (-) – (@S) – 5,3’ –dihydroxy – 4’ – 
methoxy – 6”, 6” – dimethyl chromena – (7,8,2”, 3”) flavanone along with several 
known compounds including an alkaloid five cocumarins, a flavanone, a lignan, three 
sterols and triterpene. The structures of these compounds were determind by 
spectroscopic methods, mainly 1D and 2D NMR. The antimicrobial screening of 
compound by a microdilution technique resulted in MICs in the range 25-100 mg/ ml 
 Anti fungal agents psoralen from stem bark Xanthotoxin and osthenol from root bark 
and 2,6 – dimethoxybenzoquinone from fruit shell. 
 
Actions 18,20,22 
 Stimulant 
 Stomachic 
 Astringent 
 Carminative 
 Demulcent 
 Antiscorbutic. 
 Constipating 
 Diuretic. 
 
Uses:18,20,22,23  
 Pulp of the ripe fruits, tastes like  cogulated milk and is eaten with sugar, it is useful 
in salivation, sore throat and other affections of the gums and throat. 
 Pulp with honey and pipali is given for hiccup and difficulty of breathing Pulp is 
externally applied to bring relief from bites of venomus insects and  reptiles. 
 The unripe fruit vernouses itching of the body.  It is also used for diarrhoea, 
dysentery, vomiting, tumour, Leucorrhoea, wounds and ulcers and vitiated condition 
of vata and pitta.  Womens  with excessive vaginal discharge should eat the ripe fruit. 
 The leaves are prescribed in the indigestions and slight bowel affections of the 
children. 
 The bark is occasionally prescribed for biliousness. 
 Transparent gummy substance exceeding from the stem when cut or broken 
resembling gum arabic, may be used in bowel affections and to relieve tenesmus; 
reduced to powder and mixed  with honey it is given in dysentery and diarrhoea. 
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Classical uses:21 
 
 Charaka and sushruta included the leaves and fruits of kapitta in prescription for 
diarrhoea, toxicosis, urinary disorders, ringworm and other chronic skin diseases. 
 Charaka prescribed the soup of kapitta and Bilva (Aegle marmelos) in piles: the juice, 
mixed with pipali (Piper longum) and honey in hiccough. 
 Kapithaashtaka churnam (sahasrayoga) shaarangadhara samhita) is prescribed in 
diarrhoea, dysentery, internal abcesses and piles. 
 Tender leaves of 5 trees – Feronia limonia Mangifera indica, Syzygium cuminii, 
Aegle marmelos and citrus medica – are known as the pancha pallava group and are 
used as vaginal disinfectants due to their astringent, antimicrobial and anti – 
inflammatory properties. 
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MATERIALS AND METHODS 
  
To evaluate the efficacy, Anti – microbial activity of  Vilampisin Chooranam in the 
management of “Vellai noi” (Leucorrhoea). 
 
Collection of the Drug: 
 The drug Vilampisin was collected from the indigenous raw drug stores, Tirunelveli 
and it was identified by the botanist of National Institute of Siddha, Chennai. 
 
Purification of the raw drug: 
 The drug was cleaned well by removing the waste materials and bark pieces which 
adhered with it and boiled by steam (Pittavial method and dried) 
 
Preparation of Chooranam: 
The purified gum was fried in ghee and ground well and sieved by sieving cloth. 
 
Storage of Chooranam: 
 The fine  powder was stored in a clean and dry airtight container. Life span of 
choornam is 3 months from the date of preparation.  It was used within that period. 
 
Intended therapeutic dose: 
 1 gm two times a day with milk. 
 
 Route of administration :Enteral    
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VILAM PISIN 
BEFORE   PURIFICATION  
 
 
 
  
PURIFIED VILAM PISIN CHOORNAM 
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BIO CHEMICAL ANALYSIS 
CHEMICAL ANALYSIS OF VILAMPISIN CHOORANAM 
Sl. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample Coarse fine powder  
2. Solubility: 
     a.  A little of the sample is 
shaken well with distilled water 
      b.  A little of the sample is 
shaken well with con Hcl / con 
H2So4 
 
Sparingly soluble 
 
InSoluble in Con – 
Hcl / Con H2So4 
Insoluble 
3. Action Of Heat: 
     A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
strongly 
 
No White fumes 
evolved 
 
No brown fumes 
 
Absence of Carbonate 
 
Absence of Nitrate 
4. Flame Test: 
     A small amount of the sample 
is made in to a paste with con. Hcl 
in a watch glass and introduced 
into non-luminous part of the 
Bunsen flame 
 
Red Colour appear 
 
Presence of Calcium 
5. Ash Test: 
     A filter paper is soaked into a 
mixture of sample and add cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited 
 
No Yellow Colour 
flame 
 
Absence of sodium 
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PREPARATION OF EXTRACT: 
 5 gm of Vilampisin chooranam is weighed accurately and placed in a 250 ml clean 
beaker and added with 50ml of distilled water. Then it is boiled well for about 10 minutes.  
Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml with 
distilled water. 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
I Test For Acid Radicals   
1. Test For Sulphate: 
2 ml of the above prepared extract is taken in 
a test tube, to this, add 2ml of 4% ammonium 
oxalate solution 
2 ml of the above prepared extract is added 
with 2ml of dil, Hcl is added until the 
effervescence ceases off. Then 2ml of Barium 
chloride solution is added 
 
Cloudy appearance 
Present 
 
Presence of sulphate. 
 
 
 
 
Sulphate is confirmed 
2. Test For Chloride: 
     2 ml of the above prepared extract is added 
with dil. HNo3 till the effervescence ceases.  
Then 2ml of silver nitrate solution is added 
 
No cloudy 
appearance Present 
 
Absence of chloride 
3. Test For Phosphate: 
     2 ml of the extract is treated with 2ml of 
ammonium molybdate solution and 2ml of 
Con. HNO3 
 
No cloudy yellow 
appearance 
 
Absence of phosphate 
4. Test For Carbonate: 
    2 ml of the extract is treated with 2ml of 
magnesium sulphate solution 
No Cloudy 
appearance 
Absence of Carbonate 
5. Test For Nitrite: 
    1 gm of the substance is heated with copper 
turning and concentrated H2So4 and viewed 
the test tube vertically down 
 
No characteristic 
changes 
 
Absence of Nitrate 
6. Test For Sulphide: 
     1 gm of the substance is treated with 2 ml 
of Con. Hcl 
 
No Rotten egg 
smelling gas evolved 
 
Absence of sulphide` 
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7. Test For Fluoride & Oxalate: 
     2ml of extract is added with 2ml of dil 
acetic acid and 2ml of calcium chloride 
solution and heated 
 
No cloudy 
appearance 
 
Absence of fluoride 
and oxalate 
8. Test For Nitrite: 
     3 drops of the extract is placed on a filter 
paper, on that 2 drops of acetic acid and 2 
drops of benzidine solution is placed. 
 
No Characteristic 
changes 
 
Absence of Nitrite 
9. Test For Borate: 
     2 pinches of the substance is made into paste 
by using sulphuric acid and alcohol (95%) and  
introduced into the blue flame 
 
Bluish green colour 
flame appeared 
 
Presence of Borate 
II Test For Basic Radicals   
1. Test For Lead 
     2 ml of the extract is added with 2ml of 
potassium iodide solution 
 
No yellow precipitate 
 
Absence of lead 
2. Test For Copper 
One pinch of substance is made in to paste 
with con. Hcl in a watch glass and 
introduced into the non – luminous 
part of the bunsen flame. 
2 ml of extract is added with excess of 
ammonia solution 
 
No Blue flame 
 
 
 
No Blue colour 
precipitate formed 
 
Absence of copper 
 
 
 
Absence of copper 
3. Test For Aluminium: 
     To the 2ml of the extract sodium 
hydroxide is added in drops to excess 
 
No characteristic 
changes 
 
Absence of aluminium 
4. Test For Iron. 
To the 2ml of extract add 2 ml of 
ammonium thiocyanate solution. 
To the 2ml of extract add 2ml ammonium 
thiocynate solution and 2ml of con 
HNo3 is added 
 
 
No mild red colour 
appear 
No Blood red colour 
appear 
 
Absence of Iron 
 
Absence of Iron 
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5. Test For Zinc 
          To 2ml of the extract sodium hydroxide 
solution is added in drops to excess      
 
No white precipitate 
is formed 
 
Absence of Zinc 
6. Test For Calcium 
 
         2ml of the extract is added with 2ml of 
4% ammonium oxalate solution 
 
Cloudy appearance 
white precipitate is 
obtained 
 
Presence of Calcium 
7. Test For Magnesium 
     To 2ml of extract sodium hydroxide 
solution is added in drops to excess 
 
No White Precipitate 
is obtained 
 
Absence of Magnesium 
8 Test For Ammonium: 
     To 2ml of extract few ml of Nessler’s 
reagent and excess of sodium hydroxide 
solution are added 
 
No Brown colour 
appeared 
 
Absence of ammonium 
9. Test For Potassium: 
    A pinch of substance is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% glacial acetic 
acid 
 
No Yellowish 
precipitate is obtained 
 
Absence of Potassium 
10. Test For Sodium 
     2 Pinches of the substance is made into 
paste by using Hcl and introduced in to the 
blue flame, of Bunsen burner 
 
No Yellow colour 
flame  appeared 
 
Absence of Sodium 
11. Test For Mercury 
     2 ml of the extract is treated with 2ml of 
sodium hydroxide solution 
 
No yellow precipitate 
is obtained 
 
Absence of Mercury 
12. Test For Arsenic: 
     2ml of extract is treated with 2ml of silver 
nitrate solution 
 
No brownish red 
precipitate is obtained 
 
Absence of Arsenic 
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III.           
 
 
 
Miscellaneous: 
 
  
1. Test For Starch: 
     2 ml of extract is treated with weak Iodine 
solution 
 
No blue colour 
developed 
 
Absence of starch 
2. Test For Reducing Sugar: 
    5 ml of Benedicts qualitative solution is 
taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
changes are noted 
 
No Brick red colour 
developed 
 
Absence of Reducing 
sugar 
3. Test For The Alkaloids: 
2ml of the extract is treated with 2ml of 
potassium iodide solution. 
2ml of extract is treated with 2ml of picric 
acid. 
2ml of the extract is treated with 2ml of 
phosphotungstic acid 
 
 
No red colour 
develops 
Yellow colour 
developed 
White precipitate 
obtained 
 
 
 
 
Presence of alkaloid 
 
4. Test For Tannic Acid: 
    2 ml of extract is treated with 2ml of ferric 
chloride solution 
 
Black precipitate 
appeared 
Presence of Tannic acid
5. Test For UnsaturatedCompound: 
    To the 2ml of extract 2ml of potassium 
permanganate solution is added 
 
Potassium 
Permanganate is not 
decolourised 
 
Absence of unsaturated 
compound 
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6. 
 
Test For Amino Acid: 
      2 drops of the extract is placed on filter 
paper and dried well 
 
No Violet colour 
developed 
 
Absence of amino acids
 
 
 
7. 
 
 
 
Test for Type of Compound 
2 ml of the extract is treated with 2 ml of 
ferric chloride solution 
 
 
 
No green colour 
developed 
 
No Red colour 
developed 
 
No violet colour 
developed 
 
No Blud colour 
developed 
 
 
 
Absence of oxy quinole 
epineplhrine and phro 
catechol 
Anti pyrine, Aliphatic 
amino acids and 
meconic acid are absent
Apomorphine salicylate 
and resorcinol are 
absent 
 
Morphine, phenol 
cresol and hydro 
quinine are absent 
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PHYSICAL PROPERTIES 
Loss on Drying 
 5 Gms of materials is heated in a not oven at 1050C to constant weight.  The 
percentage of loss of weight was calculated. 
Determination of ash Value 
 Weight accurately 2-3 gms of sample in tarred platinum or silica dish and incinerate 
at a temperature not exceeding 4500C until free from carbon, cool and weight.  Calculate the 
percentage of ash with reference to the air dried drug. 
Acid Insoluble ash 
 Boil the ash for 5 minutes with 25ml of 1:1 dilute HCl< collected the insoluble matter 
in Gooch – crucible on an ash less filter paper, wash with hot water and ignitge, cool in a 
dessicator and weight.  Calculate the percentage of acid insoluble ash with reference to the 
air dried drug. 
Water soluble ash 
 To the Gooch crucible containing the total ash, and 25 ml of water and boil for 5 
minutes.  Collect the insoluble matter in a sintered glass crucible or on ash less filter paper.  
Wash with hot water and ignite in a crucible for 15 minutes at a temperature not exceeding 
4500C.  Subtract the weight of the insoluble matter from the weight of the ash; the difference 
of weight represents the water soluble ash.  Calculate the percentage of water soluble ash 
reference to the air dried drug. 
Alkalinity of Water soluble ash 
 5 Gms  converted to ash, boiled with water, filtered, Filtrate was titrated against 0.1N 
of HCl using phenolphthalein as anindicator. 
 Alkalinity of water soluble ash = X x of acid / 0.1 X W. 
 X – Titre Value 
 W – Weight of the materials taken 
 Alkalinity is given as ml of 0.1 N of HCL equal to 1 gm 
pH at 10% aqucous solution 
  5 gms of Vilampisin Chooranam is weighted accurately and placed in clear 
100ml beaker.  Then 50ml of distilled water is added to it and dissolved well.  Wait for 30 
minutes and then apply in pH meter at standard buffer solution of 4.0, 7.0 and 9.2. 
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PRELIMINARY PHYTOCHEMICAL SCREENING OF PLANT 
CONSTITUENTS 
 
PREPARATION OF THE EXTRACT: 
 Stir a small porkon of the solvent free chloroform, alcoholic and water extracts 
separately with a few drops of dilute Hcl or dilute acetic acid and filter.  The filtrate may be 
tested for various alkaloidal reagents as follows:. 
 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
1. Test For Alkaloids 
Mayer’s Reagent:  Take a pinch of 
dried extract and add 2ml of 
dilute HCL, mix and filter. To  
the filtrate add a drop of Mayer’s 
Reagent 
 
Dragon Drafts Reagent:   Take a 
pinch of extract add 2ml of 2% 
acetic acid mix thouroughly and 
filter.  To the filtrate, add a drop 
of dragon droff’s reagent. 
 
 
 
White coloured 
precipitate appeared 
 
 
 
 
Orange brown 
precipitate appeared 
 
 
Presence of 
alkaloid 
 
 
 
 
 
Presence of 
alkaloid 
2. Test For Carbohydrates: 
Molisch’s Test:    
       Dissolve small quantities of 
alcoholic and aqueous extract separately 
in 4ml of distilled water and filter.  The 
filtrate may be subjected to molisch’s 
test. 
No violet coloured 
ring 
Absence of 
carbohydrate 
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3. 
 
 
Test For Glycosides: 
    Take a pinch of air dried extract in a 
watch glass and add 2 drops of alcohol 
to dissolve the extract and add equal 
quantity of anthrone, mix thoroughly 
and dry it.  Then add one drop of con 
H2So4 with a glass rod, spread the spot 
in to a watch glass. Heat thin film of 
about 2cm diameter in the watch glass 
over the water bath 
 
 
 
dark green colour not 
developed 
 
 
 
Absence of 
Glycoside 
4 Test For Steroids: 
a.  Libbermann Burchard Test for 
Sterols: 
     Residue or 1 mg of test substance 
was dissolved in a few drops of 
chloroform 3 ml of acetic anhydride was 
added followed by drops of Con. H2So4 
b. Libbermann (or) Salkowaski Test for 
steroidal Glycosides: 
   The powder or extract in chloroform is 
treated with con. H2So4 
 
 
 
bluish green colour 
not developed 
 
 
 
red colour not 
developed 
 
 
 
Absence of 
sterols 
 
 
 
Absence of 
steroidal 
Glycosides 
5 Test For Saponin: 
Foam Test:   Dilute 1ml of alcoholic and 
aqueous extracts separately with distilled 
water to 20ml and shaken  a graduated 
cylinder for 15 mts 
 
A 1cm layer of foam 
/copius lather is 
developed 
 
Presence of 
saponin. 
6 Test  For Tannins: 
     Take a small quantity of alcoholic and 
aqueous extract separately in H20 and 
tested for presence of tannins by adding 
dilute Fecl3 solution (5%) 
 
Black colour 
precipitate is obtained 
 
Presence of 
tannins 
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7 Test For Phenolic Compounds: 
     Dilute 1ml of alcoholic and aqueous 
extract separately with distilled water and 
filter and test for the presence of phenolic 
compounds 
 
Bluish green colour is 
obtained 
 
Presence of 
phenolic 
compound 
8 Test For Proteins And Free Amino 
Acids: 
Millon’s Test:   To the filtrate of water 
extract add few drops of Millons reagent 
 
 
Reddish brown 
precipitate is obtained 
 
 
Presence of 
proteins 
9 Test For Terpenoids: 
Salkowaski Test: 
    Take a pinch of dried extract in a dry 
test tube, add a bit of tinfoil and 0.5ml of 
thionyl chloride.  Heat it gently 
 
 
Pink colour is 
developed 
 
 
Presence of 
terpenoids 
10 Test For Flavonoid: 
     The extract is added with alcohol and 
filters it. To the filtrate, pieces of 
magnesium and con. HCL is added drop 
wise and heated 
 
Magenta colour 
develops. 
 
Presence of 
flavonoid 
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ANTIMICROBIAL ACTIVITY OF VILAMPISIN CHOORANAM 
 
INTRODUCTION 
The Vilampisin chooranam has a variety of traditional uses. The drug is administered 
orally for the treatment of Leucorrhoea, dysentery and diabetes. The antibacterial activity of 
the Vila leaves on Bacillus substilis, E-scherchia coli, Proteus Vulgaris, Pseudomonas 
aeruginosa, Shigella sp, Aspergillus niger, Rhizopus nodosus, Trichophyton rubrum has been 
reported. In the present study, the antibacterial activity of the Vilampisin chooranam against 
Trichomonas vaginalis, Escherichia coli, Klebsiella species, Proteus vulgaris, Candida 
albicans and Staphylococcus aureus was carried out. The antibacterial activity of the 
alkaloids, Tannins and resins from Vilampisin chooranam was recently identified and 
reported. This present study examined the activity of the Vilampisin chooranam against some 
aerobic bacteria and a fungus. 
 
MATERIALS AND METHODS 
Test organisms 
The following microorganisms were used for the study. Standard strain of 
Trichomonas vaginalis, Staphylococcus aureus, Esherichia coli, Klebsiella pneumoniae, 
Proteus vulgaris,  Candida albicans. These micro-organisms were obtained from the 
laboratory stock of the Department of Pharmaceutical biotechnology, Vel’s college, 
Pallavaram. They were maintained on agar slants at 4oC in the refrigerator. 
 
Drugs and Microbiological Media 
Vilampisin chooranam (1mg/ml) stock solution was used. Nutrient broth and nutrient 
Agar and Sabouraud Dextrose Agar. 
 
Preparation of plates for susceptibility tests 
The agar-well diffusion method, suitably modified was adopted for the susceptibility 
studies. Inocula of the test organisms obtained were prepared by growing each pure isolate in 
nutrient broth overnight 37oC. The overnight broth culture was, subcultured in fresh nutrient 
broth and grown for 3 hours, to obtain log phase culture. This was matched with 
 34
MacFarland’s turbidity standard to give approximately 108cfu/ml. Aliquots of 0.1, 0.2, 0.3ml 
was used to seed a molten nutrient agar medium, which was cooled to 45oC to obtain  
approximately 106cfu/ml. This was poured into the sterile Petridishes and used for the 
investigations. Candida albicans was grown on sabouraud 4 % glucose agar and suspension 
in 1/4 strength Ringers solution was used to prepare the seeded Sabourand 4 % Dextrose agar 
plates. The Vilampisin chooranam stock solution was reconstituted with sterile distilled water 
and stock concentration of 1mg/ml or 100mg/ml was made. The Vilampisin chooranam was 
tested at a concentration of 25mg/ml. 10, 20, 30µl of this concentration was delivered into 
wells (4mm in diameter) bored into the already seeded nutrient agar plates. Equal volume of 
distilled water was assayed as control. The nutrient agar plates were incubated at 37 ˚  C for 24 
hours while the sabouraud agar plates were incubated on the laboratory bench. The diameters  
of zones of inhibition were measured in millimeter with a ruler and recorded. This was 
repeated three times and average diameters were recorded. 
 
Determination of Minimum Inhibitory Concentration (MIC) 
The standard agar dilution protocol with doubling dilution was used. The Vilampisin 
chooranam was incorporated into nutrient agar at concentrations of 2.5 mg/ml, to 20 mg/ml. 
A control without the test drug was also set up. 10µl each of the test organisms, previously 
diluted to give 106 cfu/ml was used to inoculate the plates. These were incubated at 37 ˚ C for 
24 hours in the first instance, and for another 24 hours, before the results were recorded after 
observing for growth. The minimum inhibitory concentrations (MICs) of the Vilampisin 
chooranam for each test microorganism were regarded as the agar plate with the lowest 
concentrations without growth. 
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 MODERN CONCEPT 
       LEUCORRHOEA  
! Leucorrhoea is a condition in which there in which is a whitish discharge from the 
vagina resulting from inflammation (or) irritation of the membrane lining the genital organs 
of the females. 
  
Classification39 
Non-infective 
Physiological excess 
Cervical cause  
vaginal cause 
Infective  
specific 
non-specific 
 
Trichomoniasis: 39  
1. One of the most commonly occurring. 
2. Itching in vulva 
3. Disease almost entirely in child bearing era. 
4. By inadequate hygiene and by sexually transmissible. 
5. By use of an infected persons bath towels or clothes. 
 
Causative Organism: 
Trichomonas Vaginalis, a protozoan. 
 
Symptoms 
 Vaginal discharge is  profuse, thin, creamy or yellowish or greenish discharge. 
 Irritant and frothy 
 Pruritis and inflammation of the vulva 
 Dysuria and frequency and a low-grade urethritis 
 Low back (or) abdominal pain 
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CLINICAL STUDY 
 
Selection of patients 
 
30 female patients were selected from the outpatient department of National Institute 
of Siddha. Chennai – 47 by present inclusion, exclusion and withdrawal criteria. 
 
CRITERIA FOR SELECTION 
INCLUSION CRITERIA 
 
-   Age 15 – 45 yrs 
-   Willing to attend the OPD once in 6 days for 24 days 
 
EXCLUSION CRITERIA 
 
-   Other specific vaginal infections 
-   Blood stained discharge 
-   Pregnancy/lactation period 
-   Diabetes 
-   Malignancy 
-  Leukemia 
 
WITHDRAWAL CRITERIA 
 
-  Any other acute illness 
- If constipation persists more than 5 days. 
 
LINE OF TREATMENT 
 
 The drug “Vilampisin Chooranam” was administered internally in a dose of 1g B.d. 
with milk after food for 24 days. 
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Diet Restrictions and Medical advice 
-  Spicy food 
-  Brinjal 
-  Bitter Guard 
-  Sesban 
-  Tamarind 
-  Only Coolant foods are advised 
 
MEDICAL ADVICE 
 
-  Advice regarding personal hygiene 
-  Avoid of synthetic garments 
-  Finger nails should be clipped short 
-  Avoid of contamination of vulva with ablution water after bowel action 
-  Avoid sexual intercourse during heavy discharge 
-  Improving general health 
-  The partners should be also enquired for infection and advice for treatment. 
 40
 
RESULTS AND OBSERVATION 
 
RESULTS OF BIO-CHEMICAL ANALYSIS 
 
The given sample contains. 
 
 Calcium 
 Sulphate 
 Borate 
 Alkaloid 
 Tannic acid   
 
RESULTS OF STANDARDISATION PARAMETERS: 
 
 Loss on drying     - 1.25% 
 Total Ash Value     - 2.59% 
 Water Soluble ash    - 82.10% 
 Alkalinity as CaCo3 in water soluble Ash - 0.33% 
 Acid Insoluble Ash               - 0.83% 
 pH at 10% aqucous solution              -  7.20% 
 
RESUTS OF PHYTOCHEMICAL SCREENING OF PLANT CONSTITUENTS 
 
 Saponin 
 Flavanoids 
 Alkaloids 
 Phenolic compounds 
 Gums and mucilages  
 Triterpenoids  
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RESULTS OF ANTI MICROBIAL ACTIVITY  
 
The results of the antibacterial activity of the Vilampisin chooranam of Standard 
strains of Trichomonas vaginalis, Staphylococcus aureus, Esherichia coli, Klebsiella 
pneumoniae, Proteus vulgaris, Candida albicans Staphylococcus aureus, The minimum 
inhibitory concentrations (MICs) of the Vilampisin chooranam against the test organisms are 
shown in Table 1. The VPC did not show any activity against Esherichia coli, Klebsiella 
pneumoniae. But the activity against Candida albicans, Trichomonas vaginalis, 
Staphylococcus aureus was found to be moderate.the activity against proteus was negligible 
(Table-1).  The MIC was 20µg /ml against both the clinical isolates of Staphylococcus 
aureus, Candida albicans, Trichomonas vaginalis; and 30µg/ml against proteus. The control 
did not produce any inhibitory activity against the organisms. The Gram negative organisms 
were not inhibited within the concentration range used in this study. The zone of inhibition 
produced by 20µg /ml of the Vilampisin chooranam was 6mm as against 7mm produced by 
30 µg/ml of test drug against the clinical isolates of Staphylococcus aureus, Candida 
albicans, Trichomonas vaginalis. The zone of inhibition produced by 20 mg/ml of the 
Vilampisin chooranam against Standard strains of proteus was much lower (4mm) when 
compared with that of the clinical isolates of other organisms. 
 
Table1: In vitro antimicrobial activity of 10, 20, 30µg /ml of the VPC. 
Organisms Mean diameter of zone of inhibition in mm 
10µg/ml 20µg/ml 30µg/ml Control 
Staphylococcus aureus 0 5 7 0 
Klebsiella pneumoniae 0 0 2 0 
Esherichia coli 0 0 2 0 
Candida albicans  0 3 5 0 
Trichomonas vaginalis 2 5 6 0 
Proteus 0 2 4 0 
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ANTIMICROBIAL ACTIVITY 
 
 
 
 
TRICHOMONAS VAGINALIS 
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ANTIMICROBIAL ACTIVITY 
 
 
 
 1.   PROTEUS VULGARIS,  
 
 2.  ESHERICHIA COLI 
 
3. STAPHYLOCOCCUS AUREUS 
 
4. CANDIDA ALBICANS 
 
5. KLEBSIELLA PNEUMONIA 
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RESULTS OF CLINICAL ASSESMENT: 
        For the clinical study of Vilampisin chooranam in Vellai noi, 30 Patients were 
selected.   
 
AGE WISE DISTRIBUTION:  
 
 
 
1
3.33 4
13.33 13
43.33
4
13.33
8
26.67
0
5
10
15
20
25
30
35
40
45
15-20 21-25 26-30 31-35 36-40
AGE DISTRIBUTION
NO OF PATIENTS IN PERCENTAGE
 
 
 
       According to age wise distribution 3.33% were in 15-20 years, 13.33% were in 21-25 
years, 43.33% were in 26-30 years, 13.33% were in 31-35 years, 26.67% were in 36-40 
years. 
 
 
 
 
 
 
S.NO AGE IN YEAR NO. OF PATIENTS PERCENTAGE 
1. 15-20 1 3.33 
2. 21-25 4 13.33 
3. 26-30 13 43.33 
4. 31-35 4 13.33 
5. 36-40 8 26.67 
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IMPROVEMENT OF SIGNS AND SYMPTOMS 
 
 
 
 
IMPROVEMENT OF SIGNS AND SYMPTOMS
100
86.6
93.33
73.33
53.33
63.33
27 27
6.66
3.33
0 0 0
3.33
0
3.33
93.33
96.15
100 100 100
94.73
100
96.29
0
20
40
60
80
100
120
Yellow
Purulent
discharge
Pruritis Vulva Dysuria Lower Abd.
Pain
Low Back
Pain
Odour Inflammation
of Vulva
Tenderness
 
 
 
    From the clinical study 93.33% of patients get relieved from yellow purulent discharge, 
96.15% get relieved from pruritis vulva, 100% get relieved from dysuria, 100% get relieved 
from lower abdominal pain, 100% get relieved from low back pain, 94.73% get relieved from 
odour, 100% get relieved from inflammation of vulva, 96.29% get relieved from tenderness. 
 
S.NO SIGNS AND 
SYMPTOMS 
NO. OF PATIENTS IMPROVEMENT
BEFORE 
TREATMENT 
AFTER 
TREATMENT
1. Yellow purulent 
discharge  
30(100%) 2(6.66%) 93.33% 
2. Pruritis vulvae 26(86.6%) 1(3.33%) 96.15% 
3. Dysuria 28(93.33%) 0 100% 
4. Lower abdominal 
pain 
22(73.33%) 0 100% 
5. Low back pain  16(53.33%) 0 100% 
6. Odour  19(63.33%) 1(3.33%) 94.73% 
7. Inflammation of 
vulva 
27(90%) 0 100% 
8. Tenderness 27(90%) 1(3.33%) 96.29% 
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VAGINAL SMEAR: 
 
 
S.NO VAGINAL 
SMEAR 
NO.OF PATIENTS IMPROVEMENT 
  Before treatment  After treatment   
1. Trichomonas  
vaginalis 
30(100%) 2(6.66%) 93.33% 
 
 
 
 
VAGINAL SMEAR
94%
6%
BEFORE TREATMENT
AFTER TREATMENT
 
 
 
In vaginal smear examination 93.33%  of patients get relieved from Trichomonal infection. 
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S.NO 
 
OP.NO 
 
NAME 
 
A/S 
Yel . pru 
discharge 
Pruritis 
Vulva 
Dysuria Low.abd.
Pain 
Low.back
pain 
Odour Inf.of . 
vulva 
Tender 
ness 
Vag.smear 
Tri.vaginalis 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1. AG1755 Kamala 39/F + - + - + - - - - - + - + - + - + - 
2. AG2535 Bhuvaneshwari 23/F + - + - - - + - + - + - + - + - + - 
3. AG2777 Krishnaveni 21/F + - + - + - + - - - + - + - + - + - 
4. AG3745 Amutha 36/F + - + - + - + - + - - - - - + - + - 
5. AG3703 Revathi 40/F + + + - + - + - + - + - - - + - + - 
6. AG3887 Malini 38/F + - + - + - + - - - + - - - + - + - 
7. AH256 Maheswari 32/F + - - - + - - - + - + - + - + - + - 
8. AG4139 Gajalakshmi 18/F + - + - - - + - + - - - + - + - + - 
9. AG4837 Kavitha 13/F + - + - + - + - + - + - + - + - + - 
10. AG4336 Chitra 30/F + - + - + - + - + - + - - - + - + - 
11. AG4343 Indrani 24/F + - + - + - - - + - + - - - + - + - 
12 AG4524 Kumari 35/F + - + - + - + - + - + - + - + - + - 
13 AG4611 Tamilselvi 38/F + - + - + - + - - + + - + - + - + - 
14. AG4790 Kanaga 38/F + - - - + - - - - - - - - - + - + - 
15 AG5234 Suleka 38/F + - + - + - - - + - - - - - + - + - 
16 AG5610 Stella 26/F + - + - + - - - - - + - + - + - + - 
17 AG6258 Geetha 27/F + - + - + - + - - - - - + - + - + - 
18 AG6801 Gajalakashmi 25/F + -- + - + - + - - - - - - - + - + - 
19 AG6982 Megala 40/F + - + - + - + - - - - - - - + - + - 
20 AG7067 Thangam 34/F + - + - + - + - + - - - - - + - + - 
21 AG7035 Jaya 38/F + - + - + - + - - - + - + - + - + - 
22. AG7068 Mahalakshmi 30/F + - + - + - + - + - - - + - + - + - 
23. AG7214 Ananthadeepa 28/F + - - - + - + - + - + - + - + - + - 
24 AG7782 Hariyathal 28/F + - + - ++ - - - - - + - - - + - + - 
25. AG8935 Mala 28/F + - + - + - - - - - - - + - + - + - 
26. AG9144 Mohana 27/F + - + - + - + - - - - - + - + - + - 
27 AG9597 Kalaivani 38/F + + + - + - + - - - - - + + + - + + 
28 AG9893 Selvi 27/F + - + + + - + - - - - - + - + - + - 
29 AG3964 Maheswari 27/F + - - - + - + - + - + - + - + - + - 
30 AH1214 Uma 30/F + - + - + - + - + - + - + - + - + - 
 
Vag . Smear, tri – Vaginalis – Vaginal  smear, Trichomonas vaginalis 
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LAB INVESTICATION – BEFORE TREATMENT REPORT – VELLAI NOI 
SNO OPNO NAME A/S BLOOD URINE VPH 
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P L M E ½ 
hr 
1 
hr 
F PP PC EC  
1. AG1755 Kamala 39/F 11.6 9600 50 43 2 5 10 22 - 123 24 0.7 194 3.6 -ve Nil Nil - - 6 
2. AG2535 Bhuvaneshwari 23/F 14.5 8300 50 45 - 5 4 9 - 111 16 0.8 168 4.3 -ve Nil Nil 1-2 3-4 5 
3. AG2777 Krishnaveni 21/F 10.2 9000 54 40 1 5 15 32 - 64 24 1.8 148 3.4 -ve Nil Nil 6-8 1-2 4.5 
4. AG3745 Amutha 36/F 13 8000 54 41 2 3 20 40 80 - 15 0.8 200 4.0 -ve Nil Nil 4-6 4-6 5 
5. AG3703 Revathi 40/F 11.4 7300 50 42 3 5 10 22 - 128 14 0.8 193 3.7 -ve Nil Nil 4-6 4-6 7 
6. AG3887 Malini 38/F 12.1 6700 50 44 2 4 8 16 69 - 31 0.8 200 3.9 -ve Nil Nil - - 6 
7. AH256 Maheswari 32/F 12.1 7200 50 44 0 4 4 10 - 89 25 0.8 187 3.9 -ve Nil Nil - - 6 
8. AG4139 Gajalakshmi 18/F 13.1 6000 50 48 - 2 6 15 78 92 19 0.8 185 4.3 -ve Nil Nil 1-2 2-4 5 
9. AG4837 Kavitha 13/F 13.1 7000 51 47 - 2 4 8 84 - 70 0.8 200 4.2 -ve Nil Nil 3-4 2-3 5 
10. AG4336 Chitra 30/F 13.5 6700 51 47 - 02 3 7 - 77 16 0.8 222 4.5 -ve Nil Nil 2-4 2-4 5.5 
11. AG4343 Indrani 24/F 13 9800 50 45 - 5 14 28 - 76 28 0.8 200 4.5 -ve Nil Nil 2-4 2-4 6 
12 AG4524 Kumari 35/F 13.5 9200 59 36 - 5 17 40 73 88 13 0.8 169 4.8 -ve Nil Nil - - 6 
13 AG4611 Tamilselvi 38/F 11.4 6000 52 46 - 2 10 12 - 85 17 0.8 213 3.7 -ve Nil Nil 2-4 2-4 6.5 
14. AG4790 Kanaga 38/F 13.5 9600 58 35 - 7 34 72 109 29 11 0.4 149 4.5 -ve Nil Nil 2.4 2.4 4.5 
15 AG5234 Suleka 38/F 13.1 7000 50 48 - 2 4 8 - 79 22 0.8 179 4.3 -ve Nil Nil 2.4 2.4 5 
16 AG5610 Stella 26/F 10.2 7200 55 41 - 04 10 22 - 63 18 0.6 166 3.4 -ve Nil Nil 2.3 2.3 5 
17 AG6258 Geetha 27/F 10.2 7200 55 41 - 4 10 22 - 63 18 0.6 166 3.1 -ve Nil Nil 2.3 2.3 6 
18 AG6801 Gajalakashmi 25/F 10.7 6200 50 49 - 1 5 10 - 80 10 0.4 132 3.5 -ve Nil Nil 3.4 1.2 6 
19 AG6982 Megala 40/F 13 7600 50 48 - 2 3 7 -* 99 17 0.6 113 4.3 -ve Nil Nil 2.3 1.2 5 
20 AG7067 Thangam 34/F 8.3 7800 56 40 - 4 10 22 96 - 10 0.3 132 2.5 -ve Nil Nil 2.3 2.3 5 
21 AG7035 Jaya 38/F 13.1 7200 51 48 - 1 6 12 - 145 16 0.7 195 4.7 -ve Nil Nil 6.8 1.2 4 
22. AG7068 Mahalakshmi 30/F 7.8 7400 52 44 1 3 12 25 77 - 10 0.5 142 2.4 -ve Nil Nil 2.3 1.2 5 
23. AG7214 Ananthadeepa 28/F 10.2 6300 55 43 - 2 5 10 79 - 19 0.8 152 3.4 -ve Nil Nil 2.4 1.2 5 
24 AG7782 Hariyathal 28/F 10.6 7400 50 42 3 5 11 24 59 81 26 0.8 183 3.8 -ve Nil Nil 2.4 2.4 6 
25. AG8935 Mala 28/F 13 6700 50 47 - 7 6 13 - 107 12 0.5 188 4.5 -ve Nil Nil 5.6 1.2 5 
26. AG9144 Mohana 27/F 12.1 6800 52 4 - - 2 4 - 101 26 0.6 194 3.9 -ve Nil Nil 4.6 4.6 6 
27 AG9597 Kalaivani 38/F 12.2 6300 50 47 - 3 6 12 66 - 18 0.5 158 4.5 -ve Nil Nil - - 7 
28 AG9893 Selvi 27/F 9.2 5500 54 44 - 2 5 11 - 24  0.8 175 3.0 -ve Nil Nil - - 4 
29 AG3964 Maheswari 27/F 16 9000 54 40 - 6 4 8 - 128 23 0.8 170 5.0 -ve Nil Nil - - 5 
30 AH1214 Uma 30/F 10.2 7000 51 43 2 4 6 14 - 106 26 0.8 170 3.2 -ve Nil Nil 2.4 2.4 5 
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LAB INVESTICATION – AFTER TREATMENT REPORT – VELLAI NOI 
SNO OPNO NAME A/S BLOOD URINE VPH
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P L M E ½ 
hr 
1 
hr 
F PP    PC EC  
1. AG1755 Kamala 39/F 11.6 9600 50 43 2 5 10 22 - 123 24 0.7 194 3.6 -ve Nil Nil - - 4 
2. AG2535 Bhuvaneshwari 23/F 14.2 8300 50 46 - 5 10 96 - - 16 0.5 167 4.0 -ve Nil Nil 1.2 2.4 4.5 
3. AG2777 Krishnaveni 21/F 11.2 9000 54 44 - - 6 12 - 68 24 0.8 148 3.4 -ve Nil Nil - 1.2 4 
4. AG3745 Amutha 36/F 14.8 8900 60 40 - - 24 77 - 18 - 0.5 197 4.4 -ve Nil Nil - - 3.5 
5. AG3703 Revathi 40/F 12.4 7300 50 42 - 5 8 16 - 87 14 0.8 193 4.0 -ve Nil Nil 2.4 2.4 4 
6. AG3887 Malini 38/F 12.1 8400 54 42 - 4 5 10 - 82 18 0.8 158 4.0 -ve Nil Nil - - 5.5 
7. AH256 Maheswari 32/F 12.6 6000 56 38 2 4 14 28 89 - 25 0.8 187 3.9 -ve Nil Nil - - 4.5 
8. AG4139 Gajalakshmi 18/F 13.0 6000 50 48 - 2 2 4 74 102 19 0.8 167 4.2 -ve Nil Nil 2.4 1.2 4 
9. AG4837 Kavitha 13/F 11.6 6300 53 42 - 5 11 22 93 - 26 0.9 170 3.4 -ve Nil Nil 1.2 1.2 4 
10. AG4336 Chitra 30/F 11.3 6100 56 40 - 4 13 26 - 104 14 0.6 178 4.1 -ve Nil Nil 1.2 2.4 4.5 
11. AG4343 Indrani 24/F 11 8000 54 42 - 4 12 24 - 93 18 0.5 176 3.2 -ve Nil Nil 2.6 2.4 4 
12 AG4524 Kumari 35/F 16.0 6300 56 38 2 4 2 4 - 182 18 0.8 187 4.8 -ve Nil Nil 1.2 1.2 4 
13 AG4611 Tamilselvi 38/F 8.2 7300 51 12 3 4 10 20 - 96 17 0.6 175 2.4 -ve Nil Nil 2.6 1.2 4 
14. AG4790 Kanaga 38/F 12.6 6800 56 38 2 4 4 8 90 29 17 0.5 130 4.2 -ve Nil Nil - - 3.5 
15 AG5234 Suleka 38/F 11 7400 56 38 - 4 15 30 - 92 30 0.9 199 3.2 -ve Nil Nil - - 4 
16 AG5610 Stella 26/F 10.2 7200 55 41 - 4 10 22 - 63 18 0.6 166 3.4 -ve Nil Nil 1.2 1.2 5 
17 AG6258 Geetha 27/F 11.4 8900 58 50 1 6 10 20 83 - 31 0.8 150 3.3 -ve Nil Nil - - 5 
18 AG6801 Gajalakashmi 25/F 8.7 8000 58 40 - 2 4 8 - 96 21 0.8 142 2.6 -ve Nil Nil - - 4.5 
19 AG6982 Megala 40/F 13 6000 65 33 - 2 4 8 - 80 16 0.6 167 3.8 -ve Nil Nil 2.4 2.6 4 
20 AG7067 Thangam 34/F 10 6500 55 38 2 5 4 10 76 - 16 0.8 100 3.6 -ve Nil Nil 2.4 4.6 4 
21 AG7035 Jaya 38/F 14 7200 55 40 - 5 13 26 - 162 16 0.6 235 4.1 -ve Nil Nil 4.6 1.2 4 
22. AG7068 Mahalakshmi 30/F 12.6 7500 55 40 - - - 94 18 18 10 0.6 235 4.1 -ve Nil Nil 4.6 1.2 4 
23. AG7214 Ananthadeepa 28/F 13.1 6300 61 35 - 4 20 40 70 - 21 0.6 187 4.5 -ve Nil Nil 1.3 0.1 3.5 
24 AG7782 Hariyathal 28/F 12.6 6500 53 42 - 5 10 20 - 93 21 0.6 187 4.5 -ve Nil Nil 2.3 2.3 5 
25. AG8935 Mala 28/F 13.2 6800 58 40 - 3 7 14 - 111 14 0.7 180 4.6 -ve Nil Nil 1.3 0.1 4 
26. AG9144 Mohana 27/F 12.0 6800 58 40 - 2 2 4 - 115 24 0.8 128 3.8 -ve Nil Nil - - 4 
27 AG9597 Kalaivani 38/F 17.0 6000 50 45 2 3 8 14 - 96 35 0.9 164 4.3 -ve Nil Nil - - 6 
28 AG9893 Selvi 27/F 10.2 6800 55 40 2 3 6 12 72 - 20 0.7 141 3.2 -ve Nil Nil 2.3 - 4 
29 AG3964 Maheswari 27/F 11.6 6800 56 40 - 4 4 26 90 - 29 0.9 156 3.3 -ve Nil Nil 2.3 2.3 4.5 
30 AH1214 Uma 30/F 8.7 6600 54 40 - 6 14 25 66 - 20 0.8 164 2.5 -ve Nil Nil - - 4 
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DISCUSSION  
The drug Vilampisin chooranam has been selected to find its efficacy in the 
management of “Vellai noi”. 
 The literary evidence from Gunapadam mooligai text strongly supports the anti-
microbial activity of the drug. 
 Bio- chemical analysis of the drug Vilampisin chooranam reveals the presence of 
calcium, sulphate, borate, alkaloid and tannic acid. 
 Phyto chemical analysis of the drug Vilampisin chooranam reveals the presence of 
alkaloids, Gums, mucilages, saponins, flavonoids triterpenoids and phenolic compounds.  
Sulphate: 
 Sulphur has anti-bacterial and anti-microbial activity. Sulphates are the salts of 
sulphur. Sulphur is known as healing mineral. It aids every cell in the determination of toxic 
substance through agitation. Sulphur aids functions in enzyme reactions and is important in 
cellular respiration. Thus sulphur is very essential in curing Leucorrhoea. 
Calcium: 
 Calcium sulphate, a salt of calcium is useful in the conditions of discharge of 
gonorrhoea, leucorrhoea, yellow mixed with blood, expectoration of much blood.  
 Tannic acid: 
 The properties of tannic acid are anti-bacterial, anti-dermatotic, anti-septic and anti-
ulcer properties. Thus it works in leucorrhoea.  
Saponins: 
 Saponins, glycosidic plant constituents are known for their wide- spread occurrence 
in plants and their detergent and pesticidal like activities. Severe biological activities are 
associated with saponins like antimicrobial activity, anti tumor and molluscicidal activity. 
Flavonoids: 
 Flavonoids reported to posses many biological activities such as anti-bacterial, anti-
inflammatory, anti-viral and anti-allergic properties.  
Phenolic compounds: 
 It has very good anti-inflammatory properties. Thus it reduces the inflammation of 
vulva.  
Pharmacological study: 
 The Vilampisin chooranam showed reasonable, comparable inhibitory activity against 
staphylococcus aureus, candida albicans, Trichomonas vaginalis and proteus. 
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Clinical assessment: 
 For the clinical study of Vilampisin chooranam in Vellai noi 30 patients were 
selected.  
 According to age wise distribution 3.33% were in 15-20 yrs, 13.33% were in 21-25 
years, 43.33% were in 26-30 years,13.33% were in 31-35 years and 26.67% were in 36-40 
years. 
 From the clinical study 93.33% of patients get relieved from yellow purulent 
discharge, 96.15% get relieved from pruritis vulva, 100% get relieved from dysuria, 100% 
get relieved from dysuria, 100% get relieved from lower abdominal pain, 100% get relieved 
from low back pain, 94.73% get relieved from odour, 100% get relieved from Inflammation 
of vulva, 96.29% get relieved from tenderness.  
 In vaginal smear examination 93.33% of patients get relieved from trichomonal 
infection. And no adverse effects were observed.  
 
In siddha aspect,  
 
     “ dXkqBt<t!hqk<klK!Okie<xqz<!ouh<H!!
!!!!!!!!!dm<{uiB!uk<kqSv!lkqsivr<gt< 
    --------------------------- 
       ---------------------------- 
      sqxqK!ohVl<hiM!vk<kl<!hqvOlgr<gt<!
!!!!!!!!!Osv<f<K!ouG!hq{qhzUR<!sqxg<Gf<kiOe#/!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.skgfic!
 
 
According to siddha literature Vellai noi is a condition due to vitiated azhal humor 
Vilampisin can be given to Vellai noi which is due to increased azhal kutram, also the action 
of Vilampisin is demulcent. So, it can be is given to neutralize the increased azhal humor in 
Vellai noi.  
 
From the clinical & statistical analysis, it is proved that the drug Vilampisin 
Chooranam is statistically significant.  
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SUMMARY 
  
The drug Vilampisin chooranam has been selected for this study  to evaluate its 
efficacy in the management of “Vellai noi”. 
 
 The literature evidences strongly supports the anti- microbial activity of Vilampisin 
Chooranam in the management of “Vellai noi”. 
 
  Bio-chemical analysis of the drug reveals the presence of calcium, sulphate,  Borate, 
alkaloid and  tannic acid. 
 
 Phyto –chemical analysis of the drug reveals the presence of alkaloids, Gums and 
mucilages, saponins, Flavonoids, and triterpenoids.  
  
Pharmacological studies showed the Vilampisin Chooranam has reasonable, 
comparable inhibitory activity against staphylococcus aureus, candida albicans, Trichomonas  
vaginalis and proteus. 
  
For clinical studies 30 patients were diagnosed as Vellai noi with Trichomonas 
vaginalis infection and treated with this drug. 93.33% get relieved from the infection. Thus it 
is statistically significant. 
 
 
 
CONCLUSION 
 
 
It is concluded that the drug Vilampisin chooranam is found to be an effective drug 
for Vellai noi without producing any adverse effects.  
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INTRODUCTION 
 
 The siddha system of medicine is our heritage knowledge on health care, a treasure of 
indigenous medicine. Siddha system of medicine is being practiced from the birth of our 
Tamil language. It has its own lot of numerous specialities & incomparable to other systems 
of medicine. The roots of siddha are intertwined with the mythlogy and culture of ancient 
Tamil civilization that existed in the southern most tip of the Indian peninsula, predating 
much of recorded history. 
 
 Mythically, the origin of siddha is attributed to God Siva, who is supposed to have 
handed it down to his consort “Parvathi” (Shakthi) who in turn passed on the sacred 
knowledge to Nandhi, from where it was transmitted to siddhars. 
 
 According to siddha fundamental philosophy, all the living and non-living things in 
the world are formed by the combination of five elements (Pancha bootha). Due to the five 
fold combination of these elements (Panchikarnam), all the suvai and three humors are 
formed.  
 
 Humoral pathology explains that the three humors namely Vatha, Pitha and Kapha 
maintains the upkeep of the human body. The normal orders of Vatha, Pitha and Kapha is in 
the proportion of 1:1/2 :1/4 respectively. The maintenance of  their normal order ensures the 
“Preservation of health and harmonious functioning of the body.” Any upset in the 
proportion of the three humors causes diseases according to the derangement. 
 
 Siddhars had classified the metals and minerals as follows Metals-11, Salt-25, 
Pashanas –64, Uparasas –120. Of  these, the salts (Kara-Saram) are less toxic and more 
safety. Merely most of these salts are the constituents of human physiology. These salts have 
the properties of five elements within themselves. So they can be given to the disease caused 
due to derangement of three humors. 
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Soothagavali  (Dysmenorrhoea) is one of the common diseases affecting the 
individuals in their late teens and 20s. More than 70% of teenagers and 20-50% of 
menstruating women are affected by  dysmenorrhoea. 
 
 According to siddha pathology Soothagavali is caused due to derangement of Vatha 
kutram. 
 
 The drug “Seenalavana parpam” is a compound drug having predominantly uppu, 
inippu and pulippu suvai. It is indicated for soothagavali. Uppu  suvai controls vatha humor. 
It is mentioned in text as  
 
 “thj Nkypl;lhy; kJuk; GspAg;G 
 NrjKwr; nra;Ak; rpiwAk; - Xjf;Nfs; 
 fhue; JtHfrg;G fhl;LQ; Ritnay;yhk; 
 rhug; ghpfhuQ; rhw;W” 
    - fz;Zrhkpak; 
 
 As per mentioned in the above text, the compound drug Seenalavana parpam 
containing  uppu, inippu and pulippu suvai controls vatha humor.  These literary evidences 
drove the author to choose the compound drug Seenalavana parpam for the mangement of 
Soothagavali (Dysmenorrhoea). 
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AIM AND OBJECTIVES 
 
 
Aim: 
 
 To evaluate the efficacy of Seenalavana parpam in the management of Soothagavali 
(Dysmenorrhoea). 
 
Objective : 
 
 The clinical efficacy of Seenalavana parpam has been evaluated in the following 
aspects. 
 
 Collection of evidences in siddha aspects.  
 Collection of evidences in chemical aspects. 
 Bio- Chemical analysis.  
 Physical Properties. 
 Toxicological study. 
 Pharmacological analysis. 
 Open clinical trial on Soothagavali given orally.  
 
 
 
 
 
 
 56
 
REVIEW OF LITERATURE 
GUNAPADAM ASPECT 
rPdhf;fhuk; 
ALUMEN, ALUM 
 
NtWngaH24 gbfhuk;> gbfp> rPdk; 
 
fpilf;Fkplk;: 
 Neg;ghsk;> gQ;rhg;> gPfhH> fj;jpathH. 
 
gz;G: 
 gbfk; Nghd;W ntSg;ghAk; fl;bfshAk; ,Uf;Fk;. 
 
Rit: 
 Gspg;G> ,dpg;G> JtHg;G.  ,ijf; fhw;whl itj;jhy;> ePH ePq;fpf; fl;bfspd; 
Nky; J}s; gbAk;. nghhpj;jhy;> nghq;fp ePH ePq;fp vil FiwAk;. 
 
Rj;jp: 
 ,ij ePhpy; fiuj;J tbfl;bf; fha;r;rpf; Fok;Gg; gf;Ftj;jpy; ,wf;fpf; 
FspUk;gb nra;ar; Rj;jpahk;. 
 
nra;if: 
 JtHg;gp> FUjpg; ngUf;flf;fp> mOfyfw;wp> Gz;zhf;fp> ,rptfw;wp Kjypad 
MFk;.  ,J kyj;ijf; fl;Lk;. 
 
msT: 
 10 (650kp.fpuhk;) Kjy; 20 cSe;njil (1.3 fpuhk;) mjpf mstpy; nfhLj;jhy; 
Fkl;ly;> the;jp> tapw;Wf; fLg;G> Ngjp Kjypa JHf;Fzq;fs; fz;L> tapw;Ws; 
tpuzKz;lhFk;. 
 
nghJf;Fzk;: 
 “rPdnkDq; fhukJ rPwptU gy;yuiz  
 Midf;fhy; fz;Nzha; mdpynkhL - khepyj;jpy;  
 Jd;khq; fprk;thA Njhyhj cs;soiy 
 Fd;kkpit Nghf;Fnkdf; $W” 
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nghUs;:: 
gbfhuj;jpdhy; gy;yuiz ahidf;fhy;> fz;Nzha;> Nej;jputhA> JHkhkpr 
tsHr;rp> thA> cl;R+L> Fd;kk; Kjypad ePq;Fk;. 
 kw;Wk; ,/J ,uj;j gpj;jNeha;> ,uj;jg;ngUf;F> mjprhuk;> rPjNgjp> 
Foe;ijfSf;Ff; fhZk; the;jp> Ngjp> ff;fpUky;> fgk; tpOjy;> njhz;ilg;Gz;> 
<Wtpuzk;> nts;is> ngUk;ghL Kjypa Neha;fisAk; Nghf;Fk;. 
 
cgNahfq;fs; 
 ff;Fthd; NehapYk; tplhj tpf;fypYk; the;jpia cz;L gz;Ztjw;fhf 
,jid mjpf mstpy; 30 cSe;njil NjDld; fye;J nfhLf;fTk;. 
 gbfhuj;ij cSe;njil (65 kp.fpuhk;) tPjk; nfhLj;J tu the;jp epw;Fk;. 
 gbfp ,uz;L Fd;wpia (260 kp.fpuhk;) MlhNjhilr; rhw;wpy; ehs; xd;Wf;F 
Kk;Kiw tPjk; nfhLj;Jtu> ngz;fSf;F fhZk; nts;isAk; mjDld; 
gLfpd;w cjpuKk; epw;Fk;. 
 
gbfhu gw;W: 
 fLf;fha;j; Njhy;> gbfhuk;> fhpaNghsk; ,tw;Ws; fLf;fha;j; Njhiy ed;wha;j; 
J}shf;fpf; nfhz;L vYkpr;rk; gor;rhW tpl;liuj;J> XH ,Uk;Gf; fuz;bapy; tpl;L 
kw;w ruf;FfisAk; nghbj;Jr; NrHj;J ed;wha;f; fha;r;rp> fz;izr; R+og; 
gw;Wg;Nghl;lhy; fz; rptg;G> ePH tbjy; Kjypad jPUk;. 
 
R+jftypf;F rPdhf;fhuk; NrUk; kUe;Jfs; 
 
1   uq]Ohkq jpuhtfk;: :5 
NrUk; kUe;Jfs;: 
fwpAg;G 12 gq;F> ntbAg;G 12 gq;F gbfhuk; 11 gq;F etr;rhuk; 10 gq;F> 
tisaYg;G 10 gq;F> gplhyhtzk; 10 gq;F> ntz;fhuk; 3 ¼ gq;F> ml;Lg;G 1 gq;F. 
 
nra;Kiw: 
 ,it vy;yhtw;iwAq; fy;tj;jpw;nghbj;Jr; NrHj;J xU kzp Neukiuj;Jg; 
gPq;fhd; thiyapypl;Lg; ghfg;gb jpuhtfkpwf;fpf; nfhs;sTk;. 
msT: 2 Kjy; 5 Jspfs; 
 
Jiz kUe;J: 
 FspHe;j ePH> Njd;> rHf;fiu> Rf;Ff; FbePH> Nrhk;Gj;jP ePH> Xkj;jPePH 
KjypaitfshFk; 
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jPUk; Neha;fs;: 
 nrhpahikf; fopr;ry;> Fd;kk;> R+jftyp> mf;fpuk R+jfk;> tha;TNeha;fs;> 
fl;bfs;> Ruf;fl;b KjypaitfSk; jPUk;. 
 
2.  Njq;fha; ,sfk;7. 
 
NrUk; kUe;Jfs;: 
 Rj;jp nra;j rhjpypq;fk;> ,urk;> ney;ypf;fha;f; nfe;jfk;> fhe;jk;> rPdhf;fhuk;> 
ntq;fhuk; ,it tiff;F 5 tuhfd; vil (17 ½  fpuhk;). 
 ,e;Jg;G> ntbAg;G> rTl;Lg;G> tisaYg;G> fy;Yg;G> fUg;Gg;G> rTf;fhuk;> 
ethr;rhuk; ,it tiff;F 3 tuhfd; vil (10 ½  fpuhk;). 
 fUQ;rPufk;> fLFNuhfzp> Njrhtuk;> Xkk;> nfhj;Jky;yptpij> 
nts;isg;g+z;bjo;> mhprpj;jpg;gpyp ,tw;wpd; J}s; tiff;F 3tuhfd; vil   
(10 ½  fpuhk;). 
 nghhpj;j ngUq;fhak;> Rj;jpnra;j NeHthsg; gUg;G ,it tiff;F 1 tuhfd; 
vil (4.2 fpuhk;) gUkdhd Njq;fha; 1> cj;jhkzpr; rhW nry;yj;jf;f msT 
rpw;whkzf;nfz;nza; 5 gyk; (175 fpuhk;) 
msT: 4-6 Fd;wp vil (520 - 780 kp.fp.) 
 
jPUk; Neha;fs;: 
 tapw;Wisr;ry;> vl;Ltiff; Fd;kq;fs;> fUg;ig Ez;GOf;fs;> fUg;ig 
Ez;GOf;fs;> vl;Ltiff; fUg;ig tpg;GUjp> R+jfthA> gjpndl;Ltifr; R+iyfs; 
Mfpait jPUk;. 
 jPl;Lf; fhyj;jpy; tapw;Wtyp ,Ue;jhYk;> #jfj;jpy; thAjq;fp ,Ue;jhYk; 
jPUk;. 
 
R+jfNeha;fSf;F rPdhf;fhuk; NrUk; gpwkUe;Jfs;: 
3. rq;fj;jpuhtfk10; 
4. ntbAg;Gf;fl;L3 
5. R+hpagpuig26 
6. fHg;gf;Fok;G26 
 
 
 
 
 
 
 
 59
 
ntbAg;G 
POTASSIUM NITRATE: SALT PETRE: NITRATE OF POTASH 
 
NtWngaHfs;:24 
 nghl;bYg;G> ,zq;fd;;> giluhrd;> G+kp$Hik> ethr;rhukpj;U. 
 
fpilf;Fkplk;: 24 
 jw;fhyj;jpy; gQ;rhgpypUe;J ntbAg;G jahH nra;J mDg;gg;gLfpwJ. 
 
gad;fs;: 24 
 ntbAg;G Jg;ghf;fp kUe;J nra;tjw;Fk; ePH> rhuhak; ,itfis FspHr;rp 
nra;tjw;Fk; gbfhuk;> cg;G ,itfSld; NrHj;J nghd; eiffSf;F nkUF 
nfhLg;gjw;Fk; gad;gLfpwJ. 
 
Rj;jp 
1. ntbAg;G 1 gq;fpw;F 4 gq;F jz;zPHtpl;L mLg;Ngw;wpr; rpWjPahy; vhpj;Jf; 
nfhjpfpsk;Gk;NghJ 1 tPir (1400 fpuhk;) cg;Gf;F ehd;F NfhopKl;il 
ntz;fUitr; NrHf;f Ntz;Lk;.  NkNy mOf;Fj; jpuSk; mjid 
mfg;igahy; topj;J ePf;fp ciwAk; gjj;jpy; kWrl;bapy; rPiyfl;b mjpy; 
tbj;Jf; fhw;wpy;yh  tplj;jpy; itj;J kWehs; ePiu tbj;Jtpl;L R+hpa 
xspapy; cg;ig cyHj;jTk;.  ,t;thW VOKiw nra;a Rj;jpahFk;. 
2. ntbAg;G 1 gq;F fly;ePH (m) ePH 2 gq;F vLj;J cg;ig Ez;ikahfg; nghb 
nra;J ePhpy; fye;J itf;f ePhpy; fye;J Nghk;.  njspntLj;J ntz;ikahd 
,Ug;Gg; ghz;lj;jpy; tpl;Lf; fha;r;rp ciwAk; gjj;jpy; NtW xU nrg;Gg; 
ghz;lj;jpy; nfhl;b FspHe;j ,lj;jpy; Mwitf;f cg;ghFk;.  ,ij vLj;J 
,jw;F 2 gq;F ePH tpl;L Nkw;gbahfNt fha;r;rp cg;ghf;fTk; ,g;gb 
nkhj;jj;jpy; 5 Kjy; 7 Kiw nra;a Rj;jpahFk;. 
 
Rj;jp nra;j ntbAg;gpd; gz;G: 
 Rj;jp nra;j cg;G fk;gpfshAk;> ntz;ikahAk; ehf;fpypl;lhy; FspHr;rpahAk; 
,Uf;Fk;.  neUg;gpypl nghhpAk;. 
 
nra;;if: 
FspHr;rp cz;lhf;fp> 
tpaHit ngUf;fp> 
rpWePH ngUf;fp 
 
 60
 
Fzk;: 
 ntbAg;ig mjpf ePhpy; fiuj;Jf; nfhLf;f Ntz;Lk;. fl;baha; cl;nfhz;lhy; 
vhpr;riy cz;Lgz;Zk;.  mjpf mstpy; nfhLj;jhy; gpuhzgak; NehpLk;.  Nky; 
gpuNahfj;jpy; FspHr;rpia cz;L gz;Zk;. 
 
nghJFzk;: 
 “ky;yhU kl;lFd;k khjUj uf;fl;b 
 fy;yh kijg;GePHf; fl;lUf - nyy;yhNk 
 fk;gpfk;gp nad;Wq; fUTz;lh kq;fpepd;w 
 fk;gp fk;gp nad;Wiuf;Fq; fhy;” 
 “R+jfthAnthL Nrhzpjj;jpd; thjKk;Nghk; 
 thjtyp Fd;kkpit khWq;fhz; - kPjhq; 
 nfhba tapwpopAq; Nfhiofg NkFk; 
 ntbAg;Gj; jd;id tpsk;G” 
 gQ;rg+j cg;gpy; NjAtpd; $whfpa fk;gp cg;gpdhy; vz;tif Fd;kk;> 
fUg;ghraf;fl;b> Nrhig> %j;jpuf;fphpr;ruk;> ePHr;RUf;F> R+jpfhthjk;> thjNrhzpjk;> 
rhkhdpa thj> gpj;j> fg Fd;kq;fs;> ngUtapW> <is> fgNjhlk; ,it xopAk;.  
Nghpsk; ngz; gUtq;fle;j khjHfl;Fk; fUg;gk; cz;lhFk;. 
 ,jdhy; Ruk;>tPf;fk;> fPy;thjk;> ,uj;jgpj;jk;> gpuNkfk;> fz;Nzha;> njhz;il 
tpuzk;> Rthrfhrk; KjypadTk; ePq;Fk;. 
msT: (650 kp.fpuhk;) 5 Kjy; 10 Fd;wpnail (1.3 fpuhk;) 
 
tof;fpy; gad;gLk; tpjk;: 
 epidTj; jLkhw;wk;> jiytyp ,itfSld; $ba Ruj;jpw;Fg; nghl;bYg;G 4 
tuhfndil (16.8 fpuhk;) ethr;rhuk; 4 tuhfndil (16.8 fpuhk;) ,tw;iw 
Kf;fhy; Mohf;F (126 kp.ypl;lH) ePhpy; fiuj;J rPiyapy; eidj;J cyu cyu 
new;wpapypl;L tuf; Fzj;ij nfhLf;Fk;. 
 
 CWq;fhfpjq;fisg; nghl;bYg;G ePhpy; Cwitj;J cyHj;jpr; RUl;bf; 
nfhSj;jpg; Gif gpbf;fr; Rthrfhrk;, ,Uky; jzpAk;. ,uz;L Fd;wpnail  
(260kp.fp.) nghl;bYg;ig xU mTd;]; ePhpy; fye;J fz; typf;Ff; 
fpNyjkhfTk; cgNahfpf;fyhk;. 
 
 xU gyk; (35 fpuhk;) ntbAg;ig 2 Mohf;F (336 kp.ypl;) ePhpypl;Lf; fye;J 
mjpy; rPiyia eidj;J %l;LtPf;fk;> %l;Ltyp ,itfSf;F NkNy 
Nghl;Ltuf; FzkhFk;.  ,jid mbgl;l fhaq;fSf;Fk; cgNahfpf;fyhk;. 
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R+jftypf;F ntbAg;G NrUk; kUe;Jfs;: 
 
1. Fkl;bf;fha; Fok;G2 
 1.  50 thp Fkl;bf;fhapd; rhW> ,iyf;fs;spg;ghy; gb 1> (2yp) fy;Yg;G gb 1 
(2 ypl;lh;) ntbAg;G, tisaYg;G> ,e;Jg;G> Rf;F> jpg;gpyp> ngUq;fhak; tiff;F gyk; 
1> (35 fpuhk;) ,itfis NrHj;Jf; fha;r;rp> nkOF gjj;jpy; vLf;fTk;. 
 msT: xU tpuhfdpil (4.2 fpuhk;) 
 jPUk; Neha;fs;: cjuNuhfk;> R+jffl;L> R+jftyp Kjypaitfs; jPUk;.  kyk; 
,wq;Fk;. 
 
2.  etFd;k etePj nre;J}uk; 27 
 ruf;F: 
  ntbAg;G> tisaYg;G> ghiwAg;G> rTl;Lg;G> fy;Yg;G> mKhp cg;G> 
ctUg;G tiff;F 1-Njhyh (12 fpuhk;)> thpFk;kl;b gor;rhH 1-gb (2 ypl;lH) gRk;ghy; 
miug;gb (1 yp) 
 nra;Kiw: 
  J}s; nra;J ghy; rhWtifNahL NrHj;Jf; fiuj;J ePHRz;l vhpj;J 
vLj;J mjpy; tPuk;> g+uk;> urk;> fhe;jfk; fe;jfk; tiff;F ½ gyk; (17.5fpuhk;)> thsk;> 
1-Njhyh (12fpuhk;) Rf;F jpg;gpyp. kpsF tiff;F gyk; ¼ (8.75 fpuhk;) ,itahTk; 
J}s;nra;J cg;gpy; NrHj;J fy;tj;jpypl;L miuj;J mjpy; vYkpr;rk; gor;rhW gpd; 
jphpgiy f]hak; ,itfs; tpl;L miuj;J nkOF gjj;jpy; vLj;Jg; gj;jpug;gLj;jTk;. 
 jPUk;Neha;fs;: 
  etFd;kk;, ehs;gl;l R+jffl;b, fTir> fpue;jp> R+iy> gpbg;G> eikr;ry;> 
tapw;Wtyp> thjR+iy> ghk;Gfb tp]q;fs; 20> 30 tU]k; cs;s rj;jp Fd;kk; 
FzkhFk;.  R+jftyp> tp]jbg;G Foe;ijf;fl;b jPUk;. 
 
3. R+jfthA vs;S ,sfk;8 
 vs;S ¼ gb (1/2  yp) (,jidf; fy; Kjypaitfsha;e;J Rj;jp nra;J 
vLj;Jf; nfhs;sTk;) Nkw;Nwhy; rPtpd Rf;F> kpsF> mhprpj;jpg;gpyp> fz;lj;jpg;gpyp> 
Xkk;> rjFg;ig> tha;tpsq;fk;> ew;fLF> eha;f;fLF> ,itfisj; jdpj; jdp 
,stWg;ghf tWj;Jj; jdpj;jdp ,bj;j J}s; tiff;F ½ gyk;; (17 ½ fpuhk;).  
tWj;jpbj;j rpj;jpu%y NtHg;gl;ilj;J}s; 2 ½ tuhfd; vil ( 8 ¾ fpuhk;)> 
ngUq;fhak; 1½ tuhfd; vil (5 ¼ fpuhk;)> ntbAg;Gj;J}s; 1½  tuhfd; vil ( 5¼  
fpuhk;)> fwpAg;Gj;J}s; 1 ½ tuhfd; vil ( 5 ¼ fpuhk;))> nfe;j ntbAg;Gj;J}s; 1 ½ 
tuhfd; vil (5 ¼ fpuhk;)> tisaYg;Gj;J}s;  1¼  tuhfd; vil> NjhYhpj;j 
nts;isg;g+z;bjo; 5 gyk;. 
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msT: 2 Kjy; 3 cUz;il> fhiy> khiy ,uz;L NtisAk; miu Kjy; 
xU kz;lyk; cgNahfpf;fTk;. (24 - 48 ehs;) 
  
mDghdk;: Njd;> nea;> ntz;nza;> thiog;gok; Kjypaitfshk;.   
  
jPUk; Neha;fs;: R+jf thA> mf;fpukR+jfk;> R+jfj;jpy; fhZk; tapw;Wtyp> 
%ythA> R+jfge;jk;> fpuhzp> R+jfj;jpy; fhZk; ,Lg;Gtyp> mf;fpdpke;jk;> nrhpahik 
Mfpait jPUk;. 
 gj;jpak;: Gsp> cg;G Kjypaitfisr; rpWf NrHj;Jg; gj;jpak; itf;fTk;. 
 
4.  Fd;kk; jPu ,Nyfpak;28 
5.  Fd;kFNlhhp nkOF29 
6.  gQ;rytz fl;L 5 
7.  ,ytz Fzhjp vz;nza;27. 
 
,e;Jg;G 
SODIUM CHLORIDE IMPURA,  ROCK SALT 
 
NtWngaHfs;:24 
 ire;jtk;> rpe;J}uk;> re;jpuDg;G> kjp$Hik> kjpAg;G> kpe;jhr; nrhy;. 
 
fpilf;Fkplk;:24 
 ,t;Tg;G rpe;J Njrj;jpYk; gQ;rhg; tlNkw;Fg; ghfq;fspYk; G+kpapypUe;J 
ntl;b vLf;fpd;whHfs;. 
 
Rj;jp:24 
1. ,e;Jg;ig fhbapy; %d;W ehs; Cwg;Nghl;L nta;apypy; cyHj;jp vLf;fr; 
Rj;jpahFk;. 
2. ,e;Jg;ig fhb my;yJ nts;shl;L ePhpy; %d;W ehopif kj;jpj;J nta;apypy; 
cyHj;jpf; nfhs;s Rj;jpahFk;. 
 
nra;if24: 
 kykpsf;fp 
 mfl;Lthafw;wp 
 rpWePH ngUf;fp 
 grpj;jPj;J}z;b 
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nghJFzk;:24 
 “ml;lFd;k ke;jk; mrpHf;fuQ;R+H rPjgpj;je; 
 Jl;litak; ehbg;Gz; Nlhlq;fs; - nfl;lkyf; 
 fl;Ltpl tpe;ijaf; fhkpaNeha; td;fug;ghd; 
 tpl;Ltpl tpe;Jg;ig tps;” 
 
nghUs;:24 
 ,e;Jg;gpdhy; vz;tpj Fd;kk;> myrk;> mrpHf;fuk;> fggpj;jk;> fghjpf;fk;> 
euk;Gf;fpue;jp> jphpNjh]k;> kyge;jk;> tq]k;> Rf;fpyk;> fg cgjk;gk;> fLtd; Mfpa 
Neha;fs; ePq;Fk;. 
 
kUj;Jt cgNahfq;fs;1: 
Njfj;jpy; RSf;F te;jhy; ,e;Jg;ig gw;W Nghlyhk;. 
typAld; $ba tPf;fq;fSf;F ,ijr; R+lhf;fp xw;wlk; ,lyhk;. 
,e;Jg;ig ,sQ; R+lhd nte;ePhpy; fiuj;J the;jpia cz;Lgz;z 
cgNahfpf;fyhk;. 
mf;fpdpke;jk;> Nej;jpu Nuhfk;> fpue;jp> jhgdk;> fggpj;jk;> vyp uq]l< ,itfSf;F 
,ij Ngjpf;F nfhLj;J> ey;y Fzq;fz;ljhf lhf;lH nkh`pjPd; ]hPg; 
mtHfs; nrhy;ypAs;shHfs;. 
 
1.  gpj;jf; f]hak;: 
 epyhthiu> Nrhk;G> Rf;F> nfhj;jky;yp tiff;F ½ Njhyh (6 fpuhk;) tPjk; 
xd;wpuz;lha; ,bj;Jf; fhy;gb (325 kpypl;) ePHtpl;L ghjpaha; FWf;fpg; gpire;J 
tbfl;b mjpy; Njfgyj;jpw;Nfw;g ,uz;L (8.4 fpuhk;) Kjy; Ie;J (21 fpuhk;) 
tuhfndil tiu ,e;Jg;ig fyf;fp cl;nfhs;s NgjpahFk;. 
 
2.  ,e;Jg;G R+uzk;: 
 ,e;Jg;G 1 gq;F> rPufk; 1 gq;F> Xkk; 4 gq;F> jpg;gpyp 8 gq;F> Rf;F 16 gq;F> 
fLf;fha; 32 gq;F tPjk; epWj;njLj;j J}s;fisf; fye;J nfhs;sTk;. 
 msT: 1 Njhyh (12 fpuhk;) 
 jPUk;Neha;fs;: mf;fpdp ke;jk;> the;jp> kNfhjuk; jPUk;. 
 
3. Njq;fha;]huk;: 
 ePUs;s Njq;fhnahd;iw vLj;J mjpy; xU fz;izj; njhisj;J mjw;Fs; 
,e;Jg;ig epWj;J njhisia milj;J ed;wha; xU kz; rPiy nra;JyHj;jpg; 
Glkpl;L cg;ig vLj;Jf; nfhs;sTk;.  ,t;Tg;igr; rpwg;gha; czT rPuzkhFk;NghJ 
Njhd;Wk; tapw;W typf;F mrPuzj;jpw;Fk; ifahsyhnkd;W rf;fujj;jH $WtH. 
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 epyhtiur; R+uzk; xU gq;F> Rf;F> kpsF> Xkk;> tha;tplq;fk;> rape;j 
ytzk; (,e;Jg;G) ,tw;wpd; R+uzq;fs; tiff;F ¼ gq;F rHf;fiu 2 ¼ 
gq;F tPjq;fye;J itj;Jf;nfhz;L xd;W Kjy; (4.2 fpuhk; ,uz;L 
tuhfndil (8.4 fpuhk;) nfhLf;f tapw;Wg;Grk;> tapw;Wtyp> kyge;jk; 
Kjypad ePq;Fk;. 
 
R+jftypf;F ,e;Jg;G NrUk; kUe;Jfs;: 
 
1.  gQ;rytzf;fl;L5 
 NrUk; kUe;Jfs;: 
 fwpAg;G> ntbAg;G> tisaYg;G> fUg;Gg;G> ,e;Jg;G ,it tiff;F 1 gyk; (35 
fpuhk;)> Fg;igNkdpr; rhW nry;yj;jf;f msT.  
nra;Kiw: 
 Nkw;gb Ie;Jg;GfisAk; fytj;jpypl;Lg; nghbj;J Nkw;gbr; rhw;iwr; rpWfr; 
rpWf thHj;J ehd;F rhkk; (12 kzp Neuk;) miuj;J tpy;iy jl;bAyHj;jp Xl;bypl;L 
NkNyhL %b Ie;J rPiykz; nra;JyHj;jpf; ftrj;jpd; ,UgJ gq;F tul;bapy; 
Glkpl;L Mwpd gpd;ndLj;Jg; nghbj;J itj;Jf; nfhs;syhk;. 
 msT:  2 Kjy; 15 Fd;wpkzp vil (260 kp.fp - 1950 kp.fp) 
 JizkUe;Jk;> jPUk; Neha;fSk;: 
 KUq;ifg;gl;ilr;rhW 2 tuhfd; vil (7 fpuhk;) Njq;fhapd; jdpg;ghy; 2 
tuhfd; vil (7 fpuhk;) ,t;tpuz;ilAk; fye;J Nkw;fz;l cg;ig msTg;gb NrHj;J 
cl;nfhs;s kyl;L typ> R+jftyp Mfpaitfs; jPUk;. 
 
2.  =Njtp vz;nza;2 
 NrUk; kUe;Jfs;: 
 cj;jhkzp 
 nts;is rhuiz 
 Klf;fw;whd;   ,itfspd; NtH tiff;F 25 gyk; (875 fpuhk;) 
 rpj;jpu%yk; 
 ntz;rptij 
 
 rJuf;fs;sp 
 jpUFfs;sp   ,itfspd; NtH tiff;F 50 gyk; (1750 fpuhk;) 
 ,tw;iw rpijj;J 4 kuf;fhy; Mw;W[yj;jpy; fiuj;J vhpj;J ½ kuf;fhyhf;fpd 
frhaj;jpy;> nrt;ts;sp nfhb> fLF> jpg;gpyp%yk;> fLf;fha; jhd;wp> ney;yptw;wy;> 
Rf;F> kpsF> jpg;gpyp> fLFNuhfpzp> tpohthprp> epyNtk;G> nrt;tpak;> fLf;fha;gpQ;R> 
fHf;flfrpq;fp> ahidj;jpg;gpyp> Xkk;> nts;isg+z;L> ngUq;fhak;> ,e;Jg;G. 
 fha;r;Rytzk;  - tiff;F gyk; ½ 
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 ,tw;iw R+uzpj;J Njq;fha; ghyhy; miuj;J> fiuj;J> ey;nyz;nza;> 
Njq;fha;g;ghy; tiff;F ½ kuf;fhy; tpl;L fye;J vhpj;J tbj;J> ¼ kz;lyk; (12 
ehl;fs;) new;Glj;jpy; itf;fTk;. 
 
 msT: 1 tuhfd; (4.2 fpuhk;) (fhiyapy; kl;Lk;) 
 
 jPUk;Neha;fs;: R+jfrd;dp> R+jfthA> R+jftyp> Fd;kk;> cd;khjNuhfk; 
FzkhFk;. 
 
 gj;jpak;: ,r;rhgj;jpak;. 
 
tisaYg;G 
FULLERS EARTH 
 
NtWngaH:1                               
 “klthH fuj;Jg;G” 
 
fpilf;Fk; tpjk;24 
 tisay; nra;Ak; nghUl;Lf; fha;r;rpa cokz; cg;gpdpd;W ,aw;ifapy; 
fpilf;Fk;. 
 
Rj;jp24 
1. ,jid Ntz;ba msT vLj;Jg; Gspj;j fhbePhpy; xU K$Hj;jfhyk; (90 
epkplk;) Cwitj;njLj;J R+hpa ntg;gj;jpy; cyHj;jp naLf;f ,J Rj;jpahFk;. 
2. ,jidf; fhbapy; fiuj;Jj; njsptpWj;J R+hpa ntg;gj;jpy; itj;J cyHj;jpf; 
nfhs;sTk;. 
 
nghJFzk;24 
 “JisahH Fly;thjj; njhe;jth jj;Njh 
 gpisahr; RthrkW kpd;Dk; - tisaYg;ghw; 
 Fd;ktyp R+iy ntg;gq; $whg;gp yPfkpit 
 nrd;kk;tpl; NlhLnkdj; NjH”. 
 
nghUs;: 
 tisaYg;gpdhy; Fly;thjk;> thjgpj;jk;> ,iug;G> tapw;Wtyp> fPy;gpbg;G> Ruk;> 
gpyPfk; Kjypad ePq;Fk;. 
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R+jftypf;F tisaYg;G NrUk; kUe;Jfs; : 
 
1.  Fd;k cg;G R+uzk;30 
 NrUk; kUe;Jfs;: 
 Nrhw;Wg;G> rTl;Lg;G> tisaYg;G> fy;Yg;G> ntbAg;G> ,e;Jg;G> thpf;Fkl;bfha; 
rhW. – Njitahd msT 
 NkhH – Njitahd msT 
  
msT> JizkUe;Jk;: 
 1 Kjy; 2 fpuhk; tiu> Nrhw;wpd; ePuhfhuj;Jld; fhiyapy; ntWk; tapw;wpy; 
khjtpyf;F ehl;fspy; kl;Lk; juTk;. 
  
jPUk; Neha;fs;: 
 R+jftyp> R+jfNeha;fs;> tapw;Wtyp> fUg;igfl;b> Fd;kk;> nfz;il> 
mfl;LthA> Fd;kf;fl;b> mFitf;fl;b 
 
2.  Fd;kk; jPu Nyfpak;: 
 fUg;gl;b 
 fhuk; 
 rhuk; 
 ntbAg;G 
 rTf;fhuk; 
 tisaYg;G 
 ,e;Jg;G 
 nghhpfhuk; 
 R+lDg;G 
 fUg;gl;bia mKhpapy; fye;J nfhz;L fiuj;J vhpf;fTk;.  ghF gjj;jpy; 
Vida cg;Gfisg; NghlTk;.  Nghl;lTld; nkOF gjk; tUk;. 
 
 msT: 10 ehl;fs; cz;zTk;. 
 
 jPUk;gpzpfs;: 
 rj;jp Fd;kk;> gpj;j Fd;kk;> vhpFd;kk;> neQ;rilg;G> R+jftyp> %Hr;ir vd;gd 
jPUk;. 
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ntq;fhuk; 
SOSDII BI BORAS, SODII BORAS,BORAX 
 
NtWngaHfs;: 
 nghhpfhuk;> fhuk;> cUf;fpdk;> cUf;F kpj;jpud;> lq;fzk;> J}kj;ijalf;fp. 
 
fpilf;Fkplk;: 
 mjpf mstpy; fypNghHdpahtpYs;s fpspaH VhpapYk;> ngU vd;w ,lj;jpYk;> 
,e;jpahtpy; jpngj;> Neg;ghsk; Kjypa ,lq;fspYs;s VhpfspYk; fpilf;fpd;wJ.  
kz;Zld; fye;jpUf;Fk; ,t;Tg;Gf; fw;fis> ePhpy; fiuj;Jg; gpwnghUs;fis ePf;fp 
kWgbAk; fha;r;rp cg;ghf;fpf; nfhs;sy; tof;fk;. 
 Mifapdhy;> mjw;F ehd;F gq;F nte;ePUk;> rpwpJ Rz;zhk;Gk; $l;b> 
tbfl;b> R+hpa ntg;gj;jpy; itj;jhtJ jPapypl;nlhpj;jhtJ mjpYs;s ePiug; Nghf;fp 
cg;ig vLj;Jf; nfhs;sy; Ntz;Lk;. 
 
gz;G: 
 nts;isaha;> njsptha;> rpy Nfhzq;fNshL $bajha; nfhQ;rk; 
kpDkpDg;gha; ,Uf;Fk;.  ,J ePhpy; fiuAk;> rhuhaj;jpy; fiuahJ> fhw;Wg;gLk;gb 
itj;jhy;> cg;gpd; Nky; ntz;zpwj;J}s; gbAk;.  ntq;fhuj;ijg; nghhpj;jhy;> 
mjpypUf;Fk; ePH Rz;bg; nghhpe;J> mjpy; rpwpa Jthuq;fs; Njhd;Wk;. 
 
ntq;fhu itg;G 
 xU nghpa ghz;lj;jpy; G+ePW (1.3 ypl;) jz;zPH gb 8 (10.4 ypl;) NrHj;Jf; 
fiuj;Jj; njspntLj;J> ,jpy; gUg;Gg; NghyTk;> gyif gyifahfTk; cilj;j 
rPdk; gyk; 100 (3500 fpuhk;)> ntbAg;G gyk; 6 ¼ (219 fpuhk;) NrHj;J 1 gl;rk; R+hpa  
ntg;gj;jpy; fhaitf;fpy; fWf;Fk;.  ,ij mLg;Ngw;wp> fs;spRl;l rhk;gy; 1 gb (1.3 
ypl;)> Fd;wpapiyr;rhW 1 gb (1.3 ypl;) Mkzf;F nea; ½ gb (650 kp.ypl;) $l;b> 
nghq;fhjthW fkyk; Nghy; jP%l;b 4 ehopif vhpj;J> thafd;w ghj;jpuj;jpY}w;wp xU 
gl;rk; nta;apypy; itf;f ntq;fhukhFk;. 
 
kfpik: 
 ,e;jg; nghUs; 64 ruf;ifAk; fl;Lnkd;Wk;> cgurk; 120 – IAk; 
rj;jhf;Fnkd;Wk;> fhuj;ijf; fl;Lnkd;Wk;> fsq;F> nre;J}uk;> FU ,itfl;F 
MjpahFnkd;Wk; ,jd; kfpik $wg;gl;Ls;sJ. 
 
Rit: 
 ,dpg;Gld; $ba JtHg;Gr; Ritia cilaJ. 
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tPhpak;: 
 ntg;gnkd;W $wg;gl;Ls;sJ.  ,jid “ntq;fhuk; nta;njdpDk; Neha; 
jPHf;Fk;” vd;w mbahy; czuyhk;. 
 
nra;if: 
 FspHr;rp cz;lhf;fp> rpWePH ngUf;fp> UJ cz;lhf;fp> gpurtfhhp> fw;fiur;rp> 
rkdfhhp> cly;Njw;wp> mOfyfw;wp> JtHg;gp. 
 
nghJFzk;: 
 “nrhwpGilnaz; Fd;keik Nrhhp ahrk; 
 gwpfpufzp fy;Y}dk; gd;Ndha; - newpiaj; 
 jlq;fzq;f gq;fpUkp rHg;gtplQ; re;ep 
 aplq;fzq;f yf;fpw;Ngh nkz;.” 
 
nghUs;: 
 ntq;fhuj;jpdhy;> jtisr; nrhwp> Gil vz;tiff; Fd;kk;> jpdT> ,uj;j%yk;> 
xOf;Ff; fpufzp, m];khp> gq;Fthjk;> gy; Neha;> ehstopiaj; jLf;fpd;w 
%j;jpufphpr;ruq;fs;> fghjpf;fk;> GO> ghk;G Kjypaitfshy; cz;lhFk; eQ;R> 
re;epghjk; Kjypa Neha;fs; ePq;Fk;. 
   
“ntq;fhuf; Fzkpnjd;W tpjKlDiuf;ff; Nfsha; 
  rq;fhu khFe;Njh]e; jd;idNa rq;fhpf;F 
  Kq;fd Yjtpapy;yh Tjuj;jpy; thAkhw;Wk; 
  nghq;fpa ,Uky;khe;jk; Nghf;fpL Kz;ikjhNd.” 
nghUs;: 
ntq;fhuk; Njh]pj;j Njhlk;> cjuthA> ,Uky;> khe;jk; Kjypatw;iwg; 
Nghf;Fk;. 
“ntq;fhuQ; Nrj;Jkj;ij NtWgz;Z NkfLF 
 jq;Frpy ePHKwpaj; jhd;thq;Fk;.” 
nghUs;: 
 ntq;fhuk; fgj;ijAk; ePHg;gpzpiaAk; ePf;Fk;.  kw;Wk; ,J ke;jg;gpurtk;> tha; 
tpuzk;> Kiyf;fhk;G tpuzk;> R+jfg;ghz;L> R+jff;fl;L> R+jfr;R+iy> ngUk;ghL> 
ePHf;Nfhit> fhf;iftyp> gpurt mjprhuk; Kjypa Neha;fisAk; Nghf;Fk;.  ,jid 
ke;jg;gpurt Ntjidapy; fUg;igiar; RUq;fr; nra;af; nfhLg;gJz;L. 
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Rj;jpKiwfs;: 
 ,jidf;  fpopfl;b> vUikr; rhzj;ij ePhpy; fiuj;Jf; nfhjpf;f itj;J> 
mjpy; fpopia mOj;jp mOj;jp vLj;J> Rj;j ePhpy; fOtp R+hpa ntg;gj;jpy; 
cyHj;jr; Rj;jpahk;. 
 ntq;fhuj;ijr; rPiyapy; Kbe;J vUikr; rhzj;jpy; nghjpe;J itj;J> 3 
ehl;fs; nrd;wgpd; Rj;j ePhpy; fOtp cyHj;jr; Rj;jpahk;. 
 gRtpd; rhzg;ghypy; ,jidf; fOtp cyHj;jr; Rj;jpahk;. 
 vUik %j;jpuj;jpy; ,ij %d;W ehopif Cwitj;J vLf;fr; Rj;jpahk;. 
 ,jidr; rl;bapypl;Lg; nghhpj;Jf; fhbapy; gor;rhw;wpyhtJ miuj;J cyHj;jp 
vLf;fr; Rj;jpahk;. 
 ,jid ePHtw;Wk;gb nghhpj;Jf; nfhz;lhy; Rj;jp 
 gor;rhw;wpyhtJ mhprpf; fOePhpyhtJ miuj;J cyHj;jpf; nfhz;lhy; Rj;jp. 
 gor;rhw;wpyhtJ fhbapyhtJ nehr;rpapiy rhw;wpyhtJ Jitj;Jj; Jitj;J 
cyHj;jpdhYk; Rj;jpahFk;. 
 
cgNahfq;fs;: 
 xU tuhfndil (4.2 fpuhk;) nghhpj;j ntq;fhuj;ij fha;r;rp Kwpj;j Njd; 1 
gyj;jpy; (35 fpuhk;) fye;J> tha;g;Gz; mf;fuk; ,itfl;Fj; jlt Fzj;ijf; 
nfhLf;Fk;.  ,jid ntq;fhu kJ vd;gJ ngaH. 
 ntq;fhuk; gyk; xd;Wf;F (35fpuhk;) vl;Lg;gb (10.4 ypl;) ePh; tPl;Lf; fyf;fpf; 
nfhs;sTk;.  ,jw;F ntq;fhu ePH vd;gJ ngaH.  ,jid tha;g;Gz;> 
njhz;ilg;Gz;> ,urNtf;fhsk;> mf;fuk; Kjypa Neha;fspy; tha; 
nfhg;Gspg;gjw;Fk;> Gz;> Mrd ntbg;G ,itfisf; fOTtjw;Fk; 
cgNahfpf;ff; Fzj;ijj; jUk;. 
 ntq;fhuk; 1 tuhfndilia (4.2 fpuhk;)> 1.8 Mohf;F (21 kp.ypl;) ePhpy; 
fiuj;J> Kiyf;fhk;G ntbg;G> Gz; ,itfSf;Fj; Jzpapy; eidj;J 
NkYf;Fg; Nghlf; FzKz;lhFk;.  Foe;ijf;Fg; ghy; nfhLf;Fk;nghOJ 
];jdj;ij ed;whff; fOtpf;nfhs;s Ntz;Lk;. 
 ntq;fhuk; 2 tuhfndilia (8.4 fpuhk;)> 1 ½ Mohf;F (252 kp.ypl;) ePhpy; 
fye;J gpuNkfk;> ngz;fSf;Ff; fhZk; fUg;g Nkfk; ,itfSf;Fg; gPr;rf; 
FzKz;lhk;. 
 R+jff;fl;L> R+jfr;R+iy> R+jfg; ghz;L> ngUk;ghL> kNfhjuk;> fhf;iftyp> 
gpurt mjprhuk; Mfpa ,itfSf;F ntq;fhuk; 2 ½ (325 kp.fpuhk;) Kjy; 7 ½ 
Fd;wp (975 kp.fpuhk;) tiu> jpdk; 2 my;yJ 3 Kiw nfhLf;fyhk;.  ,ij 
czTf;Fg; gpwF nfhLf;f Ntz;Lnkd;gH. 
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R+jftypf;F ntq;fhuk; NrUk; kUe;Jfs;: 
 
1. ,q;F]<mikq cUz;il7 
 NrUk; kUe;Jfs;: 
 Nky;Njhy; rPtpd Rf;F> kpsF> mhprpj;jpg;gpyp> fUQ;rPufk;> ew;rPufk;> ,e;Jg;G> 
fUNtg;gpiy> Rj;jpnra;j ntz;zhgp nghhpj;j ntz;fhuk;> nghhpj;j ngUq;fhak;> 
Gspak; Gwzpr;rhk;gy; ,tw;wpd; J}s; tiff;F ¼ gyk; (8 ¾ fpuhk;)> ,Q;rpr;rhW> 
vYkpr;rk;gor;rhW ,it tiff;Fr; nry;yj;jf;f msT. 
nra;Kiw: 
 vy;yhtw;iwAk; xd;whff; fye;J mk;kpapy; itj;J Muk;gj;jpy; 
,Q;rpr;rhw;iwr; rpWfr; rpWf thHj;J ehYkzp Neuk; miuj;Jg; gpwF vYkpr;rk; 
gor;rhw;iwr; rpWf rpWf thHj;J ehd;Fkzp Neuk; miuj;J> Njw;whd; nfhl;ilg; 
gpukhzk; khj;jpiufs; nra;J epoypy; cyHj;jp Fg;gpapy; itj;Jf;nfhs;sTk;. 
 msT:  ½ Kjy; 1 khj;jpiu. 
 mDghdk;: Njd;> nea;> FbePH tiffs; Kjypaitfshk;. 
jPUk;Neha;fs;: mdy;ke;jk;> gpj;jthA> gytifnrhpahik Neha;> 
tapw;Wg;nghUky;> tapw;Wg;Grk;> tapw;wpiur;ry;> R+jf thA> R+jftyp Mfpaitfs; 
jPUk;. 
      gj;jpak;: 
 cly;typik> Neha;typik> clypay;G KjypaitfSf;Fj; jFe;jgb 
gj;jpaNkw;gLj;jTk;. 
 
2.  Fd;kFNlhhp nkOF29 
 NrUk; kUe;Jfs;: 
 Nrhw;Wg;G> tisaYg;G> ntq;fhuk;> fy;Yg;G> ,e;Jg;G> cokz;> ethr;rhuk;> 
ntbAg;G> Rf;F> jpg;gpyp> kpsF> Xkk;> fpuhk;G> Nkhb> Nfh]<lk;> ngUq;fhak; ,itfs; 
tiff;F 1 gyk;.  (35 fpuhk;) chpj;j g+z;L – 5 gyk;> (175 fpuhk;) gidnty;yk;> 
Njd; tiff;F 5 gyk; (175 fpuhk;). 
 nra;Kiw:  
 ,itfis fy;tj;jpypl;L ,sfpa gjk; tUk; kl;Lk; miuj;Jf; nfhs;sTk;. 
 msT: Rz;il msT ,UNtis. 
 jPUk;Neha;fs;: UJfhyj;jpy; cz;lhFk; R+jftyp> Fd;kk;> gpj;jthA> ke;jk;> 
mrPuzk;. 
3.  uq]Ohkq jpuhtfk;5 
4.  Fd;kk;jPu ,Nyfpak;.28 
5.  fHg;gf;Fok;G26 
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fy;Yg;G 
NtWngaHfs;:24 
 flw;FUtp 
 
NtWngaHfs;25 
 md;d $Hik   flw;FUtp 
 mWRitr; rhjp  Ntiy ePH 
 etHr;ry khwp  fhkp 
 kpUj;jpa nfe;jk;  ntl;lntsp tpkyd; 
 Fb nfLj;Njhd;  mow; nrhhpe;j Tg;gp 
 ctUg;gpd; Fzk;  thjk; rikf;F ytzk; 
 muf;fp    Frtd; 
 Matd;   Ntjd; 
 ctHf;fhud;   nfhs;sp 
 
fy;Yg;gpd; gpwg;G: 
fpilf;Fkplk;: 
 ,J ,aw;if tif cg;Gf;fspy; xd;W.  flYf;Fs; kiyNghyf; fl;baha;g; 
ghiwaha; tsHe;J epw;Fk; vd;Wk;> fl;bdf;fhy; fhpapy; nghd;Nghy; epd;W 
cUfpahLnkd;Wk;> kw;w cg;Gfis nky;y nky;yf; fhp Fbj;J tpLnkd;Wk; 
$wg;gl;Ls;sd. 
Rj;jp24 
 fy;Yg;igf; fhbj; jz;zPhpy; gprwp gpwF <uj;ijj; Jzpapy; Jilj;J 
nta;apypy; cyHj;jpf; nfhs;sr; Rj;jpahFk;. 
nghJFzk;: 
 “IakWQ; R+iy aNuhrpgpj;jQ; rj;jpnahL 
 nta;agpzp al;lFd;kk; tpl;NlFk; - nga;tisNa 
 thjkjp jhfk; kyf;fl;Lk; NghKyfpw; 
 NfhjW fy;Yg;igf; nfhL” 
 fy;Yg;gpdhy; fgk;> Fj;jy;> mUrp> gpj;jk;> the;jp> c];zthA> vz;tpj 
Fd;kk;> thjNeha;> kyge;jk;> ehtwl;rp NghFk; 
R+jftypf;F fy;Yg;G NrUk; kUe;Jfs; 
1.  fy;Yg;G gw;gk; 2 
 fy;Yg;ig nfhl;ilf;fue;ijapd; rhw;why; miuj;J 5 rpWGlk; Nghl;L gpwF 
rpWnrUg;gil rhw;why; miuj;J 5 rpW Glk; Nghl gw;gkhFk;. 
 jPUk;Neha;fs;:  R+jftyp> Fd;kk; Kjypaitfs; jPUk; 
 mDghdk; : nty;yk;. 
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2.  fy;Yg;G nre;J}uk;:27 
 fy;Yg;ig mOf;F Nghf myk;gp cyHj;jp nfhs;f.  xUgb fy;Yg;nghb 
nra;J xU rl;bapy; Nghl;L MLjPz;lhghisr;rhW nfhQ;rk;; nfhQ;rkha; miug;gb 
rhW tplTk;.  ,g;gb tpLk;NghJ jpuhtpf; nfhLf;f nfhLf;f cg;G fUg;gha;NghFk; 
mij vLj;J Nkw;gb rhw;why; miuj;J tpy;iyj;jl;b cyHj;jp Xl;bypl;L rPiykz; 
nra;J 8-vUtpy; Glk; NghlTk;.  ,t;tpjkhf nre;J}uk; rpfg;Gepwk; tUk;tiuapy; 
mjhtJ 8-tJ Glj;jpy; rptg;ghFk;.  Xt;nthU Glj;jpYk; vU Fiwj;Jf; nfhz;Nl 
tuNtz;Lk;. 
 msT:  gz vil (488 kp.fpuhk;) vLj;J jf;f mDghdj;jpyplTk; 
 jPUk;Neha;fs;: Fd;kk; - tapw;Wtyp> R+jftapw;Wtyp> ,Uky;> fhrk;> ]ak; 
Kjypa Nuhfq;fs; FzkhFk;. 
3.  Njq;fha; ,sfk; 7 
4.  Fd;k cg;G R+uzk; 30 
5.  Fk;kl;b fha; Fok;G 2 
6.  Fd;k FNlhhp nkOF 29 
8.  etFd;k etePj nre;J{uk;27 
fy;ehH 
ASBESTOS 
 
fpilf;Fkplk;: 
 ,g;nghUs;. ikR+H rk];jhdj;jpYk;> [g;ghd; Nghd;w rpy ehLfspYk; 
fpilf;fpd;wJ.  ,jidg; G+kpapypUe;J ntl;b vLf;fpd;whHfs;.  ,jw;F ]qfpkh 
vd;gJ [g;ghdpaH nkhopapy; ngaH.  ,J ghHg;gjw;Ff; fy;iyg; NghyTk; eRf;f 
eRf;f ehH ehuhfTk; ,Ug;gjdhy; ,g;ngaH ngw;wJ. 
 
tiffs;: 
1. ehl;Lf;fy;ehH 
2. rPikr;fy;ehH 
3. vUikf; nfhk;G fy;ehH. 
 
Nghfh; $w;Wg;gb> ,uz;L tifg;gLk; mit: 
1. gr;irf; fy;ehH 
2. nts;isf;fy;ehH  ,it ,uz;by; nts;is cj;jkk;. 
nra;if: 
 rpWePHg; ngUf;fp 
 JtHg;gp 
 rkdfhhp 
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nghJf;Fzk;: 
  “fhrgpj;jk; thjq; fLg;gPW NehnahpT 
  tPRrHj;jp ePuilg;G tpe;J el;lk; - NgRkir 
  jpd;dhiuf; $Tke;je; jPf;FlHf;fhy; jhfkpit 
  fd;dhiuf; $ttpLq; fhz;.” 
  
nghUs;:   
fy;ehhpdhy; gpj;jfhrk;> thjNuhfk;> gy;Neha;> gy;yuiz> ePHf;Fwp vhpr;ry;> 
gpj;jthe;jp> ePuilg;G> tpe;Jel;lk;> m[Puzk;> gpj;jFly;thjk;> gpj;jjhfk; Kjypad 
ePq;Fk;. 
 
Rj;jpKiwfs;: 
 fOij ePhpy; %d;W ehopif thl;bf; fOtp vLj;Jg;gpwF nta;apypy; 
fhaitj;njLf;fr; Rj;jpahk;. 
 gRtpd; ePhpy; fy;ehiug; gj;Jehs; Cwitj;Jf; fOtp vLf;fr; Rj;jpahFk;. 
 
fy;ehH NrUk; kUe;Jfs;: 
 
1.  fy;ehH Rz;zk;24 
 fy;ehUf;Fg; gor;rhW tpl;L miuj;J> tpy;iy jl;bf;fha itj;Jf; 
Fifapypl;Lj; JUj;jp> nfhz;L Cj> Rz;zhk;G epwj;Jld; $ba ntSg;ghFk;: 
fhuKilajha; ,Uf;Fk;.  fharpj;jpf;F ,jidj; jhk;G+yj;Jld; jpd;dNtz;L 
nkd;gH. 
 
2.  fy;ehH gw;gk; 24: 
 gRtpd; ePhpy; Rj;jpnra;j fy;ehUf;F MLjpd;dhg; ghisr;rhWtpl;L miuj;J 
tpy;iy nra;J cyHj;jpr; rpy;ypl;Lr; rPiy nra;J nfrGlkpl;nlLf;fg; 
gw;gkhk;. 
 ,jid 2 (260 kp.fpuhk;) Kjy; 4 Fd;wp (520 kp. Fpuhk;) viltiu nea; 
my;yJ ntz;nzapy; mDghdpj;Jf; nfhLf;f> ePHf;Fwp vhpr;ry;> ePuilg;G> 
tpe;J el;lk; Kjypad ePq;Fk;. 
 fy;ehiur; rpW Jz;lhfg; gpse;J Xl;bypl;L> mjw;Ff; fPOk; NkYk; 
Nfhq;fpytk; gl;ilia ,bj;Jg; Nghl;Lg; Glkpl;Lg; gpwF Nkw;gb FbePH 
tpl;liuj;J> %d;W Glk; Nghlg; gw;gkhk;.  ,jidj; Njd; my;yJ 
J}JNtis Nyfpaj;jpy; nfhs;s> fgNehAk; 96 tifg;gl;l Nkf fhq;ifAk; 
jPUk;.  gw;gj;jhy; gy; Jyf;fj; je;jk; ,WFk;. 
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3.  ehl;Lf; fy;ehH gw;gk; 9 
4.  nfhkl;b ,Nyfpak; 15 
5.  et%yehr khj;jpiu2 
6.  fe;jhjp ,Nyfpak;13 
7.  Nkfhjp #uzk;31 
8.  Nkfuh[hq;f gw;gk;10 
 
g+uk; 
(,urf; fw;g+uk;); 
HYDRAGYRUM SUBCHLORIDE (CALOMEL) 
 
njhiff; $wg;gl;l mWgj;J ehd;F ghlhzq;fSs; fhzg;glhjpUe;Jk;> G+uk; 
kUj;JtHfshy; ghlhz tiffs; xd;whfNt fUjg;gLfpd;wJ.  ,.J ,urk;> cg;G 
,itfspd; $l;bdhy; nra;ag;gLfpd;w ruf;fhFk;. 
nra;Kiw: 
 xU ghz;lj;jpy; 16 tuhfndil (67.2 fpuhk;) fe;jfk; itj;J cUf;fp> 80 
tuhfndil (336 fpuhk;) ,urk;> NrHj;J Johtpf; nfhz;bUe;jhy;> fWj;Jj; 
J}shfptpLk;.  gpwF NtnwhU ghz;lj;jpy; ghjpf;Fr; nrq;fy; nghbiag; Nghl;L> 
mjd;Nky; miug;gb (650 kp.ypl;) fwpAg;ig itj;J> cg;gpd; Nky; Nkw;gb 
,urfe;jpia itj;J> rPiykz; nra;J> 12 kzpNeuk; fhlhf;fpdpaha; vhpj;J vLj;Jf; 
FspHe;j gpwF Nky;ghz;lj;ijr; rhf;fpuijaha; ePf;fpg; ghHj;jhy; g+uk; fl;baha;g; 
gbe;jpUf;Fk;. 
Rit:  cg;G> fhHg;G 
tPhpak; : ntg;gk; 
gphpT : fhHg;G 
nra;if clw;Njw;wp> ckpo;ePH ngUf;fp> fpUkp ehrpdp> gpj;jePH ngUf;fp>  
NgjpAz;lhf;fp 
nghJFzk;: 
  “,ilthj R+iy nahpR+iy Fd;ke; 
  njhilthio thjkhQ; Nrhzp – apilahNjh 
  nthf;Fur fHg;G+u nkhd;Nw asnthLey; 
  ,f;Fnty;yj; NjOeh sP”. 
  
nghUs;: ey;y ,ur fHg;G+uj;ij msTld; fUk;G nty;yj;jpy; VOehs; 
nfhLf;f> ,Lg;igg; gw;wpa R+iy> Mq;fhq;F vhpr;riyj; jUfpd;w R+iy> thj 
Fd;kk;> njhilthio> thjuj;j Neha; Kjypad jPUk;. 
 75
Nkw; $wpa nra;As; rpy Neha;fisNa Fwpg;gpbDk; G+uj;ij Ruk;> kQ;rl; 
fhkhiy> gpj;j Njhlk;> rPjNgjp> ePHf;Nfhit> tpuzre;ep> Mwhj tpuzq;fs;> Nkf 
tpahjp> nrhpahik> the;jp> Ngjp> fpUkp Neha;> fPy;thjk;> nrhwp> rpuq;F> kyge;jk; 
Kjypaitfl;Fk;> jiytyp Nghd;w kw;iwa Neha;fSf;Fk; cgNahfpg;gijg; 
gof;fj;jpy; fhzyhk;. 
Rj;jpKiw: 
 fk;khW ntw;wpiy> kpsF Mfpa ,uz;ilAk; fhy;gyk; (8.75 fpuhk;) tPjk; 
epWj;njLj;Jr; rpwpJ ePH tpl;L miuj;J> fy;fj;ij xU gb (1.3 ypl;) ePhpy; 
fye;J> xU gyk; (35 fpuhk;) g+uj;ijr; rPiyapy; Kbe;J Jyhae;jpukha; ePhpy; 
mkpOk;gb nra;J> rpW jPahy; vhpf;f Ntz;Lk;.  ePH Kf;fhw;gq;F Rz;ba gpwF 
g+uj;ij vLj;J ePHtpl;Lf; fOtp nta;apypy; cyHj;jp vLf;fr; Rj;jpahk;. 
 xU gyk; (35 fpuhk;) g+uj;jpw;F Kiyg;ghypdhy; %d;W kzp Neuk; RUf;Ff; 
nfhLj;Jg; gpwF nts;isg; g+z;Lj; ijyj;jpdhy; xd;gJ kzp Neuk; 
RUf;fpl;L vLj;Jf; nfhs;sTk;. 
 ,Nyfpaq;fspy; NrHf;f Ntz;ba g+uj;ij> KRKRf;ifr; rhw;wpdhy; RUf;fpl;Lf; 
fOtTk;. 
G+uk;NrUk; kUe;Jfs;: 
1.  G+u gw;gk;: 
 Rj;jp nra;j g+uj;ijf; fy;tj;jpypl;L VOehs; ed;wha; miuj;Jg; gpwF 
Nrfhpj;Jf; nfhs;sTk;.  ,JNt G+ugw;gnkd;W ifahsg;gLfpd;wJ. 
 msT:  miu cSe;njil (32 kp.fpuhk;) apypUe;J %d;W cSe;njhil (195 
kp.fpuhk;) tiu cgNahfpf;fyhk;.  ,uz;L cSe;njil (130 (kp. fpuhk;) f;F Nkw;glf; 
nfhLj;jhy; NgjpahFk;. 
 JizkUe;Jk; jPUk; Neha;fSk;: fUk;G nty;yj;jpy; VO ehs; mUe;j> nghJf; 
Fzj;jpd; fPo;f; $wg;gl;l Neha;fs; ePq;Fk;. 
2.  G+uf;fl;L: 
 rhk;gpuhzp> fUg;G+uk; ,uz;ilAk; rkdha;r; NrHj;jiuj;J> xU gyk; (35 fpuhk;) 
G+uf;fl;bapd; Nky; ftrkpl;L> cyHj;jpf; nfhSj;jp vhpj;j gpwF> ftrj;ij 
ePf;fptpl;Lr; ruf;if vLj;Jf; nfhs;sTk;. 
3.  g+u vz;nza;: 
 ,urf;fUg;g+uk;> Vyhprp> Rf;F tiff;F xU gyk; (35 fpuhk;) vLj;Jg; 
nghbj;Jf;nfhz;L> G+uj;ijAk;> ed;wha;g; nghbj;J> rpw;whkzf;nfz;nza; 40 gyk; 
(1400 fpuhk;) vLj;J mijr; rpwpJ rpwpjha;g; G+ug; nghbapy; tpl;liuj;J Kbtha; 
kw;iwa ,uz;L ruf;ifAk; fye;J nfhs;sTk;. 
 msT:  miu (14 kp.ypl;) Kjy; xU mTd;]; (28 kp. ypl;) %d;W ehs; fhiy 
khj;jpuk; nfhLf;fTk; 
 cgNahfk; : kyk; fopAk;> Foe;ijfspd; khe;j Neha; jPUk;.  Nkf 
Nuhfq;fSk; Fd;kKk; ePq;Fk;. 
 ,t;ntz;nzAld; tha;tplq;fj;J}s; NrHj;J cgNahfpf;f fpUkp ePq;Fk;. 
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R+jftypf;F G+uk; NrUk; kUe;Jfs;: 
 
1.  ,ur,ypq;f nkOF: 2 
  
     NrUk; kUe;Jfs;; ,urfHg;G+uk;> ,ypq;fk; - rk msT 
 nra;Kiw:  
,t;tpuz;ilAk; Kiyg;ghyhy; 1rhkKk; (3kzpNeuk;)> vYkpr;rk;gor;rhw;why; 1 
rhkKk; (3 kzpNeuk;)> Njdhy; 1 rhkKk; (3 kzpNeuk;)>  miuj;J xU ,Uk;Gf; 
fuz;bapy; Nghl;L Nkw;gb rhW nfhQ;rk; tpl;L jPgj;jpd; Nky; gpbf;f cUfp 
nkOfhFk;. 
 msT:  gzvil (488 kp.fp.) 
 mDghdk; : gid nty;yk; 
 jPUk; Neha;fs; : R+jftyp> tapw;Wtyp. 
 
R+jfNeha;f;F ,ur fw;G+uk; NrUk; kUe;Jfs;: 
 
1. gQ;retNyhf nkOF 10 
2. ekdhr nkOF9 
3. NfhNuhrid nkOF6 
4. rz;lkhUj nre;J}uk;6 
5. Kg;G+u nre;J}uk;6 
 
gidnty;yk; 
BORASSUS FLABELLIFORMIS - JAGGERY 
 
“tl;Lgd nty;yj;jhy; khHnthpr;ry; Fd;kkWk; 
Kl;Lj; jphpNjh]k; Kd;dpw;fh - fl;Lglh 
the;jp Urpapd;ik thsh Aw;wp bDk; 
rhe;jp ngUFnkd;Nw rhw;W34 
 
nghUs;: 
gidnty;yj;jhy; Rure;jpghjk;> jphpNjh]! njhe;jq;fs;> mNuhrfk;> Fd;kk;> 
khHG vhpr;ry; ,it ePq;Fk; 
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CHEMICAL ASPECT 
SEENAKARAM 
 
ALUMEN 
 
 Sans-Sphatikari; Surashtraja; Kamakshi; Tuvari. Eng-Alum; Sulphate of Alumina and 
Potash  Arab-Shabb-zaje-abyaz; zaj. Hind-Phitikhari; Phitkari. Ben –Phatkiri.  Mah-Turati; 
Tam-Pati-karam; Padikharam; Shinacarum. Tel-Pattikaramu;  
 Source- Chiefly found with peroxide of iron in Silajit or in Alum earths of Nepal or 
prepared from the alum shales in the Punjab, Rajputana, Bihar and with states. As found is 
the bazaars, it is often mixed with impurities; it may be rendered fit for medicinal purposes 
by dissolving it in boiling water, straining the solution and evaporating it so as to obtain 
crystals, which should be preserved for use. 
 Characters- Colourless, transparent crystals, with acid, sweetish astringent taste. 
 Action- Astringent,caustic, haemostatic, antispasmodic and antiseptic; irritant and 
purgative in large doses; emetic in repeated doses. It constringes small vessels and organic 
fibres and thus acts in diminishing the exhalations, secretions and supply of blood to a part. 
USES: 
 It is useful also in strangury and vomiting in small doses, i.e  2 to 10 grains. Ten 
grains of it arrests the spasms of asthma.  
Alum in 5-grain doses thrice a day with the juice of Adhatoda vasica works 
wonderfully in certain forms of leucorrhoea, especially when the flow is tinged with blood.  
In haemorrhages from kidneys, uterus and other internal organs alum in does of 10 to 
12 grains thrice daily with or without opium is given with benefit, but not when much fever 
is present.  
Alum whey or ‘lime whey’  prepared by boiling for 10 minutes two drachms of 
powdered alum in a point of milk and  strained is beneficial in doses of ½ to 2 ounces thrice 
daily in menorrhagia and  bleeding piles. 
 “Alum lotion, internally, is administerd to check haemorrhage from lungs, stomach, 
kidneys and other organs or to arrest excessive menstrual flow.”   
slimier alum plugs combined with glyarine or alum douches may be used in 
leucorrhoea. 
 In cases of post partum haemorrhage or menorrhagia, sterilized cotton plugs 
saturated with alum powder or sterilized alum lotion (5.p.c.) immediately stop the bleeding. 
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POTASSIUM  NITRATE: POTASSIUM NITRAS  
VEDIUPPU 
San   : yavakshar, saindhava  
Eng   : salt petre, Nitre, Nitrate of potesh 
Arab   : Abkar 
Tamil              : pottil uppu 
Mal   : vedi-uppu 
Tel   : patlu-uppoo 
Guj   : shoratchar 
SOURCE: 
 It is also obtained from collections of the saline earth after the rains, from the land 
inundated during the rains and from mud heaps, mud buildings, and other places on which it 
is formed and then subjected to a process of solution and filtration through a crude mud 
filter.The impure nitre is known as dhoah and contains about 45 to 75 percent of the actual 
salt, the remainder being sulphate and chloride of sodium and insoluble matter.  
ACTION: 
 Refrigerant, efficient, diuretic, diaphoretic, Irritant it acts on the vascular system and 
thus reduces the frequency of the pulse.  
USES: 
 In week solutions, 1 to 2 drachms in a quart of thin warm rice conjee it is an 
excellent refrigerant drink in fevers with hot and dry skin, parched tongue, with 
great thirst and scanty and highcoloured urine. 
 It is useful also in the early stages of dropsy, in cases of smallpox, measles, 
influenza, catarrh, gonorrhoea, acute rheumatism, bleeding from the lungs , 
stomach, uters or other internal organs attended by fever. 
 It is used in colicky pains.  
 A confection made of nitre5, cinnamon 4, chebulic myrobalan and Iris 
pseudocorus, each 3, cardamoms 5 and sugar 20 parts is used in chronic 
gonorrhoea and gleat Dose –1 drachm. In obstinate cases of leucorrhoea a  
combination of nitre 10 grains and alum 5 grains is recommended to be taken 
thrice daily. 
 In the early stages of inflammatory sore-throat , a small piece of nitre allowed to 
dissolve slowly in the mouth is a successful popular remedy.  
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 In asthma, in chronic bronchitis and other spasmodic coughs, inhalation of the 
fumes of burning nitre papers, previously soaked in saturated solution of the 
nitrate and dried gives great relief.   
 Also internally it may be given in doses of 40 grains gradually increased to 60, 
90, up to 120 grains twice daily, the vehicle being half a pint of warm rice conjee. 
SODIUM CHLORIDE IMPURA 
INDUPPU 
 
 Sans   :  Saindhava 
 Eng   : Rock salt, Sodium chlorate 
 Hind   : Sendhalon 
 Tel   : Saindhalavanam 
 Tam   : Indu-uppu 
 Mal   : Indu-uppu 
Source: 
Found in Nature in extensive beds mostly associated with clay and calcium sulphate. 
To Obtain it, holes are dug into these rocks which soon become filled up with salt water; the 
water is evaporated and the salt is left ready for use. 
Characters:  
It is found in small white crystalline grains or transparent cubes. It is brownish white 
externally and white internally. It has a pure saline taste and burns with a yellow flame.  
Action:  
 In small doses it is highly carminative, stomachic  and digestive.  
 In large doses (1 to 2 drachms) it is cathartic;  In still larger doses (4 to 8 drachms) it 
is emetic.  
Uses:  
 It is given in dyspepsia and other abdominal disorders.  
 To digestion weakened by diarrhoea, rock-salt and yavakshar (alkali-Potassium 
carbonas impure) are given in convalescence.  
 Vadavanal churna containing rock salt, long pepper, pipli, cubebs, chitrak, ginger 
and myrobalans in equal parts, mixed and made into a powder is used in anorexia, 
flatulence and biliousness. Dose is 5 to 15 grains two or three times a day with water.  
 A medicinal salt called Nariekelakshara is highly recommended in Chakradatta as 
valuable in the form of dyspepsia which is attended with pain two or three hours after 
meals.   
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 As a digestive, a compound powder made of rock salt, chebulic murobalan, emblic 
myrobalan and long  pepper in equal parts is recommended in doses of 10grains twice 
a day.  
 A powder containing Pancha lavana 5 parts, impure oxide of iron 5 parts and emblic 
myrobalan 4 parts is useful in doses of 10 grains in dyspepsia, congested liver etc. 
FULLERS EARTH 
VALIALUPPU 
Synonyms  : Fuller’s earth, Attapulgite. 
Chemical family : Magnesium aluminium    silicate. 
  
 Fuller’s earth (Hindi- Multani) is the name given to certain adsorbent clays used for 
removing grease and dirt from woollen goods, a process known as fulling. These clays 
possess the property of declourizing  and  clarifying oils- animals, vegetable and mineral- 
and a few other liquids. Fuller’s earth is distinguished from bentonite which, though 
mineralogically not very different, possesses little adsorptive power unless activated by acid 
treatment.  
Characters: 
 It has high water content and foliated structure: dehydrated samples show a tendency 
to adhere strongly to the tongue. Montmorillonite (Mg.Ca) O, Al2O3.  
5SiO2. nH2O) is the dominant clay mineral in some of them. 
 Indian fuller’s earth consists of well-bedded , non –arenaceous, unctuous clay or 
shale, varying in colour from cream to  yellow, yellowish brown, buff, greenish grey or light 
grey. It is essentially a hydrated aluminium silicate with lime, magnesia and iron oxide as 
impurities; it contains a large proportion (Up to  30 %) of water. The decolourizing properties 
of the earths from different deposits and even from different parts of the same deposit vary 
over a wide range. In drying at room temperature, the bleaching power of the earth is slightly 
altered; usually an improvement is observed. 
Source: 
 Bihar, Bombay,Hyderabad,Madhya Bharat, Madhya Pradesh,Mysore,Rajasthan. 
 Madras and Andhra- Small Quantities of fuller’s earth are reported to have been 
mined in Anantapur district. Fuller’s earth has also been reported from Omalur in Salem 
District.  
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SODII BIBORAS;  S.BORAS 
VENGARAM 
 
Sans-Tankana Borax; Tunkana; Rasashodhan. Eng-Sodium Biborate; Sodium Borate; 
Biborate of soda; Hind-Tinkal; Tincal; Sohaga.Ben. Duk & Punj- Sohaga; Suhaga; Tel-
Velligaram, Tam-Venkaram; Vengaram. Mal-Ponkaram. Can-Biligara.  
Source:  
It occurs as a natural deposit. Crude borax is found in masses by evaporation of 
water, on shores of dried up lakes in India and Tibet; it is also obtained from the mud of lakes  
surrounded by hills in  Nepal. In this crude state it is known as Sohagoor or tinkala. When 
purified by dissolving it in water, straining through cloth, evaporating to dryness and 
crystallizing, it is called borax or tankan khar. 
Characters:  
It is composed of boric acid and soda. In the native state it exists as an impure saline 
incrustation of a dirty-white colour. It exsists as crystalline tough masses or  in the form of 
translucent irregular masses. Exposed to the air it becomes opaque. Another variety known as 
Telio tankana is an impure salt met with in small pieces or smooth, translucent six-sided 
prisms. The colour is grayish –white; on exposure it becomes opaque or dirty white. It  has a 
faintly balsamic odour and tastes like papada khar.  
Purification: Borax is purified by being steeped for a night in kanjika (whey) and dried in 
the sun.  
Action: 
Diuretic, Emmennagogue,  
Astringent 
Antacid  
Local sedative 
Antiseptic 
Uses:  
 Borax is given internally in doses varying from 10-30 grains, in acidity of the  
uterine pains during labour, As a solvent it is given in uric stomach, amenorrhoea, 
dysmenorrhoea, menorrhagia, puerperal convulsions and to promote acid 
diathesis with good results. Dose is from 20 to 40 grains for an adult. 
 In cases of suspension or irregularity of the menstrual discharge and in some 
chronic uterine affections, doses of 10 grains with 10 grains of cinnamon 
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occasionally prove useful. It acts with betel juice in 4 to 8 grain doses as 
preventive of ague.  
 A mixture of equal parts of borax, long pepper and baberang seeds is given for 
five days at the menstrual periods for the purpose of preventing conception. 
 It is also used for procuring abortion and inducing labour pains. Externally borax 
is used in lotion (1 in 40 of water) in acne, freckles, chloasma etc., to allay itching 
in urticaria, psoriasis, pruritus pudendi, vulvi, scroti and ani, in gangrenous 
buboes, and sloughing ulcers.  
 In  the distressing irritation of the genital organs both in males and females, cloths 
saturated with a strong solution of borax (1 in 16 ) kept to the parts afford much 
relief. In the case of women, the solution should be  used in the form of vaginal 
injection. The solution (1 in 5 ) proves very useful as injection in  cystitis, 
leucorrhoea and gonorrhoea and in lithic acid deposits.  
HYDARGYRUM SUBCHLORIDE :  CALOMEL 
RASACARPOORAM 
 
Mercury (I) Chloride is the chemical compound with the formula Hg2Cl2. Also known 
as calomel or mercurous chloride this dense white or yellowish-white, odourless solid is the 
principal example of a mercury (I) Compound. 
 
PHYSICAL CHARACTERISTICS: 
 
 Color is white, gray or yellow.  
 Luster is adamantine. 
 Transparency: 
 Crystal are translucent  
 Crystal system is tetragonal; 4/m 2/m 2/m  
 Crystal  Habits are small tabular to pyramidal or horn –like crystals usually seen 
as coatings or crusts on other minerals. 
 Cleavage is distinct in one direction. 
 Fracture is conchoidal.  
 Hardness is 1-2.  
 Specific Gravity is 6.4-6.5 (very heavy for translucent minerals)  
 Streak is white.  
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Other Characteristics:  
Fluorescent red and crystals darken upon exposure to light over time.  Associated 
Minerals include mercury , cinnabar, metacinnabar and other mercury minerals.  
Notable Occurrences include Almaden, spain; Idria, Serbia; Hunan Prov., China and 
New Idria, California, Oregon, Terlingua, Texas, and Arkansas, USA.  Best Field Indicators 
are  density, associations, fluorescens, hardness and crystal habit. 
Action: 
 Diuretics,  
 Antiseptics,  
 Laxatives 
 Antibacterials . 
Uses: 
 
 Its pharmacopeial preparations are the “Black wash” in which calomel and lime react 
to form mercurous oxide, a pill known as plummer pill and an oinment.  
 Internally the salt is given in doses – for and adult of from one-half to five grains. It is 
and admirable  aperient, acting especially on the  upper part of the intestinal canal, 
and causing a slight increase of intestinal secretion. The stimulant action occurring 
high up in the canal (duodenum and jejunum),  it is well to follow a dose of calomel 
with a saline purgative a few hours afterwards.  
 The special value of the drug as an aperient  depends on its antiseptic power and its 
stimulation of the liver.  
 The salt is often used in the treatment of  syphilis, but is probably less useful than 
certain other mercurial compound. 
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MATERIALS AND METHODS 
Preparation of the drug: 
 To evaluate the efficacy of “Seenalavana parpam” for “Soothagavali” 
(Dysmenorrhoea) has been selected as per siddha literature. Kannusamiyam Paramparai 
Vaithiam by Kannusamy Pillai.  
The Ingredients of Seenalavana parpam are, 
 
 Padikaram 
 Vediuppu 
 Induppu 
 Valaialuppu 
 Vengaram 
 Kalluppu 
 Naatu kalnar 
 Rasakarpooram 
 
Collection of Drugs: 
 The raw drugs like padikaram, vediuppu, Induppu, valaialuppu, vengaram, kalluppu, 
Naatukalnar, Rasakarpooram were collected from the indigenous drug shop, Chennai.  
 
METHOD OF  PREPARATION: 
 
INGREDIENTS: 
 Padikaram (Alumen)   - 105g 
 Vediuppu (Potassium nitrate)  - 17.5g 
 Induppu (Sodium chloride impura) - 17.5g 
 Valaialuppu  (Salt of fullers earth) - 17.5g 
 Vengaram (Borax)   - 17.5g 
 Kalluppu (Rock salt)   - 17.5g 
 Naatu kalnar (Asbestos)  - 17.5g 
 Raskarpooram (Hydragyrum subchloride)- 2.1g 
 
 
 85
 
 
 
Purification: 
  To Purify the Padikaram, first dissolve within water, then filter it and melt it in to 
semisolid consistency and then allow to cool it. 
Vediuppu: 
 To the 1 Part of Vediuppu add  4  Parts of water, then heat it gently. On melting add 
sour butter milk and stir it. Remove the impurities accumulating on the surface. In semisolid 
consistency filter it in another vessel and cool it. Repeat the procedure for 7 times to get 
highly purified Vediuppu. 
Induppu: 
 Soak the Induppu in kadineer for 3 days and dry it in sun light. 
Valaialuppu: 
 Soak the Vaalialuppu in kadineer for 3 hours and dry it in sun light. 
Vengaram:  
Fry the Vengaram to remove the moisture condition and powder it.  
Kalluppu: 
 Mix the Kalluppu which kadineer and dry it.  
Naatu kalnar: 
 Soak the Naatu kalnar in cow’s urine for 10 days and wash it. 
Rasakarpooram: 
 Take equal quantity of betel leaf and pepper to the quantity of pooram. Mix it and 
grind them in to paste and dissolve it in water. To this take pooram in a piece of cloth and 
submerge it in to the betel leaf and pepper paste dissolved water like thulayanthiram. Then 
heat it until the water is reduced 3/4 and wash.  
Preparation of the drug: 
 In earthan ware versed put the half part of padikara powder then above purified in 
gredients then remaining part of padikara powder  and heated till the contents melt, and 
allowed to cool and powdered and preserve it, in a porcelain dish. 
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INGREDIENTS OF SEENALAVANA PARPAM 
 
     BEFORE   PURIFICATION                     AFTER   PURIFICATION 
SEENAKARAM 
 
 
                                                 VEDIUPPU 
 
                                                                    INDUPPU
 
 
VALAIALUPPU 
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                                                              NAATUKALNAR 
 
                                                            RASAKARPOORAM 
 
   BEFORE   PURIFICATION          VENGARAM     AFTER PURIFICATION 
                                                                  KALLUPPU 
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SEENALAVANA PARPAM 
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BIOCHEMICAL ANALYSIS 
CHEMICAL ANALYSIS OF SEENALAVANA PARPAM. 
 
 
 
Sl. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample White in colour  
2. Solubility: 
     a.  A little of the sample is 
shaken well with distilled water 
      b.  A little of the sample is 
shaken well with con Hcl / con 
H2So4 
 
Sparingly soluble 
 
Completely soluble 
 
 
 
Absence of silicate 
 
3. Action Of Heat: 
     A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
strongly 
 
White fumes evolved 
 
No brown fumes 
 
Presence of Carbonate 
 
Absence of Nitrate 
4. Flame Test: 
     A small amount of the sample 
is made in to a paste with con. Hcl 
in a watch glass and introduced 
into non-luminous part of the 
Bunsen flame 
 
No bluish green 
flame appeared. 
 
Absence of copper 
5. Ash Test: 
     A filter paper is soaked into a 
mixture of sample and add cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited 
 
No Yellow Colour 
flame 
 
Absence of sodium 
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PREPARATION OF EXTRACT: 
 5 gm of Seenalavana parpam is weighed accurately and placed in a 250 ml clean 
beaker and added with 50ml of distilled water. Then it is boiled well for about 10 minutes.  
Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml with 
distilled water. 
SL.NO EXPERIMENT OBSERVATION INFERENCE 
I Test For Acid Radicals   
1. Test For Sulphate: 
2 ml of the above prepared extract is taken 
in a test tube, to this, add 2ml of 4% 
ammonium oxalate solution 
 
2 ml of the above prepared extract is 
added with 2ml of dil, Hcl is added 
until the effervescence ceases off. 
Then 2ml of Barium chloride solution 
is added 
 
Cloudy appearance 
Present 
 
 
 
A white precipitate in 
soluble in con. 
HCL.is obtained. 
 
Presence of sulphate. 
 
 
 
 
Sulphate is confirmed 
2. Test For Chloride: 
     2 ml of the above prepared extract is added 
with dil. HNo3 till the effervescence ceases.  
Then 2ml of silver nitrate solution is added 
 
Cloudy appearance 
Present 
 
Presence of chloride 
3. Test For Phosphate: 
     2 ml of the extract is treated with 2ml of 
ammonium molybdate solution and 2ml of 
Con. HNO3 
 
No cloudy yellow 
appearance 
 
Absence of phosphate 
4. Test For Carbonate: 
    2 ml of the extract is treated with 2ml of 
magnesium sulphate solution 
No Cloudy 
appearance 
Absence of Carbonate 
5. Test For Nitrite: 
    1 gm of the substance is heated with copper 
turning and concentrated H2So4 and viewed 
the test tube vertically down 
 
No characteristic 
changes 
 
Absence of Nitrate 
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6. Test For Sulphide: 
     1 gm of the substance is treated with 2 ml 
of Con. Hcl 
 
No Rotten egg 
smelling gas evolved 
 
Absence of sulphide` 
7. Test For Fluoride & Oxalate: 
     2ml of extract is added with 2ml of dil 
acetic acid and 2ml of calcium chloride 
solution and heated 
 
No cloudy 
appearance 
 
Absence of fluoride 
and oxalate 
8. Test For Nitrite: 
     3 drops of the extract is placed on a filter 
paper, on that 2 drops of acetic acid and 2 
drops of benzidine solution is placed. 
 
No Characteristic 
changes 
 
Absence of Nitrite 
9. Test For Borate: 
     2 pinches of the substance is made into paste 
by using sulphuric acid and alcohol (95%) and  
introduced into the blue flame 
 
Bluish green colour 
flame appeared 
 
Presence of Borate 
II Test For Basic Radicals   
1. Test For Lead 
     2 ml of the extract is added with 2ml of 
potassium iodide solution 
 
No yellow precipitate 
 
Absence of lead 
2. Test For Copper 
One pinch of substance is made in to paste 
with con. Hcl in a watch glass and 
introduced into the non – luminous 
part of the bunsen flame. 
2 ml of extract is added with excess of 
ammonia solution 
 
No Blue flame 
 
 
 
No Blue colour 
precipitate formed 
 
Absence of copper 
 
 
 
Absence of copper 
3. Test For Aluminium: 
     To the 2ml of the extract sodium 
hydroxide is added in drops to excess 
 
No characteristic 
changes 
 
Absence of aluminium 
4. Test For Iron. 
a.To the 2ml of extract add 2 ml of 
ammonium thiocyanate solution. 
b.To the 2ml of extract add 2ml 
 
No mild red colour 
appear 
 
 
Absence of Iron 
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ammonium thiocynate solution and 2ml of 
con HNo3 is added 
 
 
No Blood red colour 
appear 
Absence of Iron 
5. Test For Zinc 
          To 2ml of the extract sodium hydroxide 
solution is added in drops to excess      
White precipitate is 
formed 
Presence of Zinc 
6. Test For Calcium 
         2ml of the extract is added with 2ml of 
4% ammonium oxalate solution 
 
Cloudy appearance 
white precipitate is 
obtained 
 
Presence of Calcium 
7. Test For Magnesium 
     To 2ml of extract sodium hydroxide 
solution is added in drops to excess 
 
 White Precipitate is 
obtained 
 
Presence of 
Magnesium 
8 Test For Ammonium: 
     To 2ml of extract few ml of Nessler’s 
reagent and excess of sodium hydroxide 
solution are added 
 
No Brown colour 
appeared 
 
Absence of ammonium 
9. Test For Potassium: 
    A pinch of substance is treated with 2ml of 
sodium nitrate solution and then treated with 
2ml of cobalt nitrate in 30% glacial acetic 
acid 
 
 
No Yellowish 
precipitate is obtained 
 
Absence of Potassium 
10. Test For Sodium 
     2 Pinches of the substance is made into 
paste by using Hcl and introduced in to the 
blue flame, of Bunsen burner 
 
No Yellow colour 
flame  appeared 
 
Absence of Sodium 
11. Test For Mercury 
     2 ml of the extract is treated with 2ml of 
sodium hydroxide solution 
 
No yellow precipitate 
is obtained 
 
Absence of Mercury 
12. Test For Arsenic: 
     2ml of extract is treated with 2ml of silver 
nitrate solution 
 
No brownish red 
precipitate is obtained 
 
Absence of Arsenic 
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III.           
 
Miscellaneous: 
  
1. Test For Starch: 
     2 ml of extract is treated with weak Iodine 
solution 
 
No blue colour 
developed 
 
Absence of starch 
2. Test For Reducing Sugar: 
    5 ml of Benedicts qualitative solution is 
taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract 
and again boil it for 2 minutes. The colour 
changes are noted 
 
No Brick red colour 
developed 
 
Absence of Reducing 
sugar 
3. Test For The Alkaloids: 
2ml of the extract is treated with 2ml of 
potassium iodide solution. 
2ml of extract is treated with 2ml of picric 
acid. 
2ml of the extract is treated with 2ml of 
phosphotungstic acid 
 
 
No red colour 
develops 
 
Yellow colour 
developed 
White precipitate 
obtained 
 
 
 
 
Presence of alkaloid 
 
4. Test For Tannic Acid: 
    2 ml of extract is treated with 2ml of ferric 
chloride solution 
 
No black precipitate 
appeared 
 
Absence of Tannic acid 
5. Test For Unsaturated 
Compound: 
    To the 2ml of extract 2ml of potassium 
permanganate solution is added 
 
 
Potassium 
Permanganate is not 
decolourised 
 
 
Absence of unsaturated 
compound 
6. Test For Amino Acid: 
      2 drops of the extract is placed on filter 
paper and dried well 
 
No Violet colour 
developed 
 
Absence of amino acids
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7. 
 
 
 
Test for Type of Compound 
2 ml of the extract is treated with 2 ml of 
ferric chloride solution 
 
 
 
No green colour 
developed 
 
No Red colour 
developed 
 
No violet colour 
developed 
 
No Blud colour 
developed 
 
 
 
Absence of oxy quinole 
epineplhrine and phro 
catechol 
Anti pyrine, Aliphatic 
amino acids and 
meconic acid are absent
Apomorphine salicylate 
and resorcinol are 
absent 
Morphine, phenol 
cresol and hydro 
quinine are absent 
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PHYSICAL PROPERTIES 
Loss on Drying 
 5 Gms of materials is heated in a not oven at 1050C to constant weight.  The 
percentage of loss of weight was calculated. 
Determination of ash Value 
 Weight accurately 2-3 gms of sample in tarred platinum or silica dish and incinerate 
at a temperature not exceeding 4500C until free from carbon, cool and weight.  Calculate the 
percentage of ash with reference to the air dried drug. 
Acid Insoluble ash 
 Boil the ash for 5 minutes with 25ml of 1:1 dilute HCl< collected the insoluble matter 
in Gooch – crucible on an ash less filter paper, wash with hot water and ignitge, cool in a 
dessicator and weight.  Calculate the percentage of acid insoluble ash with reference to the 
air dried drug. 
Water soluble ash 
 To the Gooch crucible containing the total ash, and 25 ml of water and boil for 5 
minutes.  Collect the insoluble matter in a sintered glass crucible or on ash less filter paper.  
Wash with hot water and ignite in a crucible for 15 minutes at a temperature not exceeding 
4500C.  Subtract the weight of the insoluble matter from the weight of the ash; the difference 
of weight represents the water soluble ash.  Calculate the percentage of water soluble ash 
reference to the air dried drug. 
Alkalinity of Water soluble ash 
 5 Gms  converted to ash, boiled with water, filtered, Filtrate was titrated against 0.1N 
of HCl using phenolphthalein as an indicator. 
 Alkalinity of water soluble ash = X x of acid / 0.1 X W. 
 X – Titre Value 
 W – Weight of the materials taken 
 Alkalinity is given as ml of 0.1 N of HCL equal to 1 gm 
pH at 10% aqucous solution 
  5 gms of Seenalavana parpam is weighted accurately and placed in clear 
100ml beaker.  Then 50ml of distilled water is added to it and dissolved well.  Wait for 30 
minutes and then apply in pH meter at standard buffer solution of 4.0, 7.0 and 9.2.
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QUANTITATIVE ANALYSIS 
 
Aim  
To determine the metals and minerals in Seenalavana parpam. 
  
Instrument 
 
 Atomic Absorption Spectrometer with Air – acetylene. 
 
Apparatus and equipment 
 
 500 ml glass beakers, hot plate, watch glass, 100 ml standard flask. 
 
Chemicals 
 
 Nitric acid, hydrochloric acid, certified reference standards. 
 
Sample Preparation 
 
 Transfer a weighted sample in to a 50ml beaker. Add 10ml of 1 + 1 HNO3 and 10 ml 
of 1+1 HCL and heat on a hot plate until the sample gets dissolved. Cool and filter to remove 
insoluble material. Transfer sample to 100 ml volumetric flask, adjust volume to 100 ml and 
mix. Take all precautions to avoid contamination at all stages. Prepare a reagent blank 
containing same amounts of acids used in the preparation of sample Aspirate the standards 
and sample into AAS instrument as per instrument procedure. 
Calculation 
 Percentage of the element = A / B x 100 
 A:  Concentration of sample in ppm 
 B:  Dilution factor 
 
Reference: APHA 21st edition method. 
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ACUTE TOXICITY STUDY OF SEENA LAVANA PARPAM 
 
Experimental Animals-  
Sexually mature male Wistar albino mice weighing 18.2-24.5g were obtained from the 
Animal Facility, Vel’s college of pharmacy. The animals were kept in a well-ventilated room 
of 12 hr light and 12 hr darkness. All the animals were fed with standard mouse cubes from 
Sai meera foods PVT Ltd. Bangalore, while water was provided ad libitum. The principles of 
laboratory animal care were followed, while the department’s ethical committee approved the 
use of the animals and the study design. 
 
Acute Toxicity Test.   
 
The animals were divided into seven groups of six mice per cage. 2% CMC was used as 
vehicle. Starting dose was 50mg/kg. And the subsequent doses are 100, 250, 500, 1000, 2000 
and 4000mg/kg p.o. used in this study. Group 1 was administered with vehicle (5ml/kg, p.0). 
Groups 2-7 received 100-4000mg/kg (p.0) respectively. The animals were observed for 
physical signs of toxicity for 24h. 
 
 
ANTISPASMODIC ACTIVITY OF SEENALAVANA PARPAM ON GUINEA 
 PIG ILEUM 
 
INTRODUCTION 
 
           The drug Seenalavana parpam has been mentioned in Kannusamiyam  paramparai 
vaithiam for Dysmenorrhoea. So, this drug has been selected for the evaluation of anti - the 
spasmodic activity in Dysmenorrhoea.  Seenalavana parpam siddha drug has been shown to 
be effective in the treatment of Soothagavali, Vellai, Vettai, Neersurukku. There are several 
analgesic anticholinergic combinations available as antispasmodics for the treatment of 
abdominal spasm and colic. The aim of the present study was to investigate the 
antispasmodic activity of Seenalavana parpam, the commonly used anticholinergics against 
acetylcholine- induced spasm. 
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MATERIALS AND METHODS 
Drugs 
 
Seenalavana parpam were dissolved in modified Ringer’s solution and pH was made 
up to 7.4. Acetylcholine (Loba Chemic Pvt. Ltd, India) BaCl2 was dissolved in deionized 
water. 
 
Procedure:  
 
Spasmodic abdominal pain generally associated with renal or ureteric colic has been 
described as one of the most excruciating pains in man, demanding immediate therapeutic 
attention. In the present study, the antispasmodic activity of Seenalavana parpam against 
acetylcholine induced specific spasm as well as barium chloride induced nonspecific spasm 
of guinea pig ileum were investigated. Guinea pig ileum is supposed to be a more suitable 
preparation to study the spasmogenic and anti-spasmodic activity. Guinea pig ileum was 
prepared following standard procedure and about 2-3 cm long was mounted in 10 ml organ 
bath containing Tyrode solution (pH 7.4) maintained at 37oC and bubbled with carbogenated 
air. The preparation was allowed to equilibrate for 30 min under 0.5g tension. The 
concentration dependent contractions due to acetylcholine and barium chloride (contact time 
60 seconds) were recorded using a kymograph recorder (Inco, India) in the absence and 
presence of Seenalavana parpam. The percentage of maximum response was calculated. 
Seenalavana parpam, was allowed to act for 20 minutes during which time preparation was 
washed every 5 minutes with bath solution. Acetylcholine (10-320 ng/ml organ bath fluid) 
produced concentration dependent contractions of guinea pig ileum. Seenalavana parpam  
(25x1O-5 m.mol L-1) shifted the concentration response curve of acetylcholine to the right. 
Seenalavana parpam induced an unsurmountable blockade of acetylcholine. When the tissue 
was exposed to Seenalavana parpam potentiated the antispasmodic effect. Barium chloride 
(500-8000ng/ml organ bath fluid) produced concentration dependent contraction of guinea 
pig ileum. 
 
 
 
 
 99
 
 
 
ANALGESIC ACTIVITY OF SEENA LAVANA PARPAM 
 
Animals 
 
Albino mice (15 - 30 g) were housed in groups of 5 - 6 animals in polypropylene 
cages (23 x 38 x 23 cm) at 23-30°C and maintained on a standard pellet diet and water ad 
libitum. Animals of either sex were used for experiments. 
 
Drugs 
 
1 gm of Seenalavana parpam dry powder was weighed using digital balance and 
suspended in 2% CMC solution to prepare stock solution of 100mg/ml. 
Analgesic studies 
 
Acetic acid-induced writhing in mice.  
 
In acetic acid writhing test, Writhing was induced by injecting 0.1ml of 0.7% w/w 
acetic acid intraperitoneally. The test drug 400 mg/kg were administered 30 min prior to 
administration of irritant. Standard group received 45mg/kg paracetamol and control group 
animals received 0.2ml of normal saline. The number of writhes produced in these animals 
was counted for 20 min.  
 
Safety evaluation 
 
The drugs were administered to groups of 6 albino mice at doses upto 4 g/kg p.o. and 
the animals were observed for mortality, gross behavioural effects upto a period of 13 days 
and further they were observed for any untoward effects and mortality. From this dose one 
tenth of the dose was used as therapeutic dose. 
 
Statistics 
 
All data were expressed as mean ± SEM. One-way ANOVA followed by Bonferroni 
test was applied for analysis of results and their interpretation; p values < 0.05 were 
considered significant. 
 100
 
MUSCLE RELAXANT PROPERTY OF SEENA LAVANA PARPAM 
 
OBJECT 
To study the muscle relaxant property of Seena Lavana Parpam (muscle grip 
strength) using rota-rod apparatus (INCO). 
PRINCIPLE 
The loss of muscle-grip is an indication of muscle relaxation. This effect can be easily 
studied in animals using rotating rods.  The difference in the fall of time from the rotating rod 
between the control and Seenalavana Parpam -treated animal is taken as an index of muscle 
relaxation. The rate of rotation of the rod was adjusted such that normal rats can stay on the 
rod for an appreciable period (3-5 min) of time.  
 
REQUIREMENTS 
Animal: Rats (200-250 g), Drugs: Seenalavana Parpam (400mg/kg), Diazepam (Dose 4 
mg/kg, ip; stock solution containing 0.4 mg/ml of the drug and 1 ml/100 g of body weight of 
the animal was injected. Diazepam was suspended in 1% w/v carboxy methylcellulose). 
Equipment: Rota-rod apparatus.  
 
PROCEDURE 
The animals were weighed and numbered.  
The rota-rod was turned on and an appropriable rod speed was selected  
(15-20 rpm) 
The animals were placed one by one on the rotating rod.  
The ‘fall off time’ when the rat falls from the rotating rod was Noted.  
The appropriate dose of test drug Seenalavana Parpam (400mg/kg) and diazepam (4 mg/ 
kg) was administered to the respective group of animals. After 30 min the experiment was 
repeated.  
The fall off time was noted. 
The fall off time of animals before and after drug treatment was compared.  
Statistical analysis 
The results were statistically analysed by one way anova followed by dunnet multiple 
comparison test using INSTAT computer software programme. 
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MODERN ASPECT 
  
 DYSMENORRHOEA 
  
Definition 39 
Dysmenorrhoea means painful cramps accompanying menstruation. 
 
Types: 
1. Primary dysmenorrhoea 
  
- Not associated with any identiable pelvic pathology 
- Affects more than 50% of post-pubescent women in the age groups of 18 to 25 
years. 
 
2. Secondary dysmenorrhoea 
-   Associated with presence of organic pelvic pathology i.e. fibroids, adenomyosis,  
   PID, endometriosis etc. 
 
VARIETIES  
 
These are three groups of dysmenorrhoea. 
 
1. Spasmodic (or) Primary dysmenorrhoea 
2. Congestive (or) secondary dysmenorrhoea 
3. Membranous  
 
1. Spasmodic dysmenorrhoea 
 
-    More than 70% of teenagers and 30 – 50% of mensturating womens are affected.  
-  The coliky type of pain is felt in the suprapubic region and last for 12 – 24 hours  
-  The pain usually disappears on the second day of the period 
 
Clinical Features: 
  
    Uterine Cramping, nausea, vomiting, backache, diarrhoea, giddiness, syncope  
     and  fainting.    
     There is substantial relief from pain after childbirth, but  this is generally seen  
     only after a vaginal delivery. 
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2. Congestive dysmenorrhoea 
-   Dull, dragging type of premenstrual pain 
-   Relieved by menstrual flow 
 
Aetiology 
-  Myoma 
-  Adenomyosis 
   -  Pelvic endometriosis 
 
Symptoms 
- Menorrhagia 
- low backache 
- leucorrhoea 
 
3. Membranous dysmenorrhoea 
 
-  Extreme form of spasmodic dysmenorrhoea run in families 
-  Recur after pregnancy 
-  Accompanied by the passage of membranes  
-  Prognosis is worse 
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CLINICAL STUDY 
Selection of Patients 
 
 30 Female patients were selected from the out patient department of National Institute 
of Siddha, Chennai – 47 by present inclusion, exclusion of and withdrawl criteria. 
 
CRITERIA FOR SELECTION 
 
INCLUSION CRITERIA 
Age 18 – 40 years 
Regular menstural cycle with dysmenorrhic complaints 
primary dysmenorrhoea with normal USG abdomen 
willing to attend the OPD for 3 consecutive menstrual cycle. 
 
EXCLUSION CRITERIA 
Congestive (secondary) dysmenarrhoea 
Premenstrual tension 
Pelvic inflammatory disease 
 
WITHDRAWAL CRITERIA 
   Menorrhagia 
   Drug intolerance 
   Any other acute illness 
LINE OF TREATMENT 
The drug “Seenalavana parpam” was administered internally in a dose of 130 mg 
with Palm jaggery after food for the first 5 days of menstrual cycle consecutively for 3 
cycles. 
DIET RESTRICTION 
 
         Patients  were advised to avoid 
bitter guard,mango,brinjal,cluster bean,pumpkin,sesban,semi cooked diet,mustard 
sesame. 
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STASTISTICAL ANALYSIS 
  
Paired t-test was used to  study the significant between before and after treatment  on  
time taken (quantitative variable) to get relief from pain.  
 
 Chi-square test was used to study the significant between before and after treatment 
on severity of pain (qualititative variable)    
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RESULTS AND OBSERVATION 
 
RESULTS OF THE BIO – CHEMICAL ANALYSIS : 
 
 The given sample contains, 
 Calcium 
 Magnessium 
 Zinc 
 Chloride 
 Alkaloids 
 Sulphate 
 
RESULTS OF STANDARDISATION PARAMETERS: 
 Loss on drying     - 0.85% 
 Total Ash Value     - 62.80% 
 Water Soluble ash    - 72.80% 
 Alkalinity as CaCo3 in water soluble Ash - 0.42% 
 Acid Insoluble Ash               - 1.05% 
 PH at 10% aqucous solution              -  3.70% 
 Mercury as Hg                -  Trace 
 
RESULTS OF ACUTE TOXICITY STUDY OF SEENALAVANA PARPAM 
 
 No death was produced during the treatment period in test drug treated groups given 
upto 4000mg/kg of Seena lavana parpam orally at once. The animals did not show any 
major and significant changes in general behavior or other physiological activities till the 
maximum of 4000mg/kg dose. The LD50 (p.o.) of Seena lavana parpam was found to be 
greater than 4000mg/kg body weight in mice.  
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Table-1:  Incremental dose finding experiment and its Signs of Toxicity of Seenalavana parpam 
 
No Treatment 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. I 50 + - - - - + - - - - - - - - - - - - - - 
2. II 100 + - - - - + - - - - - - - - - - - - - - 
3. III 250 + - - - - + - - - - - - - - - - - - - - 
4. IV 500 + - - - - + - - - - - - - - - - - - - - 
5. V 1000 + - - - + + - - - - - - - - - - - - - - 
6. VI 2000 + - - + + + - - - - - - - - - - - - + - 
7. VII 4000 + - - + + + - - - - - - - - - - - - + 1+ 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Increased Motor 
Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Number of Deaths (Mortality) 
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RESULTS OF ANTI – SPASMODIC ACITVITY OF SEENALAVANA 
PARPAM 
 
Acetylcholine (100µg/ml organ bath fluid) produced concentration dependent 
contractions of the smooth muscle. Seenalavana parpam dose dependently shifted the 
concentration- response curve of acetylcholine to the right with no change in maximal 
response, whereas Seenalavana parpam induced blockade was unsurmountable in maximal 
response. Acetylcholine-induced contractions were completely blocked by Seenalavana 
parpam. Seenalavana parpam induced reversible blockade of barium chloride induced 
spasm. The present study confirms the antispasmodic activity of Seenalavana parpam on 
guinea pig intestinal smooth muscle (Ileum). Seenalavana parpam was found to block 
cholinergic spasm as well as non-specific spasm induced by barium chloride. Seenalavana 
parpam potentiated the antispasmodic effect against acetylcholine and barium chloride 
induced spasm. Present study suggested that Seenalavana parpam may prove to be effective 
as antispasmodic for specific and non-specific spasm. 
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RESULTS OF ANALGESIC ACTIVITY OF SEENALAVANA PARPAM 
 
Chemical stimulus: Acetic acid induced writhing  
The test drug Seenalavana parpam (400 mg/kg, p.o.) significantly reduced (p < 0.05) the 
number of writhing episodes in treated mice (Table 1). The comparison was made between 
SLP and Paracetamol – treated animals. The analgesic effect shown by Seenalavana parpam 
were significantly different from that of standard drug paracetamol group indicating 
comparable activity at the dose used.  
Treatments 
Effect of Seena lavana parpam on acetic acid induced writhes in mice. 
Treatment 
Dose (mg/kg) 
No. of writhing 
(in 20 minutes) 
% inhibition 
Control (saline) 0.5 ml 51.18±4.71 Nil 
Standard (Paracetamol) 45 22.12±1.86* 56.77 
Seenalavana parpam (400)  28.74±2.18*@ 43.84 
P < 0.05 All values are expressed as mean ± SE; *P <0.05 Significant compared to control. 
@P <0.05 Significant compared to standard 
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RESULTS OF MUSCLE RELAXANT PROPERTY OF SEENALAVANA 
PARPAM 
 
Groups Dose (mg/kg) Fall of time in seconds 
Before drug  After drug 
Seenalavana 
parpam 
400 97.5±1.6 72.37±0.99* 
Diazepam 4 96.7±1.81 38.5±2.12** 
Normal control 2ml of 1% CMC solution 102±1.46 99.3±1.03 
Values are expressed as mean±S.E.M. *P<0.05; **P<0.01 was considered as significant 
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The Seenalavana parpam at the dose level of 400mg/kg showed moderate muscle relaxant 
property when compared to standard drug diazepam at the dose of 4mg/kg. The percentage of 
activity was calculated as 25.77% for test drug and 60.18 for standard. (Table-1) 
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CLINICAL ASSESMENT 
 
 For the clinical study of Seenalavana parpam in “Soothagavali” 30 patients were 
selected. 
 
AGE DISTRIBUTION  
 
SNO AGE IN YEARS NO.OF PATIENTS PERCENTAGE 
1. 15 –20 4 13.33 % 
2. 21 – 25 12 40.00 % 
3. 26 – 30 9 30.00% 
4. 31  -35 2 6.67% 
5. 36  - 40 3 10.00 % 
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According to age wise distribution 13.33% were in below 20 yrs, 40% were in 21-25 
yrs, 30% were in 26-30 years, 6.67% were in 31-35 years, 10% were in 36-40 years. 
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MARITIAL STATUS: 
 
 
SLNO MARITAL STATUS NO. OF PATIENTS PERCENTAGE 
1. Un married 19 63.33% 
2. Married 11 36.6% 
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According to marital status 36.67% were in married, 63.33% were in unmarried.    
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IMPROVEMENT OF SIGNS AND SYMPTOMS: 
 
 
SLNO SIGNS AND 
SYMPTOMS 
NO .OF PATIENTS IMPROVEMENT 
BEFOR  AFTER 
1. Spasmodic abdominal  
pain 
30 (100%) 1 
(3.33%) 
96.6 % 
2. Uterine Cramping 30 (100%) 1 
(3.33%) 
96.6% 
3. Nausea 25(83.33%) 0 100% 
4. Vomitting 15 (50%) 0 100% 
5. Backache 15 (50%) 0 100% 
6. Fainting 20(66.67%) 0 100% 
7. Abdominal discomfort 27 (90%) 0 100% 
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From the clinical study 96.67% of patients get relieved from spasmodic abdominal pain, 
96.67% get relieved from uterine cramping, 100% get relieved from nausea, 100% get 
relieved from vomitting, 100% get relieved from back ache, 100% get relieved from fainting, 
100% get relieved from Abdominal discomfort. 
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RESULTS OF STATISTICAL ANALYSIS: 
  
Seenalavana parpam is statiscally associated with relieving signs and symptoms of 
Soothagavali. 
PAIN RELIEVED BY HOUR: 
 
HOUR I CYCLE II CYCLE III CYCLE 
2hr 4(13.33%) 0 0 
1.5hr 6 (20%) 2 (6.67%) 0 
1hr 13(43.33%) 3 (10%) 5 (16.67%) 
0.5HR 7(23.33%) 20(66.67) 6 (20%) 
0 0 5(16.67%) 19(63.33%) 
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 At the first cycle an average of  66 minutes required for relieving pain and 31.8 
minutes for second cycle.  Which is statistically highly significant (P<0.0001) 
 At the second cycle an average of 31.8 minutes required for relieving pain and 16 
minutes for third cycle which statistically highly significant (P<0.0004) 
 At the  first cycle an average of 66 minutes required for relieving pain and 16 
minutes for third cycle.  Which is statistically highly significant (P<0.0001) 
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SEVERITY OF PAIN 
 
SEVERITY I CYCLE II CYCLE III`CYCLE 
Severe 8  (26.675) 0 0 
Moderate 19  (63.33%) 5  (16.67%) 1  (3.33%) 
Mild 3  (10%) 19  (63.33%) 8  (26.67%) 
No 0 6 (20%) 21  (70%) 
 
26.67
0 0
63.33
16.67
3.33
10
63.33
26.67
0
20
70
0
10
20
30
40
50
60
70
PER
C
EN
TA
G
E
SEVERE MODERATE MILD NO
SEVERITY
SEVERITY
1ST CY IIND CY III RD CY
 
 
1st  and 2nd cycle: There is significant difference between land 2nd cycle improvement 
on relieving pain (P<0.002) ie number  of patients with no symptom of pain at 1st cycle is 
zero, but at and cyle number of patients with no symptom of  pain at 1st cycle is zero, but at 
2nd cycle number  of patients with no pain is 20% (6/30). 
1st and 3rd cycle: 
There is significant difference between 1 and 3rd cycle improvement on relieving pain 
(P<0.001) ie. number of patients with no symptom of pain at 1st cycle is zero, but at 3rd cycle 
number of patients with no pain is 70% .(21/30)  
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.crap 
Nausea Vomit 
ting 
Back 
ache 
Fainting Abdomi
discom 
B
T
A
T 
1st 
cy 
2nd
cy 
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A
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BT AT BT AT B
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AT BT AT BT AT 
1. AG1377 Stella 26F M + - se mi no 1 1/2 - + - + - + - - - - - + - 
2. AG1404 Jeyanthi 25F UM + - mo mi mi 2 1 1 + - + - + - +  - - + - 
3. AG2429 Sangeetha 25F UM + - se mi no 1/2 1/2 - + - + - + - - - + - + - 
4. AG2599 Kamatchi 26F UM + - se mo no 1/2 1/2 - + - + - + - + - + - + - 
5. AG2906 Amutha 30F M + - mo mo mi 11/2 1/2 1/2 + - + - + - + - -- - + - 
6. AG4089 Ramu 27F M + - se mo mi 2 11/2 1 + - + - + - + - + - - - 
7. AG3832 Nagajothi 28F M + - mo mi no 1/2 1/2 - + - + - + - + - + - + - 
8. AG4190 Shakilabanu 23F UM + - mo mi no 1 1/2 - + - + - - - - - - - + - 
9. AG4230 Hemalatha 24F UM + - mo mi mi 1 1/2 1/2 + - + - - - + - + - + - 
10. AG4268 Loganayagi 30F M + - mo mi no 1 1/2 - + - - - - - + - + - + - 
11. AG4508 Manjari 26F UM + - mo mi no 11/2 1/2 - + - + - - - - - + - + - 
12. AG4509 Gladish 25F UM + - mo mi mi 1 1/2 1/2 + - + - - - - - + - + - 
13. AG4791 Selvi 40F M + - mo mi no 11/2 1/2 - + - + - + - + - - - + - 
14. AG4816 Geetha 26F UM + - se mi no 11/2 1 - + - + - - - + - + - + - 
15. AG4875 Kezia 38F M + + se mo mo 2 11/2 1/2 + + - - - - - - + - + - 
16. AG4918 Revathy 23F UM + - se mi no 11/2 1/2 - + - + - + - - - + - + - 
17. AG5237 Swapna 20F UM + - mo no no 1 - - + - - - - - - - + - + - 
18. AG5725 Chithra 22F UM + - mo mi no 1 1/2 - + - + - + - - - - - + - 
19. AG6312 Vaishnavi 20F UM + - mo mi mi 11/2 1/2 1/2 + - + - + - - - - - + - 
20. AG6456 Kajalakshmi 18F UM + - mi no no 1/2 1/2 - + - + - - - - - + - + - 
21. AG6436 Shanthi 23F UM + - mo mi no 1 1/2 - + - - - -- - - - + - + - 
22. AG7224 Vijayalakshmi 26F M + - mo mi no 1/2 - - + - + - + - - - + - - - 
23. AG7293 Malathy 40F M + - mi no no 1/2 - - + - + - - - + - - - + - 
24. AG7681 Bhuvaneswari 23F UM + - mi no no 1 - - + - + - - - + - + - + - 
25. AG8098 Maheswari 25F UM + - mo mi no 1 1/2 - + - + - + - + - + - + - 
26. AG3323 Sabana 20F UM + - se no no 1 1/2 - + - + - - - + - - - + - 
27. AG8828 Vennila 21F UM + - mo no no 1/2 - - + - + + - - - - - - + - 
28. AG9091 Sumathi 33F M + - mo mi mi 1 1/2 1/2 + - - - - - + - + - + - 
29. AG9212 Sudha 32F M + - mo mo mi 2 1 1 + - + - + - - - + - + - 
30. AG9326 Sunitha 24F UM + - mo mi no 1 1/2 - + - + - + - + - + - - - 
M  - Married,  UM -  Un married , SE – Severe, MO – Moderate, MI -  Mild. 
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LAB INVESTIGATION -  BEFORE TREATMENT -  SOOTHAGAVALI  
 
Sl 
No  
OPNO Hb 
mgm 
Blood ESR TRBC
millian 
B.T C.T B.C 
Hol 
Bu 
Rea 
B 
Cre 
Sugar Urine        Dep 
   TC 
Mi/cumm P% L% E% M% 1/2hr 1hr
Cu/mm Min/sec Min/sec Mg/dl Mg/dl Mg/dl F PP Alb Sug Pus Epi 
1. AG1377 12.0 9400 57 38 4 1 4 8 4.0 3 4/50 138 14 0.6 80 - Nil Nil 2-4 2-4 
2. AG1404 11.2 7200 50 45 5 - 11 22 3.2 3 4/20 180 23 0.6 - 78 Nil Nil 2-4 2-4 
3. AG2429 9.6 8600 53 40 6 1 5 12 3.2 2/40 4 193 27 0.8 78 - Nil Nil 1-2 1-2 
4. AG2599 12.6 6000 58 40 2 - 8 17 4.2 2/20 4/5 156 25 0.8  - Nil Nil 1-2 3-4 
5. AG2906 9.2 5500 50 40 8 2 13 27 3.2 2/40 4 205 35 0.8 61 128 Nil Nil 2-4 6-8 
6. AG4089 10.3 8200 54 40 4 2 13 28 3.4 2 4 133 23 0.8 96 84 Nil Nil 1-2 1-2 
7. AG3832 12.0 7800 55 40 4 - 13 28 4.1 3/10 5 207 15 0.8 - 73 Nil Nil 1-2 1-2 
8. AG4190 14.5 6500 54 44 2 - 5 11 4.6 2/10 4/15 185 18 0.8 65 63 Nil Nil 4-5 2-3 
9. AG4230 12.5 7800 56 38 1 - 12 24 4.2 2/40 4 193 20 0.8 - - Nil Nil Nil Nil 
10. AG4268 11.4 6400 50 46 4 - 11 22 3.2 2/20 4/10 160 23 0.8 77 120 Nil Nil 1-2 1-2 
11. AG4508 10.2 7500 52 40 6 - 5 10 3.4 2 4/20 138 18 0.8 80 - Nil Nil Nil Nil 
12. AG4509 8.8 5000 50 48 2 - 6 12 2.9 2/20 4/50 121 19 0.17 90 - Nil Nil Nil Nil 
13. AG4791 13.2 7200 50 47 2 - 6 12 4.8 2/30 4/15 123 14 0.8 68 - Nil Nil 3-4 2-3 
14. AG4816 12.8 6000 52 46 2 - 10 12 4.2 3 4/20 139 14 0.4 82 - Nil Nil 2-4 1-2 
15. AG4875 11.8 6700 50 45 - - 11 22 3.2 2/10 4 122 19 0.8 71 113 Nil Nil 2-4 2-4 
16. AG4918 11.0 6900 57 37 6 - 6 12 3.6 2/40 4 144 16 0.8 -- 99 Nil Nil 2-4 2-4 
17. AG5237 13.3 7000 55 44 1 - 3 6 4.5 2 4 135 16 0.8 - 83 Nil Nil 2-4 1-2 
18. AG5725 11.7 7800 56 39 1 - 12 24 3.9 2/40 4/40 140 16 0.16 - 83 Nil Nil 2-4 Nil 
19. AG6312 10.7 6500 50 47 3 - 11 22 3.5 2/30 4/15 208 20 0.7 - 78 Nil Nil 2-4 1-2 
20. AG6456 13.0 6000 50 48 2 - 11 22 4.3 2/20 4 196 19 0.8 - 8 Nil Nil Nil Nil 
21. AG6436 10.3 7200 60 38 2 - 10 18 3.5 2 3/40 135 13 0.8 74 87 Nil Nil 1-2 1-2 
22. AG7224 10.7 5200 53 46 1 - 4 8 3.5 3 4/40 125 12 0.8 - - Nil Nil Nil Nil 
23. AG7293 7.5 6800 54 40 4 - 10 22 2.3 2/10 4 186 30 0.9 68 60 Nil Nil 2-4 4-6 
24. AG7681 14.2 8300 50 46 4 - 5 10 4.0 2/40 4 167 16 0.5 - - Nil Nil Nil Nil 
25. AG8098 12.1 6300 58 40 2 2 11 22 4.0 2/20 3/50 168 15 0.5 96 86 Nil Nil 2-4 1-2 
26. AG3323 12.1 7200 58 40 2 - 5 12 3.9 2/30 4/15 149 21 0.7 - 149 Nil Nil Nil Nil 
27. AG8828 12.2 6400 53 41 4 2 8 16 3.8 2/30 4/15 153 23 0.6 - 90 Nil Nil 2-3 1-2 
28. AG9091 12.1 6500 50 47 3 - 7 14 4.0 2 4/30 196 150.4 0.14 - 88 Nil Nil Nil Nil 
29. AG9212 11.7 10000 65 28 6 - 9 14 3.7 2 4/15 178 180.7 0.17 - 91 Nil Nil 1-2 1-2 
30. AG9326 11.3 7200 50 45 05 - 11 22 3.2 2/10 4/15 153 230.6 0.16 - 85 Nil Nil Nil Nil 
 119
 
LAB INVESTIGATION -  AFTER TREATMENT -  SOOTHAGAVALI 
Sl 
No  
OPNO Hb 
mgm 
Blood ESR TRBC
millian 
B.T C.T B.c 
Hol 
Bu 
Rea 
B 
Cre 
Sugar Urine Dep 
   TC 
Mi/cumm P% 
Cu/mm E% M% 1/2hr 1hr Mg/% Min/sec Min/sec Mg/dl Mg/dl Mg/dl F PP Alb Sug Pus Epi 
1. AG1377 12.0 69000 56 33 6 - 4 8 9.5 8 4 159 37  7 3 Nil Nil 2-4 2-3 
2. AG1404 11.2 7200 50 45 5 - 11 22 3.2 3/20 4/40 180 23 0.6 - 78 Nil Nil Nil Nil 
3. AG2429 10.2 6900 58 36 6 - 12 24 3.3 2/40 3/50 172 34 0.7 - 115 Nil Nil Nil Nil 
4. AG2599 12.8 6000 58 4 1 - 8 10 3.2 2 4 163 18 0.6 61 98 Nil Nil Nil Nil 
5. AG2906 10.0 7900 54 42 4 - 10 20 3.3 3 4 153 24 0.8 - 105 Nil Nil Nil Nil 
6. AG4089 10.0 7400 54 42 4 - 22 44 2.6 2 4 173 29 0.6 - 107 Nil Nil 2-4 2-4 
7. AG3832 11.6 6300 54 40 4 - 11 22 3.4 3 5 154 23 0.7 90 - Nil Nil Nil Nil 
8. AG4190 14.5 6800 59 34 7 - 11 23 4.6 2 4 159 21 0.8 85 195 Nil Nil Nil Nil 
9. AG4230 11.8 6400 56 40 4 - 11 22 3.9 3 4 156 23 0.8 90 140 Nil Nil Nil Nil 
10. AG4268 8.0 6900 62 32 6 - 4 8 2.6 2/4 3/50 135 32 0.4 222 - Nil Nil 1-2 2-4 
11. AG4508 10.0 6200 60 34 6 - 6 12 3.4 2/4 2 149 22 0.5 - 91 Nil Nil Nil Nil 
12. AG4509 8.0 6900 62 32 6 - 4 8 2.6 3 4 135 32 0.4 222 - Nil Nil 1-2 2-4 
13. AG4791 11.0 7200 60 34 6 - 6 12 3.6 2/10 10 135 34 0.7 - 117 Nil Nil 1-2 2-3 
14. AG4816 8.5 7400 52 43 5 - 4 8 2.6 - 4 162 36 1.0 96 120 Nil Nil 1-2 2-2 
15. AG4875 12.0 6700 50 45 5 - 11 12 3.2 2/10 4 122 19 0.8 - 113 Nil Nil 1-2 1-2 
16. AG4918 11.0 6900 57 37 6 - 6 12 3.6 2/40 4 144 21 1.8 99 - Nil Nil Nil Nil 
17. AG5237 13.0 7800 55 43 2 - 6 12 4.0 2/4 2 148 30 1.0 - 88 Nil Nil Nil Nil 
18. AG5725 12.0 7600 50 46 4 - 11 22 - 3 5/10 156 18 0.5 70 - Nil Nil 1-2 1-2 
19. AG6312 11.0 7400 63 31 6 - 14 28 3.6 3 2/4 202 32 0.4 - 91 Nil Nil 6-7 4-6 
20. AG6456 13.2 7000 50 45 2 - 4 8 4.3 2/2 4 176 19 0.8 75 110 Nil Nil Nil Nil 
21. AG6436 10.0 6200 57 38 3 - 8 16 3.2 2/10 4 149 21 0.5 - 95 Nil Nil Nil Nil 
22. AG7224 9.0 6900 61 34 5 2 8 16 3.0 2 4/10 140 28 1.0 78 - Nil Nil Nil Nil 
23. AG7293 9.0 7900 61 34 5 - 8 16 3.0 2/10 4 172 19 0.5 - 89 Nil Nil Nil Nil 
24. AG7681 14.5 8300 50 45 5 - 4 9 4.3 2/30 4 168 16 0.8 - 111 Nil Nil 1-2 3-4 
25. AG8098 12.0 7000 50 47 2 - 4 9 3.6 2/45 4 172 24 0.7 96 112 Nil Nil 2-4 2-4 
26. AG3323 14.5 7900 - - - - 10 20 4.6 2 4/10 158 35 1.1 - 102 Nil Nil 2-4 2-4 
27. AG8828 12.4 6500 53 42 4 1 8 16 3.8 2/30 4/15 150 21 0.6 91 102 Nil Nil 2-4 1-2 
28. AG9091 11.6 7400 63 31 6 - 10 20 3.6 3 4 205 23 0.8 98 - Nil Nil 6-7 4-6 
29. AG9212 12.0 8200 61 31 8 - 22 44 - 2 4/10 170 22 1.0 97 - Nil Nil 4-6 8-10 
30. AG9326 11.4 7300 56 40 4 - 12 24 3.7 2 4/20 218 28 1.0 - 91 Nil Nil Nil Nil 
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DISCUSSION 
 
 The drug Seenalavana parpam has been selected to find its efficacy in the management of 
‘Soothgavali’. 
 The literary evidence from Kannuswami paramparai vaithiam text strongly supports the anti-
spasmodic activity, analgesic activity & muscle relaxant property of the drug. 
 Bio chemical analysis of the drug Seenalavana parpam reveals the presence of calcium, 
magnesium, zinc, chloride , alkaloids , sulphate and carbohydrate. 
Calcium: 
 Calcium may relieve cramping, backache & nervousness. Muscles need calcium  to maintain 
their normal muscle tone. 
Magnesium: 
 Magnesium may have a beneficial effect on both lower abdominal pain & low back pain. When 
taken a few days prior to menses and for the initial days of the period, It has  a direct muscle relaxant 
and vasodilatory effect. Magnesium also has the ability to lower the ‘bad’ prostaglandins that may be 
causing the womb to over contract. 
 Finally, along with vitamin B6, magnesium is required by our body to help convert the essential 
fats in to the beneficial prostoglandins. 
Zinc: 
 Zinc is important for eliminating period pains because it is needed for the proper conversion of 
essential fatty acids. 
Chloride: 
 Oxybutynin chloride exerts direct antispasmodic effect on smooth muscle and inhibits the 
muscarinic action of acetylcholine on smooth muscle. 
Sulphate: 
  Sulphates are the salts of sulphur. Sulphur is known as healing mineral. It aids every cell in the 
determination of toxic substance through agitation. Sulphur aids functions in enzyme reactions and is 
important in cellular respiration. Thus sulphur is  very essential in curing Dysmenorrhoea. 
 
Pharmacological study: 
 In the acute toxicity studies no mortality is occurred up  to the dose level of 4000mg/kg. It 
proves that the above drug is having wide safety margin.  
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Anti-spasmodic activity: 
 The results of recent studies at clinical level suggested the superiority of Seenalavana parpam as 
an antispasmodic  over non – narcotic spasmolyetics. The presents study on intestinal smooth muscle 
supports the above contention of antispasmodic activity of Seenalavana parpam. In moderate 
concentrations  Seenalavana parpam was found to block Ach-induced spasm in a dose dependent 
fashion. However, in higher concentration. Its effect was nonspecific. Seenalavana parpam at a lower 
concentration showed potentiation of antispasmodic activity completely abolished the Ach-induced 
contrations. Seenalavana parpam may prove to be very effective and useful antispasmodic preparation 
for intestinal and associated painful situations  in human beings. 
Analgesic activity: 
 The test drug treated animals elicited potential analgesic effect. The test drug Seenalavana 
parpam (400mg/kg.p.o) significantly reduced (P<0.05) the number of writhing episodes in treated mice. 
The comparison was made between Seenalavana parpam and paracetamol treatment animals. The 
analgesic effect shown by Seenalavana parpam were significantly different from that of standard drug 
paracetamol group indicating comparable activity at the dose used. The analgesic activity may there 
fore, be attributed to a combined action of different ingredients present in the Seenalavana parpam 
preparation.  
Muscle relaxant property: 
 The Seenalavana parpam at the dose level of 400mg/kg showed moderate muscle relaxant 
property when compound to standard drug diazepam at the dose of 400mg/kg. The percentage of 
activity was calculated as 25.77% for test drug and 60.18 for standard.  
Clinical assessment: 
 For the clinical study of Seelavana parpam in ‘Soothagavali’ 30 patients were selected.  
 According to age wise distribution 13.33% were in below 20 yrs, 40% were in 21-25 yrs, 30% 
were in 26-30yrs, 6.67% were in 31-35 years, 10% were in 36-40 yrs.  
 According to marital status 36.675 were in married, 63.33% were in unmarried.  
 From the clinical study 96.67% of patients get relieved from spasmodic abdominal pain, 96.67% 
get relieved from uterine cramping,100% get relieved from nausea,100% get relieved from vomitting, 
100% get relieved from back ache, 100% get relieved from fainting, 100% get relieved from abdominal 
discomfort.  
 
Pain relieved by hour: 
 At the first cycle an average of 66 minutes required for relieved pain and 16 minutes for third 
cycle. Which statistically highly significant. (P<0.00001). 
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Severity of pain:  
 There is a significant difference between 1st and 3rd cycle improvment of pain (P<0.001) i.e  
Number of patients with no symptom as pain at 1st cycle is  Number of patients with no pain in 70% 
(21/30). 
 From the clinical, pharmacological and statistical analysis, it is proved that the drug Seenalavana 
parpam is statistically significant.  
 No adverse effect had been observed during the course of treatment .  
In siddha aspect: 
 According to siddha pathology Soothagavali is caused due to derangement of vatha kutram.  
  
“thj Nkypl;lhy; kJuk; GspAg;G 
 NrjKwr; nra;Ak; rpiwAk; - Xjf;Nfs; 
 fhue; JtHfrg;G fhl;LQ; Ritnay;yhk; 
 rhug; ghpfhuQ; rhw;W” 
    - fz;Zrhkpak; 
 
 The drug Seenalavana parpam has predominantly uppu, inippu and pulippu suvai. As these, 
three suvai helps in neutralizing the elevated vali kutram. The drug Seenalavana parpam containing 
uppu, inippu and pulippu suvai will definitely helps to give relief from Soothagavali, which is caused by 
elevated valikutram.  
 
 Also, the palm jaggery (vehicle) has the properties of neutralizing the attained vatham, pitham 
and kabam. So it can be given as the vehicle to all the vatha, pitha & kapha diseases.  
 
 All the above studies showed that Seenalavana parpam was efficacious in Soothagavali.  
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SUMMARY 
 The drug Seenalavana parpam has been selected for this study to evaluate its efficacy in the 
management of “Soothagavali’. 
 
 The literature evidences strongly supports the anti-spasmodic activity  analgesic activity & 
muscle relaxant property of Seenalavana parpam  in the management of ‘Soothagavali’. 
 
 Bio-chemical analysis of the drug reveals the presence of calcium, magnesium, zinc, chloride, 
alkaloids  sulphate and carbohydrate. 
 
 The acute toxicity study shows  that the drug is very safe and no significant adverse effects up to 
dose level of 4000mg/kg. 
 
 Pharmacological studies showed that the Seenalavana parpam has  significant anti-spasmodic 
activity, analgesic activity and  muscle relaxant property at the dose level of 4000mg/kg. 
  
 From the clinical study, the drug Seenalavana parpam is more effective in ‘Soothagavali’. 
 
 The ingredients of the drug Seenalavana parpam is easily available and the method of 
preparation is easy and most effective.  
 
 
CONCLUSION 
 
 From the pharmacological and clinical studies it is concluded that the drug Seenalavana parpam 
is found to be an effective drug for “Soothagavali’.   
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A CLINICAL TRIAL OF SIDDHA DRUG VILAMPISIN CHOORNAM 
FOR THE TREATMENT OF VELLAI NOI ( LEUCORRHOEA ) 
                                                                  - A PILOT STUDY 
FORM-I   SELECTION PROFORMA 
 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________ 3. S.No: ________    
 
4. Name: ________________ 5. Age (years):        6. Nationality: _______________ 
 
7. Religion:  ____________8. Occupation: ____________ 9.Income: ______________ 
 
10. Address:  
  
                                                              
11. Complaints and duration:  
 
 
 
12. History of present illness:  
 
  
13. Past history:  
 
 
14. Family history:  
 
 
15. Menstrual & Obstetric history:  
 
 
    
 
Habits                                                                      Yes ( 1 )         No ( 2 ) 
  
 
16. Betalnut chewer                                     
 
17. Tea                  
 
18. Coffee              
 
19. Milk   
                   
20. Non-vegetarian  
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GENERAL EXAMINATION   
                                                         
21. Built:          Normosthenic           Hypersthenic           Hyposthenic 
 
22. Nutrition:    Normal         Overweight           Underweight  
 
 
23. Weight (kg)                                                    
      
24. Temperature (°F)        . 
  
25. Pulse rate / minute                                        
 
26. Heart rate / minute        
 
27. Respiratory rate / minute                             
   
28. Blood pressure (mmHg)                              /       / 
 
                                                      1. Yes                   2. No 
29. Pallor                                 
 
30. Jaundice                       
 
31. Cyanosis 
           
32. Lymphadenopathy 
  
33. Pedal oedema  
  
34. Clubbing                                
 
35. Jugular vein pulsation            
    
VITAL ORGANS EXAMINATION 
 
                                    1. Normal            2. Affected 
36. Heart                                                                    _________________ 
 
37. Lungs                                                                   _________________ 
 
38. Brain                                           ________________ 
 
39. Liver              ________________ 
                  
40. Kidney                                                              ________________ 
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41. Spleen                           __________________ 
 
42. Stomach                                     __________________ 
 
CLINICAL EXAMINATION 
 
     SIGNS AND SYMPTOMS            
 
   1. Yes                  2.No 
 
43. White discharge  
          
44. Pruritis vulva                                                                                                                
    
45. Dysuria    
 
46. Lower abdominal pain 
 
47. Low back pain 
 
     PER VAGINA 
 
     VAGINAL DISCHARGE 
   
48. Colour                 1. Yellow               2. Green                 3. White 
 
49. Consistency         1. Thin                   2. Thick                 3. Creamy 
 
50. Amount               1. Mild                   2. Moderate     3     3. Profuse 
 
     1. Yes                        2.No 
   
51. Odour 
 
52. Inflammation of vulva 
 
53. Tenderness 
 
SIDDHA SYSTEM OF EXAMINATON 
 
      IYMPORI 
                                      1. Normal        2. Affected 
  
54. Mei             _____________________ 
 
55. Vaai                    ______________________ 
 
56. Kan              _____________________ 
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57. Mookku                        _____________________ 
 
58. Sevi                              _____________________ 
  
KANMENTHIRIUM    
  
59. Kai              _____________________ 
 
60. Kaal        _____________________ 
 
61. Vaai        _____________________ 
 
62. Eruvai        ____________________ 
 
63. Karuvaai        _____________________ 
 
PARUVA  KAALAM 
 
      64. Kaar kaalam         65.Koothir kaalam                
  
     66. Elavenil kaalam          67. Muthuvenil kaalam 
  
   68. Munpani kaalam        69. Pinpani kaalam     
 
THINAI 
 
      70. Kurunji          71. Mullai             72. Marutham     
 
      73. Neithal            74. Paalai 
      
 
YAKKAI 
  75. Vali                76. Azhal           77. Iyam     
  
    78. Valiazhal     79. Valiaiyam           80. Azhalvali   
    
  81. Azhaliyam   82. Iyavali           83. Iyaazhal  
  
 GUNAM 
    84. Sathuva gunam                  85. Rajo gunam              
 
    86. Tamo gunam 
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UYIR THATHUKKAL      
 VALI     
                                        1. Normal       2. Affected 
87. Pranan                                        ____________________ 
 
 
88. Abanan                                        _____________________ 
 
89. Samanan                                         ____________________ 
 
90. Udhanan                                        _____________________ 
 
91. Viyanan                                        _____________________ 
 
92. Nagan                                        _____________________ 
 
93. Koorman                                         ____________________ 
 
94. Kirukaran                                       _____________________ 
 
95. Devathathan                                    ______________________ 
 
96. Tananjeyan                  _____________________ 
  
    
 AZHAL 
                                     1. Normal          2. Affected 
 
97. Anala pittham            ____________________ 
 
98. Prasaka pittham             __________________ 
 
99. Ranjaka pittham                       ______________________ 
 
100. Aalosaka pittham               ______________________ 
 
101. Saathaka pittham                ______________________  
      
 IYAM 
                                     1. Normal          2. Affected                                     
 
102. Avalambagam          ______________________ 
 
103. Kilethagam                                                         _____________________  
 104. 
Pothagam                          ______________________ 
 
105. Tharpagam                _______________________     
 
107. Santhigam          ______________________ 
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 UDAL THATHUKKAL 
                                     
      1. Normal         2. Affected 
108. Saaram                      _______________________ 
  
109. Chenneer                                                         _______________________ 
 
110. Oon                              _____________________ 
 
111. Kozhuppu                    _______________________ 
 
112. Enbu                       _______________________ 
 
113. Moolai                                      _______________________ 
 
114. Suronitham         _______________________ 
         
 
  ENVAGAI THERVUKAL 
 
                                    1. Normal        2. Affected 
115. Naa                                          _____________________ 
 
116. Niram                                      _____________________ 
 
117. Mozhi                               _____________________ 
 
118. Vizhi                                                            ______________________   
               
    
Malam        1. Normal       2. Affected     
 
119. Niram                  ______________________ 
 
120. Thanmai                  ______________________ 
    
Moothiram          
Neerkuri   
 
121. Niram                         ______________________ 
 
122. Eadai                                       _____________________ 
                                
123. Manam                            ______________________  
 
124. Nurai                         ______________________ 
 
125. Enjal                               ______________________ 
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Neikuri:  126.Vali                        127. Azhal                    128. Iyam      
 
 
Naadi:    129. Vali             130. Azhal                 131. Iyam          
  
     132. Valiazhal                 133. Valiiyam              134. Azhalvali   
  
     135. Azhaliyam               136. Iyavali                 137. Iyaazhal    
    
Sparisam:       138. Mithaveppam         139. Miguveppam         
                    
 140. Thatpam 
 
INVESTIGATION        
BLOOD 
 
141. TC (cells /cumm): 
 
142. DC (%):    1. P                   2. L                    3. E                      4. B                  
 
  5. M                       
 
143. Hb (gms %):                  . 
 
144. ESR (mm/hr):        1. 1/2hr                           2.1hr 
 
145. Blood Sugar (R) (mg %): 
 
146. Blood Urea (mg %): 
 
147. Serum Creatinine (mg %):              .  . 
  
148. Serum Cholesterol (mg %): 
 
149. VDRL                                  1.  Positive             2.  Negative 
 
 
URINE 
 
150. Albumin:      0. Nil  1. Trace  2. +  3. + + 
  
    4. + + +                                                                                       
151. Sugar:            0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
 
 
 
 
152. Deposit                           1. Yes          2. No 
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1. Pus cells                       
 
2. Epithelial cells             
 
3.. RBC                               
 
4.. Crystals                             
  
 MOTION                         
                                      1. Yes         2.No    
153. Ova                           
 
154. Cyst                           
 
155. Occult blood              
 
 
  VAGINAL SWAB 
 
 
 
VAGINAL PH______________________________________ 
 
156. ADMITTED TO TRIAL:     1.Yes          2. No   
 
If yes   
 
157. S. No:    
                 
158. I.P / O.P       1. I.P        2. O.P  
 
159. Drug issued for OP patient (g): 
 
 
 
 Station                                            Signature of Investigator 
 
 
 Date                                               Signature of Medical Officer 
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A  PILOT OPEN CLINICAL TRIAL OF VILAMPISIN CHOORNAM  FOR THE 
TREATMENT OF VELLAI NOI ( LEUCORRHOEA ) 
 
FORM II-ASSESSMENT PERFORMA 
 
1. OP/IP No:_________________              2.BED No:_______3.S.No:_______________ 
 
4. NAME:__________________________ 
 
5. DATE OF ADMISSION: 
 
6. DATE OF ASSESSMENT: 
 
7. DAY OF ASSESSMENT: 
 
 
CLINICAL EXAMINATION 
 
     SIGNS AND SYMPTOMS 
            
 
   1. Yes                  2.No 
 
8. White discharge  
          
9. Pruritis vulva                                                                                                                
    
10. Dysuria    
 
11. Lower abdominal pain 
 
12. Low back pain 
 
 
     PER VAGINA 
 
     VAGINAL DISCHARGE 
   
13. Colour                 1. Yellow               2. Green                 3. White 
 
14. Consistency         1. Thin                   2. Thick                 3. Creamy 
 
15. Amount               1. Mild                   2. Moderate     3     3. Profuse 
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     1. Yes                        2.No 
   
16. Odour 
 
17. Inflammation of vulva 
 
18. Tenderness 
 
  ENVAGAI THERVUKAL 
                                    1. Normal        2. Affected 
19. Naa                                          _____________________ 
 
20. Niram                                      _____________________ 
 
21. Mozhi                               _____________________ 
 
22. Vizhi                                                            ______________________   
          
Malam        1. Normal       2. Affected     
 
23. Niram                  ______________________ 
 
24. Thanmai                  ______________________ 
    
Moothiram    
         
Neerkuri   
 
25. Niram                         ______________________ 
 
26. Eadai                                               _____________________ 
                                
27. Manam                            ______________________  
 
28. Nurai                         ______________________ 
 
29. Enjal                               ______________________ 
 
 
Neikuri:  30.Vali                            31. Azhal                       32. Iyam      
 
 
Naadi:    33. Vali                    34. Azhal                 35. Iyam          
  
     36. Valiazhal                 37. Valiiyam              38. Azhalvali   
 
  
     39. Azhaliyam               40. Iyavali                 41. Iyaazhal    
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Sparisam:       42. Mithaveppam         43. Miguveppam         
                    
 44. Thatpam 
 
INVESTIGATION ( ONLY ON THE DAY 24 ) 
 
BLOOD 
 
45. TC (cells /cumm): 
 
46. DC (%):    1. P                   2. L                    3. E                      4. B                  
 
  5. M                       
 
47. Hb (gms %):                  . 
 
48. ESR (mm/hr):        1. 1/2hr                           2.1hr 
 
49. Blood Sugar (R) (mg %): 
 
50. Blood Urea (mg %): 
 
51. Serum Creatinine (mg %):              .  . 
  
52. Serum Cholesterol (mg %): 
 
53. VDRL                                  1.  Positive             2.  Negative 
 
 
 
 
URINE 
 
54. Albumin:      0. Nil  1. Trace  2. +  3. + + 
  
    4. + + +    
                                                                                                                                      
55. Sugar:            0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
 
 
56. Deposit                           1. Yes          2. No 
 
1. Pus cells                       
 
2. Epithelial cells             
 
3.. RBC     
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4.. Crystals                             
  
 MOTION                         
                                      1. Yes         2.No    
57. Ova                           
 
58. Cyst                           
 
59. Occult blood              
 
 
VAGINAL SWAB 
 
 
 
 
60. RESULT:            Cured                         Improved                       No change 
 
FOR O.P.PATIENTS: 
 
61. Drugs returned: 
    1. No of packs:……………..   
 
 
 
 
 
62. Date: 
 
63. Station:                                                                                   Signature of Doctor 
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A CLINICAL TRIAL OF SIDDHA DRUG VILAMPISIN CHOORANAM  
FOR THE TREATMENT OF VELLAI NOI 
( LEUCORRHOEA) 
- A PILOT STUDY 
 
                                                     CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               
by the patient. 
 
Date: _____________ 
                                                            Signature: ________________ 
Station: ___________ 
                                                            Name: ____________________ 
 
                                              
                                                   CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of the drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 
  I, exercising my free power of choice, hereby give my consent to be included as a subject 
     in the clinical trial of Vilampisin chooranam on Vellai noi 
 
  Date: _____________                                            
                                                                Signature: _________________ 
  
 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
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A CLINICAL TRIAL OF SIDDHA DRUG SEENALAVANA PARPAM 
FORTHE TREATMENT OF SOOTHAGAVALI 
( DYSMENORRHOEA ) 
                                                 - A PILOT STUDY 
FORM-I   SELECTION PROFORMA 
 
 
1. O.P.No / I.P No:  ________ 2.  Bed No: ________        3. S.No: ________    
 
4. Name: ________________ 5. Age (years):             6. Religion: ____________ 
 
 
7. Nationality: ___________   8. Occupation: ___________9. Income: ____________ 
 
10. Address:  
  
 
                                                              
11. Complaints and duration:  
 
 
 
12. History of present illness:  
 
  
11. Past history:  
 
 
13. Family history:  
 
 
14. Menstrual & Obstetric history:  
 
 
    
Habits                                                                    Yes ( 1 )         No ( 2 ) 
 
15. Betalnut chewer:                                      
 
16. Tea:                    
 
17. Coffee:              
 
18. Milk:    
                   
19. Non-vegetarian: 
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GENERAL EXAMINATION 
 
20. Built:                            1.  Normosthenic          2. Hypersthenic          3.Hyposthenic 
 
21. Nutrition:                     1.  Normal                     2. Overweight             3.Underweight 
                                          
22. Weight (kg):                                                    
        
23. Temperature (°F):        . 
  
24. Pulse rate / minute:                                          
 
25. Heart rate / minute:        
 
26. Respiratory rate / minute:                              
   
27. Blood pressure (mmHg):                               /       / 
 
                                                      1. Yes                   2. No 
28. Pallor:                                 
 
29. Jaundice:                       
 
30. Cyanosis:  
           
31. Lymphadenopathy:  
  
32. Pedal oedema:  
  
33. Clubbing:                                
 
34. Jugular vein pulsation:            
 
    
 
  VITAL ORGANS EXAMINATION 
 
                                        1. Normal         2. Affected 
35. Heart                                                                    _________________ 
 
36. Lungs                                                                   _________________ 
 
37. Brain                                           ________________ 
 
38. Liver              ________________ 
 
39. Kidney                                   ________________ 
 
40. Spleen                           __________________ 
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41. Stomach                               __________________ 
 
42. Uterus                                                                    __________________ 
 
     CLINICAL EXAMINATION 
 
     SIGNS AND SYMPTOMS 
 
43. Spasmodic abdominal pain               1. No      2. Yes 
 
44. Severity:   0. NA        1. Mild    2.  Moderate  
 
              3. Severe 
  
    1. Yes                  2.No 
 
45. Uterine cramping:    
 
46. Nausea: 
 
47. Vomiting: 
   
48. Backache: 
 
49. Fainting: 
 
50. Abdominal discomfort: 
     
  SIDDHA SYSTEM OF EXAMINATON 
 
      IYMPORI 
                                      1. Normal        2. Affected 
  
51. Mei             _____________________ 
 
52. Vaai                    ______________________ 
 
53. Kan              _____________________ 
 
54. Mookku                        _____________________ 
 
55. Sevi                              _____________________ 
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KANMENTHIRIUM  
   
  
56. Kai              _____________________ 
 
57. Kaal       _____________________ 
 
58. Vaai        _____________________ 
 
59. Eruvai        ____________________ 
 
60. Karuvaai        _____________________ 
 
PARUVA  KAALAM 
 
 
     61. Kaar kaalam          62.Koothir kaalam 
  
     63. Elavenil kaalam          64. Muthuvenil kaalam 
  
   65. Munpani kaalam         66. Pinpani kaalam     
 
THINAI 
 
      67. Kurunji           68. Mullai             69. Marutham     
 
      70. Neithal            71. Palai 
      
 
YAKKAI 
  72. Vali                73. Azhal          74. Iyam     
  
    75. Valiazhal     76. Valiaiyam          77. Azhalvali   
    
  78. Azhaliyam   79. Iyavali           80. Iyaazhal  
  
 GUNAM 
 
    81. Sathuva gunam                  82. Rajo gunam         
 
    83. Tamo gunam 
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UYIR THATHUKKAL 
      
 VALI     
                                        1. Normal       2. Affected 
 
84. Pranan                                        ____________________ 
 
85. Abanan                                        _____________________ 
 
86. Samanan                                         ____________________ 
 
87. Udhanan                                        _____________________ 
 
88. Viyanan                                        _____________________ 
 
89. Nagan                                        _____________________ 
 
90. Koorman                                         ____________________ 
 
91. Kirukaran                                       _____________________ 
 
92. Devathathan                                    ______________________ 
 
93. Tananjeyan                  _____________________ 
  
    
 AZHAL 
                                     1. Normal          2. Affected 
 
94. Anala pittham            ____________________ 
 
95. Prasaka pittham            __________________ 
 
96. Ranjaka pittham                       ______________________ 
 
97. Aalosaka pittham                     ______________________ 
 
98. Saathaka pittham                 ______________________  
      
 IYAM 
                                     1. Normal          2. Affected                                     
 
99. Avalambagam          ______________________ 
 
100. Kilethagam                                                         _____________________  
 
101. Pothagam                         ______________________ 
 
102. Tharpagam                _______________________     
 
103. Santhigam          ______________________ 
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 UDAL THATHUKKAL 
                                     
      1. Normal         2. Affected 
104. Saaram                      _______________________ 
  
105. Chenneer                                                         _______________________ 
 
106. Oon                              _____________________ 
 
107. Kozhuppu                    _______________________ 
 
108. Enbu                       _______________________ 
 
109. Moolai                                      _______________________ 
 
110. Suronitham         _______________________ 
         
 
  ENVAGAI THERVUKAL 
 
                                    1. Normal        2. Affected 
111. Naa                                          _____________________ 
 
112. Niram                                      _____________________ 
 
113. Mozhi                               _____________________ 
 
114. Vizhi                               ______________________   
 
Malam        1. Normal       2. Affected     
 
115. Niram                  ______________________ 
 
116. Thanmai                  ______________________ 
    
Moothiram    
         
Neerkuri   
 
117. Niram                         ______________________ 
 
118. Eadai                                       _____________________ 
                                
119. Manam                            ______________________  
 
120. Nurai                         ______________________ 
 
121. Enjal                               ______________________ 
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Neikuri:  122.Vali                        123. Azhal                    124. Iyam   
 
 
Naadi:    125. Vali             126. Azhal                 127. Iyam         
   
     128. Valiazhal                 129. Valiiyam              130. Azhalvali   
  
     131. Azhaliyam               132. Iyavali                 133. Iyaazhal    
    
Sparisam:       134. Mithaveppam         135. Miguveppam         
                    
 136. Thatpam 
 
INVESTIGATION 
        
BLOOD 
 
137. TC (cells /cumm): 
 
138. DC (%):    1. P                   2. L                    3. E                      4. B                  
 
  5. M                       
 
139. Hb (gms %):                  . 
 
140. ESR (mm/hr):        1. 1/2hr                           2.1hr 
 
141. Blood Sugar (R) (mg %): 
 
142. Blood Urea (mg %): 
 
143. Serum Creatinine (mg %):              .  . 
  
144. Serum Cholesterol (mg %): 
 
 
 
 
URINE 
 
145. Albumin:      0. Nil  1. Trace  2. +  3. + + 
  
    4. + + +    
                                                                                                                              
146. Sugar:            0. Nil  1. Trace  2. +   3. + +         
 
      4. +          
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Deposit                                1. Yes          2. No 
 
147. Pus cells                       
 
148. Epithelial cells            
 
149. RBC                               
 
150. Crystals                             
  
 MOTION                         
                                      1. Yes         2.No    
151. Ova                           
 
152. Cyst                           
 
153. Occult blood              
 
ULTRA SONOGRAPHY:                       
 
 
 
 
154. ADMITTED TO TRIAL:     1.Yes          2. No   
 
If yes   
 
155. S. No:    
                 
156. I.P / O.P       1. I.P        2. O.P  
 
157. Drug issued for OP patient (g): 
 
 
158. Station                                      159. Signature of investigator 
 
                                               
 160. Date:                                        161.   Signature of Medical Officer 
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AN  OPEN CLINICAL TRIAL OF SEENALAVANA PARPAM  FOR THE 
TREATMENT OF SOOTHAGAVALI ( DYSMENORRHOEA ) 
- A PILOT STUDY 
 
FORM II-ASSESSMENT PERFORMA 
 
1. OP No: _______  2.Name: ___________________            3.S.No:_______________                    
 
4. DATE OF START OF TRIAL:  
              
5. DATE OF ASSESSMENT: 
 
6. MONTH OF ASSESSMENT: 
 
 
CLINICAL EXAMINATION 
 
  SIGNS AND SYMPTOMS 
            
7. Spasmodic abdominal pain               1. No           2. Yes 
 
8. Severity:   0. NA          1. Mild         2.  Moderate  
 
              3. Severe 
 
9.Pain relieved in hour:   ½              1               11/2               2 
 
 
   1. Yes                  2.No 
 
10. Uterine cramping:    
 
11. Nausea: 
 
12. Vomiting: 
   
13. Backache: 
 
14. Fainting: 
 
15. Abdominal discomfort: 
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  ENVAGAI THERVUKAL 
                                    1. Normal        2. Affected 
16. Naa                                          _____________________ 
 
17. Niram                                      _____________________ 
 
18. Mozhi                               _____________________ 
 
19. Vizhi                                                            ______________________   
          
Malam        1. Normal       2. Affected     
 
20. Niram                  ______________________ 
 
21. Thanmai                  ______________________ 
    
Moothiram    
         
Neerkuri   
 
22. Niram                         ______________________ 
 
23. Eadai                                               _____________________ 
                                
24 Manam                            ______________________  
 
25. Nurai                         ______________________ 
 
26. Enjal                               ______________________ 
 
 
Neikuri:  27.Vali                            28. Azhal                       29. Iyam      
 
 
Naadi:    30. Vali                    31. Azhal                 32. Iyam         
   
     33. Valiazhal                 34. Valiiyam                 35. Azhalvali   
  
     36. Azhaliyam               37. Iyavali                   38. Iyaazhal    
    
Sparisam:       39. Mithaveppam         40. Miguveppam         
                    
 41. Thatpam 
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INVESTIGATION ( ONLY ON THE MONTH 3 ) 
 
BLOOD 
 
42. TC (cells /cumm): 
 
43. DC (%):    1. P                   2. L                    3. E                      4. B                  
 
  5. M                       
 
44. Hb (gms %):                  . 
 
45. ESR (mm/hr):        1. 1/2hr                           2.1hr 
 
46. Blood Sugar (R) (mg %): 
 
47. Blood Urea (mg %): 
 
48. Serum Creatinine (mg %):              .  . 
  
49. Serum Cholesterol (mg %): 
 
50. VDRL                                  1.  Positive             2.  Negative 
 
 
 
 
URINE 
 
51. Albumin:      0. Nil  1. Trace  2. +  3. + + 
  
    4. + + +    
                                                                                                                             
52. Sugar:            0. Nil  1. Trace  2. +   3. + +         
 
      4. + + + 
 
 
53. Deposit                           1. Yes          2. No 
 
1. Pus cells                       
 
2. Epithelial cells             
 
3.. RBC                               
 
4.. Crystals                             
  
 
 
 
 153
 
 
 MOTION                         
                                  
                                                1. Yes         2.No  
   
54. Ova                           
 
55. Cyst                           
 
56. Occult blood              
 
57. RESULT:            Cured                         Improved                       No change 
 
FOR O.P. PATIENTS: 
 
58. Drugs returned: 
 
    1. No of packs:……………..   
 
 
 
 
 
59. Date:                                                                                      Signature of investigator 
 
 
60. Station:                                                                                   Signature of Doctor 
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A CLINICAL TRIAL OF SIDDHA DRUG SEENALAVANA PARPAM  
FOR THE TREATMENT OF SOOTHAGAVALI 
( DYSMENORRHOEA ) 
- A PILOT STUDY 
 
                                                        CONSENT FORM 
 
CERTIFICATE BY INVESTIGATOR 
 
 I certify that I have disclosed all details about the study in the terms readily understood               
by the patient. 
 
Date: _____________ 
                                                            Signature: ________________ 
Station: ___________ 
                                                            Name: ____________________ 
 
                                              
                                                   CONSENT BY PATIENT 
 
  I have been informed to my satisfaction, by the attending physician, the purpose of the 
clinical trial, and the nature of the drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my body functions. 
 
  I, exercising my free power of choice, hereby give my consent to be included as a subject in 
the clinical trial of Seenalavana parpam on Soothagavali. 
 
  Date: _____________                                            
                                                                Signature: _________________ 
  
 Station: _____________                        Name: _____________________ 
 
                                                                Signature of witness: _____________ 
 
 
 Date: ____________                             Name: ___________________   
   
 Station:  ___________                          Relationship: _________________ 
     
 
 
 
ANTISPASMODIC ACTIVITY OF SEENALAVANA PARPAM USING GUINEA PIG ILEUM 
 
 
 
